Back to GetFilings.com
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-K
|
|
|
þ
|
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the fiscal year ended November 30, 2004 |
|
or |
|
o
|
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 |
|
|
|
For the transition period
from to . |
Commission file number 1-1520
GenCorp Inc.
(Exact name of registrant as specified in its charter)
|
|
|
Ohio
|
|
34-0244000 |
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification No.) |
|
Highway 50 and Aerojet Road |
|
95742 |
Rancho Cordova, California |
|
(Zip Code) |
(Address of principal executive offices) |
|
|
|
P.O. Box 537012 |
|
95853-7012 |
Sacramento, California |
|
(Zip Code) |
(Mailing address) |
|
|
Registrants telephone number, including area code
(916) 355-4000
Securities registered pursuant to Section 12(b) of the
Act:
|
|
|
Title of each class |
|
Name of each exchange on which registered |
|
|
|
Common stock, par value of $0.10 per share
|
|
New York Stock Exchange and
Chicago Stock Exchange |
Securities registered pursuant to Section 12(g) of the
Act:
None
Indicate by check mark whether the registrant (1) has filed
all reports required to be filed by Section 13 or 15(d) of
the Securities Exchange Act of 1934 during the preceding
12 months (or for such shorter period that the registrant
was required to file such reports), and (2) has been
subject to such filing requirements for the past
90 days. Yes þ No o
Indicate by check mark if disclosure of delinquent filers
pursuant to Item 405 of Regulation S-K (§229.405
of this chapter) is not contained herein, and will not be
contained, to the best of the registrants knowledge, in
definitive proxy or information statements incorporated by
reference in Part III of this Form 10-K or any
amendment to this
Form 10-K. þ
Indicate by check mark whether the registrant is an accelerated
filer (as defined in Rule 12b-2 of the
Act). Yes þ No o
The aggregate market value of the voting common equity held by
nonaffiliates of the registrant as of May 28, 2004 was
approximately $503 million.
As of January 31, 2005, there were 54,519,818 outstanding
shares of the Companys Common Stock, $0.10 par value.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the 2005 Proxy Statement of GenCorp Inc. relating to
its annual meeting of shareholders scheduled to be held on
March 30, 2005 are incorporated by reference into
Part III of this Report.
GENCORP INC.
Annual Report on Form 10-K
For the Fiscal Year Ended November 30, 2004
Table of Contents
|
|
* |
The information called for by Items 10, 11, 12, 13
and 14, to the extent not included in this document, is
incorporated herein by reference to the information to be
included under the captions Election of Directors,
Section 16(a) Beneficial Ownership Reporting
Compliance, Board Committees, Executive
Compensation, Director Compensation,
Employment Contracts and Termination of Employment and
Change in Control Arrangements, Compensation
Committee Interlocks and Insider Participation,
Report of the Organization and Compensation Committee of
the Board of Directors on Executive Compensation,
Performance Graph, Security Ownership of
Officers and Directors, and Ratification of
Registered Public Accounting Firm, in GenCorp Inc.s
2005 Proxy Statement, which is expected to be filed by
February 28, 2005. |
1
PART I
Item 1. Business
Unless otherwise indicated or required by the context, as
used in this Annual Report on Form 10-K, the terms
we, our and us refer to
GenCorp Inc. and all of its subsidiaries that are consolidated
in conformity with accounting principles generally accepted in
the United States.
We are a technology-based manufacturer operating primarily in
the United States. Our continuing operations are organized into
two segments:
Aerospace and Defense includes the operations
of Aerojet-General Corporation, or Aerojet, which develops and
manufactures propulsion systems for defense and space
applications, armament systems for precision tactical weapon
systems and munitions applications. We are one of the largest
providers of both liquid and solid propulsion systems in the
United States. Primary customers served include major prime
contractors to the United States (U.S.) government, the
Department of Defense (DoD), and the National Aeronautics and
Space Administration (NASA).
Real Estate includes activities related to
the development, sale, and leasing of our real estate assets.
Through our Aerojet subsidiary, we own approximately 12,600
acres of land adjacent to U.S. Highway 50 between Rancho Cordova
and Folsom, California just east of Sacramento, which we refer
to as the Sacramento Land. We are currently in the process of
seeking zoning changes and other governmental approvals to allow
the development of a portion of the Sacramento Land to optimize
its value. We have filed applications with governmental and
regulatory authorities for approvals necessary to develop over
5,800 acres of the Sacramento Land.
During the second quarter of fiscal 2004, we announced plans to
sell our GDX Automotive (GDX) business which developed and
manufactured vehicle sealing systems for automotive original
equipment manufacturers. This decision was a result of declining
volumes and continued challenges in this market environment
including adverse customer pricing pressures, increased material
costs, high development and start-up costs and increased working
capital requirements. In accordance with our plan to sell the
GDX business, we classified our GDX business segment as a
discontinued operation during the second quarter of fiscal 2004.
During the third quarter of fiscal 2004, we completed the sale
of GDX to Cerberus Capital Management, L.P. for
$147 million, subject to adjustment, of which
$140 million had been received as of November 30,
2004. In addition, on October 15, 2004, we announced our
strategic decision to sell our Fine Chemicals business, which,
through Aerojet Fine Chemicals, is a custom manufacturer of
active pharmaceutical ingredients and registered intermediates
for pharmaceutical and biotechnology companies. This plan was a
result of managements decision to focus our capital and
resources on our Aerospace and Defense and Real Estate
businesses. We will continue to operate our Fine Chemicals
business in the ordinary course of business pending any sale. We
classified our Fine Chemicals business segment as a discontinued
operation as of the third quarter of fiscal 2004.
We were incorporated in Ohio in 1915 and our principal executive
offices are located at Highway 50 and Aerojet Road, Rancho
Cordova, CA 95670. Our mailing address is P.O. Box 537012,
Sacramento, CA 95853-7012 and our telephone number is
916-355-4000.
Our Internet web site address is www.GenCorp.com. We have made
available through our Internet web site, free of charge, our
Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, Current Reports on Form 8-K and amendments
to those reports filed or furnished pursuant to
Section 13(a) or 15(d) of the Exchange Act as soon as
reasonably practicable after such materials are electronically
filed with, or furnished to, the Securities and Exchange
Commission (SEC). We also make available on our Internet web
site our corporate governance guidelines and the charters for
each of the following committees of the Companys Board of
Directors: Audit; Corporate Governance and Nominating; Finance;
and Organization & Compensation. Our corporate governance
guidelines and such charters are also available in print to any
shareholder who requests them.
2
Our fiscal year ends on November 30 of each year. When we
refer to a fiscal year, such as fiscal 2004, we are referring to
the fiscal year ended on November 30 of that year.
Aerospace and Defense
For over 60 years, Aerojet has been an industry leader and
pioneer in the development of critical products and technologies
that have strengthened the U.S. military and enabled the
exploration of space. Aerojet focuses on creating military
defense systems, as well as military, civil and commercial space
systems, that address the needs of two broad industry sectors:
defense systems and space systems. Aerojet believes it is in a
unique competitive position, due to the diversity of its
propulsion technologies (solid, liquid, air-breathing and
electric) and synergy of its product lines to offer its
customers the most innovative and advanced solutions available
in the domestic propulsion market. Aerojet has historically been
able to capitalize on its strong technical capabilities to
become a critical provider of components and systems for major
propulsion programs. Aerojet propulsion systems have flown
prominently on manned and unmanned missions for NASA and the DoD
since the inception of the U.S. Space Program. Principal
customers include the DoD, NASA, The Boeing Company (Boeing),
Lockheed Martin Corporation (Lockheed Martin) and Raytheon
Company (Raytheon).
|
|
|
|
|
Defense systems Our defense systems
products include liquid, solid and air-breathing propulsion for
strategic and tactical missiles, precision strike missiles and
interceptors required for missile defense. In addition, Aerojet
is a leading supplier of armament systems to the DoD and its
prime contractors. Product applications for defense systems
include strategic and tactical missile motors, maneuvering
propulsion systems, attitude control systems and warhead
assemblies used in precision weapon systems and missile defense,
as well as advanced airframe structures required on the F-22
Raptor aircraft and fire suppression systems for military and
commercial vehicles. |
|
|
|
Space systems Our space systems
products include liquid, solid and electric propulsion systems
for launch vehicles, transatmospheric vehicles and spacecraft.
Product applications for space systems include liquid engines
for expendable and reusable launch vehicles, upper stage
engines, satellite propulsion, large solid boosters and
integrated propulsion subsystems. |
Aerojet has been proactively engaged in the consolidation of the
propulsion industry. In the third quarter of fiscal 2004,
Aerojet acquired from Pratt & Whitneys Chemical
Systems Division (CSD) certain intellectual property and
real property associated with several solid rocket motor
programs for a nominal amount. This transaction highlights a key
event in the continuing consolidation of the propulsion industry
because CSD has now exited the solid propulsion business. In the
fourth quarter of fiscal 2003, Aerojet acquired substantially
all of the assets of the propulsion business of Atlantic
Research Corporation (ARC) a subsidiary of Sequa
Corporation. This acquisition makes Aerojet a leading supplier
of solid rocket motors for tactical and missile defense
applications and complements Aerojets capabilities for
air-breathing and strategic systems. In fiscal 2002, Aerojet
acquired the assets of the General Dynamics Ordnance and
Tactical Systems Space Propulsion and Fire Suppression business
(Redmond, Washington operations), a leading supplier of
satellite propulsion systems for defense, civilian and
commercial applications. These acquisitions have strengthened
our market positions in both the defense systems and space
systems industry sectors, and have provided leadership positions
in the tactical and in-space propulsion market.
Industry Overview
Following a period of budget decreases in the post-Cold War era,
the U.S. defense budget, as appropriated by Congress, has
increased in recent years. Under the Bush Administration, the
defense budget has experienced the first double-digit increase
since the early 1990s. The national defense budget, which
totaled $350 billion in 2002, has risen steadily to over
$375 billion in 2004, $416 billion in 2005, and there
are proposals to increase it to $423 billion in 2006. We expect
the U.S. defense budgets for research, development, test and
evaluation, and procurement, the primary funding sources for
Aerojets programs, to grow as well, with annual forecasts
continuing to show increases through 2009. While the ultimate
distribution of the
3
defense budget remains uncertain, Aerojet is well positioned to
benefit from DoD investment in high priority transformational
systems that address contemporary war fighting needs and
requirements.
The United States is demonstrating renewed commitment to space
and planetary exploration. The Bush Administration has announced
plans, which are subject to Congressional approval, to increase
NASAs 2004 budget of $15.4 billion by an average of 5%
over the next three years and by approximately 1% in the two
subsequent years. Near-term activities included in NASAs
budget are development of a new manned vehicle (the Crew
Exploration Vehicle), robotic moon missions, and continued
development of propulsion technologies for deep space
exploration. We believe we are well-positioned to compete for
significant roles on these projects. Furthermore, as a result of
NASAs intention to retire the Space Shuttle from service
as early as 2010, and the limited time and funding to develop a
replacement vehicle, we believe that NASA will focus on
maneuvering and long-duration propulsion systems that are
flight-proven, which will present opportunities for existing
Aerojet systems.
Competition
Participation in the defense and space propulsion market is
capital intensive and requires long research and development
periods that represent significant barriers to entry. Aerojet
may partner on various programs with its major customers or
suppliers, some of whom are, from time to time, competitors on
other programs.
The table below lists the primary participants in the propulsion
market serving the U.S. government and its agencies:
|
|
|
|
|
|
|
Company |
|
Parent |
|
Propulsion Type |
|
Propulsion Application |
|
|
|
|
|
|
|
Aerojet
|
|
GenCorp Inc. |
|
Solid, liquid, air- breathing, electric |
|
Launch, in-space, tactical, strategic, missile defense |
Alliant Techsystems
|
|
Alliant Techsystems Inc. |
|
Solid, air-breathing |
|
Launch, tactical, strategic, missile defense |
Astrium
|
|
European Aeronautics Defense and Space Company and
BAE Systems |
|
Solid, liquid |
|
In-space, tactical |
Northrop Grumman Space Technology (Formerly TRW)
|
|
Northrop Grumman Corporation |
|
Liquid |
|
Launch, in-space |
Pratt & Whitney Space Operations
|
|
United Technologies Corporation |
|
Liquid, air-breathing, electric |
|
Launch, in-space |
Rocketdyne
|
|
The Boeing Company |
|
Liquid |
|
Launch, in-space, missile defense |
Rocketdyne and Alliant Techsystems currently hold the largest
share of the launch market segment, largely due to their
sole-source production contracts for liquid (Rocketdyne) and
solid (Alliant) propulsion systems on the current NASA Space
Shuttle (now scheduled to be retired from service as early as
2010) and on the Delta family of expendable launch vehicles.
Aerojet believes it is in a unique competitive position, due to
the diversity of its technologies and synergy of its product
lines, to offer its customers the most innovative and advanced
solutions available in the domestic propulsion market. The basis
on which Aerojet competes in the aerospace and defense industry
varies by program, but generally is based upon price,
technology, quality and service. Although competition is
intensive for all of Aerojets products and services,
Aerojet believes it possesses adequate resources to compete
successfully.
Major Customers
As a merchant supplier to the aerospace and defense industry, we
do not align ourselves with any single prime contractor except
on a project-by-project basis. We believe that our position as a
merchant supplier has helped us become a trusted partner to our
customers, enabling us to maintain strong relationships with a
variety of prime contractors. Under each of our contracts, we
act either as a prime contractor, where we sell directly to the
end user, or as a subcontractor, where we sell our products to
other prime contractors.
4
The principal end-user customers of our products and technology
include agencies of the U.S. government. Since a majority of
Aerojets sales are, directly or indirectly, to the U.S.
government, funding for the purchase of Aerojets products
and services generally follows trends in U.S. defense spending.
However, individual government agencies, which include the
military services, the Defense Advanced Research Projects Agency
(DARPA), NASA, the Missile Defense Agency, and the prime
contractors that serve these agencies, exercise independent
purchasing power within budget top-line limits.
Therefore, sales to the U.S. government are not regarded as
sales to one customer and, accordingly, each contracting agency
is viewed as a separate customer. Thus, while we believe the DoD
and NASA budgets are generally relevant to our business outlook,
closer examination of the needs and priorities of the U.S.
government agencies provides a better indication of product area
stability and growth potential.
Aerojet contracts directly with a number of major prime
contractors and directly with agencies of the U.S. government.
During fiscal 2004, Lockheed Martin, Raytheon, and Boeing
accounted for approximately 33%, 15%, and 10%, respectively, of
aerospace and defense segment sales.
Aerojets direct sales to the U.S. government and its
agencies, or government customers, and indirect sales to
government customers via direct sales to prime contractors
accounted for a total of approximately 85% of net sales, or
approximately $420 million, in fiscal 2004. The following
are approximate percentages of Aerojets net sales by
principal end user in fiscal 2004:
|
|
|
|
|
U.S. Army
|
|
|
32 |
% |
U.S. Air Force
|
|
|
28 |
% |
U.S. Navy
|
|
|
15 |
% |
NASA
|
|
|
9 |
% |
Other government customers
|
|
|
1 |
% |
|
|
|
|
Total government customers
|
|
|
85 |
% |
Commercial and international customers
|
|
|
15 |
% |
|
|
|
|
Total
|
|
|
100 |
% |
|
|
|
|
5
Major Programs
A subset of our key defense systems programs is listed below:
|
|
|
|
|
|
|
|
|
Program |
|
Primary Customer |
|
End Users |
|
Program Description |
|
Program Status |
|
|
|
|
|
|
|
|
|
Army Tactical Missile System (ATACMS)
|
|
Lockheed Martin |
|
U.S. Army |
|
Tactical solid rocket motors |
|
Production |
F-22 Raptor Aircraft
|
|
Boeing |
|
U.S. Air Force |
|
Advanced electron beam welding for airframe structures |
|
Production |
Force Application and Launch from Continental United States
(FALCON)
|
|
Lockheed Martin |
|
U.S. Air Force |
|
Advanced hypersonic (air-breathing) propulsion, solid rocket
motors |
|
Development |
Ground Based Mid-Course Defense (GMD) Exoatmospheric Kill
Vehicle Liquid Divert and Attitude Control Systems (DACS)
|
|
Raytheon |
|
Missile Defense Agency |
|
Liquid propulsion divert and attitude control propulsion systems |
|
Development/ Production |
Minuteman III
|
|
Northrop Grumman |
|
U.S. Air Force |
|
Liquid maneuvering propulsion |
|
Development/ Production |
HyFly (Hypersonic Flight)
|
|
Boeing |
|
U.S. Navy |
|
Dual combustion ramjet (air-breathing) |
|
Development |
Javelin
|
|
Lockheed Martin |
|
U.S. Army |
|
Tactical solid rocket motors |
|
Production |
Joint Common Missile (JCM)
|
|
Lockheed Martin |
|
U.S. Army |
|
Tactical solid rocket motors |
|
Development |
Multiple Launch Rocket System (MLRS)
|
|
Lockheed Martin |
|
U.S. Army, International |
|
Tactical solid rocket motors |
|
Production |
Non-Line of Sight Missile (NLOS)
|
|
Raytheon |
|
U.S. Army |
|
Tactical solid rocket motors |
|
Development |
Patriot Advanced Capability (PAC)-3
|
|
Lockheed Martin |
|
U.S. Army, Missile Defense Agency |
|
Tactical solid rocket motors |
|
Development/ Production |
Tube-launched, Optically-tracked, Wire-guided Missile (TOW)
|
|
Raytheon |
|
U.S. Army |
|
Tactical solid rocket warheads |
|
Production |
Standard Missile
|
|
Raytheon |
|
U.S. Navy, Missile Defense Agency |
|
Tactical solid rocket motors |
|
Development/ Production |
Small Diameter Bomb
|
|
Boeing |
|
U.S. Air Force |
|
Precision munitions |
|
Development/ Production |
Terminal High Altitude Air Defense (THAAD)
|
|
Lockheed Martin |
|
U.S. Army, Missile Defense Agency |
|
Tactical solid rocket motors |
|
Development |
Supersonic Sea Skimming Target (SSST)
|
|
Orbital Sciences Corporation |
|
U.S. Navy |
|
Variable flow ducted rocket(air-breathing) |
|
Development |
Tomahawk
|
|
Raytheon |
|
U.S. Navy |
|
Tactical solid rocket motors and warheads |
|
Production |
Crown Victoria
|
|
Ford |
|
Law Enforcement |
|
Vehicle safety products |
|
Production |
Space Systems Programs Aerojet improved its
already strong market position in the space systems industry
segment in fiscal 2004 with several successful space exploration
missions including both the MARS Rover missions, Cassini,
Stardust and Mercury Messenger. In late 2004, Lockheed Martin
and NASA
6
selected Aerojet to provide de-orbit propulsion for the Hubble
Space Telescope. These successes, coupled with NASAs plans
to embark on the development of new manned and unmanned
missions, provide opportunities to grow our over 40 year
legacy of providing critical propulsion systems for the U.S.
space program.
A subset of our key space systems programs is listed below:
|
|
|
|
|
|
|
|
|
Program |
|
Primary Customer |
|
End Users |
|
Program Description |
|
Program Status |
|
|
|
|
|
|
|
|
|
A2100 Commercial Geostationary Satellite Systems
|
|
Lockheed Martin |
|
Various |
|
Electric and liquid spacecraft thrusters |
|
Production |
Mercury Messenger
|
|
Johns Hopkins Advanced Physics Lab (APL) |
|
NASA |
|
Liquid spacecraft propulsion system |
|
Development/ Production |
Advanced Extremely High Frequency MilSatCom
|
|
Lockheed Martin |
|
U.S. Air Force |
|
Electric and liquid spacecraft thrusters |
|
Development |
Hubble De-Orbit Module
|
|
Lockheed Martin |
|
NASA |
|
Maneuvering propulsion |
|
Development/ Production |
Atlas® V
|
|
Lockheed Martin |
|
U.S. Air Force, Commercial |
|
Solid strap-on booster motors for this
medium-to-heavy lift launch vehicle |
|
Development/ Production |
Cassini Mission
|
|
Lockheed Martin |
|
NASA |
|
Liquid spacecraft thrusters |
|
Development/ Production |
Mars Rover Missions
|
|
Lockheed Martin |
|
NASA JPL |
|
Liquid spacecraft thrusters |
|
Development/ Production |
Delta II
|
|
Boeing |
|
NASA, U.S. Air Force, Commercial |
|
Upper stage pressure-fed liquid rocket engines |
|
Production |
Titan IV
|
|
Lockheed Martin |
|
U.S. Air Force |
|
First and second stage liquid rocket booster engines |
|
Production |
Upper Stage Engine Technology
|
|
U.S. Air Force Research Laboratory |
|
NASA, U.S. Air Force |
|
Develop design tools for future upper stage liquid engines |
|
Development |
Telkom
|
|
Orbital Sciences Corp |
|
Commercial |
|
Liquid spacecraft thrusters |
|
Production |
Time History of Events and Macroscale Interactions During
Substorms (THEMIS)
|
|
Swales Aerospace |
|
NASA |
|
Liquid spacecraft propulsion system |
|
Development/ Production |
Aerojets top five programs accounted for less than 30% of
fiscal 2004 net sales. No single program accounted for more than
10% of Aerojets fiscal 2004 net sales and most programs
accounted for less than 5% of Aerojets fiscal 2004 net
sales.
Contract Types
Under each of its contracts, Aerojet acts either as a prime
contractor, where it sells directly to the end user, or as a
subcontractor, selling its products to other prime contractors.
Research and development contracts are awarded during the
inception stage of a programs development. Production
contracts provide for the production and delivery of mature
products for operational use. Aerojets contracts can
generally be categorized as either cost-reimbursable
or fixed-price. During fiscal 2004, approximately
57% of Aerojets total sales were achieved on fixed-price
contracts, 41% on cost-reimbursable contracts, and 2% on other
contract types.
7
Cost-reimbursable contracts are typically (i) cost plus
fixed fee, (ii) cost plus incentive fee, or (iii) cost
plus award fee contracts. For cost plus fixed fee contracts,
Aerojet typically receives reimbursement of its costs, to the
extent the costs are allowable under contractual provisions, in
addition to receipt of a fixed fee. For cost plus incentive fee
contracts and cost plus award fee contracts, Aerojet receives
adjustments in the contract fee, within designated limits, based
on its actual results as compared to contractual targets for
factors such as cost, performance, quality, and schedule.
Fixed-price contracts are typically (i) fixed-price,
(ii) fixed-price-incentive, or (iii) fixed-price level
of effort contracts. For fixed-price contracts, Aerojet performs
work for a fixed price and realizes all of the profit or loss
resulting from variations in costs of performance. For
fixed-price-incentive contracts, Aerojet receives increased or
decreased fees or profits based upon actual performance against
established targets or other criteria. For fixed-price level of
effort contracts, Aerojet generally receives a structured fixed
price per labor hour, dependent upon the customers labor
hour needs. All fixed-price contracts present the risk of
unreimbursed cost overruns.
Many programs under contract have product lifecycles exceeding
10 years, such as the Delta, Standard Missile, and Tomahawk
programs. It is typical for U.S. government propulsion contracts
to be relatively small ($2.5 million a year on average)
during development phases that can last from five to seven
years, followed by low-rate and then full-rate production, where
annual funding can grow as high as $30 million a year over
many years.
Backlog
Aerojets contract backlog as of November 30, 2004 was
$879 million compared to $830 million as of
November 30, 2003. Funded backlog, which includes only the
amount for which money has been directly authorized by the U.S.
Congress, or for which a purchase order has been received from a
commercial customer, was $538 million as of
November 30, 2004, compared to funded backlog of
$425 million on November 30, 2003. Overall, backlog
growth reflects contract awards in excess of sales on both
production and development programs.
Research and
Development
Aerojet views its research and development efforts as critical
to maintain its leadership positions in markets in which it
competes. We maintain an active research and development effort
supported primarily by customer funding. Customer-funded
research and development expenditures are funded under contract
specifications, typically research and development contracts,
several of which we believe will become key programs in the
future. Historically, over 90% of our research and development
expenditures were customer funded. We believe customer-funded
research and development activities are vital to our ability to
compete for contracts and to enhance our technology base.
Aerojets company-funded research and development effort
include expenditures for technical activities that are vital to
the development of new products, services, processes or
techniques, as well as those expenses for significant
improvements to existing products or processes.
The following table summarizes Aerojets research and
development expenses during the past three fiscal years:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Customer-funded
|
|
$ |
132 |
|
|
$ |
92 |
|
|
$ |
99 |
|
Company-funded
|
|
|
8 |
|
|
|
7 |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
Total research and development expenses
|
|
$ |
140 |
|
|
$ |
99 |
|
|
$ |
104 |
|
|
|
|
|
|
|
|
|
|
|
8
The ARC acquisition in October 2003 contributed an additional
$30 million in customer-funded research and development
expense in fiscal 2004 as compared to fiscal 2003 (see
Note 11 in Notes to Consolidated Financial Statements).
Raw Materials, Suppliers and
Seasonality
Availability of raw materials and supplies to Aerojet is
generally sufficient. Aerojet is sometimes dependent, for a
variety of reasons, upon sole-source suppliers for procurement
requirements but has experienced no significant difficulties in
meeting production and delivery obligations because of delays in
delivery or reliance on such suppliers.
Aerojets business is not subject to predictable
seasonality. Primary factors affecting the timing of
Aerojets sales include the timing of government awards,
the availability of U.S. government funding, contractual product
delivery requirements and customer acceptances.
Where appropriate, Aerojet obtains patents in the U.S. and other
countries covering various aspects of the design and manufacture
of its products. We consider these patents to be important to
Aerojet as they illustrate Aerojets innovative design
ability and product development capabilities. We do not believe
the loss or expiration of any single patent would have a
material adverse effect on the business or financial results of
Aerojet or on our business as a whole.
Real Estate
Through our Aerojet subsidiary, we own approximately 12,600
acres of land (Sacramento Land), located 15 miles northeast of
downtown Sacramento, along U.S. Highway 50, a key growth
corridor in the region. Our Real Estate segments primary
activity is the development of a substantial portion of the
Sacramento Land, which is one of the largest single owner land
tracts in the Sacramento region. The Sacramento Land was
acquired by Aerojet in the early 1950s for the manufacturing and
testing of propulsion products. Most of the Sacramento Land was
never used for production or testing purposes; rather, most of
such land was used to provide safe buffer zones for testing
propulsion products. Aerojets testing operations now
require a much smaller industrial footprint within the
Sacramento Land as a result of recent aerospace and defense
acquisitions and their testing capabilities, advances in
manufacturing processes, propulsion technologies, and increased
use of government testing facilities.
|
|
|
Sacramento Real Estate Market |
Demand for residential real estate in the Sacramento area has
grown dramatically in recent years due to population and
non-agricultural employment growth, increases in household
income and continued low mortgage interest rates. The result of
this demand has led to substantial appreciation in the value of
raw land, residentially-zoned land, and new homes in the
Sacramento area.
We believe the compelling demographic and real estate dynamics
in the Sacramento area provide an opportunity to create value by
developing a substantial portion of the Sacramento Land for a
wide variety of uses, including residential, office, and
commercial/retail. Developed as contemplated, we expect that the
Sacramento Land will have significantly greater value than as
currently zoned.
|
|
|
Government and Regulatory Approvals |
Despite limited acreage that was used for propulsion testing and
production, much of the Sacramento Land is encumbered by
environmental restrictions imposed by federal and state
regulatory agencies. These restrictions were imposed because of
the historical propulsion activities of our Aerospace and
Defense segment. Until these restrictions are released, we will
be unable to develop those portions of the Sacramento Land. In
1997, state regulators released 1,115 acres of the Sacramento
Land from environmental restrictions. This land was sold to a
regional homebuilder in fiscal 2001. In fiscal 2002, state and
federal regulators released
9
environmental restrictions on an additional 2,600 acres of the
Sacramento Land. Additionally, the development process requires
various governmental and regulatory approvals. We have made
applications for general plan amendments and zoning changes for
the initial portions of the Sacramento Land to be developed.
Descriptions of those portions of the Sacramento Land and
additional information regarding the government and regulatory
approval process are included below.
We have filed applications with government and regulatory
authorities for approvals necessary to develop over 5,800 acres
of the Sacramento Land, of which over 3,300 acres are restricted
by environmental regulations. Under California law, these
government and regulatory authorities are required to determine
if an Environment Impact Report (EIR) is necessary and, if
necessary, what, if any, impacts a project will have on the
environment. In the preparation of this report, the authority
must consider numerous elements. One important element is the
projects source of water. We have attempted to address
this critical element with our 2003 settlement agreement with
Sacramento County (the County). Pursuant to the agreement with
the County, Aerojet agreed to transfer all of its remediated
groundwater to the County. Subject to various provisions in the
agreement with the County, including approval under the
California Environmental Quality Act, the County will assume
Aerojets responsibility for providing replacement water to
impacted water purveyors up to the amount of remediated water
Aerojet transfers to the County. If the amount of Aerojets
transferred water is in excess of the replacement water provided
to the impacted water purveyors, the County has committed to
make such water available for the development of the Sacramento
Land in an amount equal to the excess.
The table below summarizes the Sacramento Land by use and by
environmental status (in acres):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2004 | |
|
|
|
|
| |
|
|
|
|
Environmentally | |
|
Environmentally | |
|
|
|
|
Unrestricted | |
|
Restricted(1) | |
|
Total | |
|
|
| |
|
| |
|
| |
Land Currently Available for Development(2)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Easton(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Rio Del Oro
|
|
|
|
|
|
|
2,724 |
|
|
|
2,724 |
|
|
|
Glenborough and Easton Place
|
|
|
1,052 |
|
|
|
330 |
|
|
|
1,382 |
|
|
|
Westborough and Easton Place
|
|
|
1,388 |
|
|
|
277 |
|
|
|
1,665 |
|
|
|
Office Park/ Auto Mall
|
|
|
56 |
|
|
|
9 |
|
|
|
65 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total for Easton
|
|
|
2,496 |
|
|
|
3,340 |
|
|
|
5,836 |
|
Land Available for Future Development
|
|
|
1,525 |
|
|
|
103 |
|
|
|
1,628 |
|
Aerojet Operations Land
|
|
|
24 |
|
|
|
5,108 |
|
|
|
5,132 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Sacramento Land
|
|
|
4,045 |
|
|
|
8,551 |
|
|
|
12,596 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Land is subject to federal and/or state environmental
restrictions that must be lifted before development on that land
can proceed (see Note 13(c) in Notes to Consolidated
Financial Statements). |
|
(2) |
In addition to the lifting of environmental restrictions,
various government and regulatory approvals, such as general
plan amendments and zoning changes, as more fully described
below, are necessary to further this development. |
|
(3) |
Our initial applications identified two development projects,
Easton and Rio Del Oro. In connection with our most recent
application submission, we have decided to use the
Easton name for all of our development activities on
the Sacramento Land. |
10
|
|
|
Land Currently Available for Development |
Rio Del Oro In fiscal 2002, we filed an
application for general plan amendments and requests for
rezoning of a 2,724 acre development project called Rio Del Oro,
which is now part of the City of Rancho Cordova (Rancho Cordova)
which was incorporated in fiscal 2003. Rio Del Oro is planned as
a mixed-use master-planned community that includes office and
industrial uses, retail and support services, recreational
opportunities, and a broad range of housing types. This project
has extensive areas of habitat for certain species on the
Federal Endangered Species List and these areas will be
preserved as part of the development. Our application was
submitted in conjunction with an application by a regional
homebuilder for the property the homebuilder owns west and
adjacent to the Rio del Oro land. We have granted a regional
homebuilder the right to purchase 400 acres of Rio Del Oro.
Rancho Cordova is having an EIR prepared for this project and it
is expected that the first draft of the EIR will be ready for
review by Rancho Cordova in April 2005. Rancho Cordovas
approval of our application is not expected before late fiscal
2006. For development to proceed, certain state environmental
restrictions must be lifted. We are working with state
regulators to determine actions necessary to remove these
restrictions. We believe the first portions of the Rio Del Oro
land should have environmental restrictions lifted at
approximately the same time that our general plan amendment and
zoning application is approved.
Glenborough and Easton Place In early fiscal
2004, we announced plans for an approximately 1,400 acre master
planned community originally called Easton (and now referred to
as Glenborough and Easton Place) and filed applications with the
County for general plan amendments and rezoning requests. The
Glenborough plan comprised of approximately 1,250 acres,
incorporates a wide mix of residential, commercial and
recreational uses, including an approximate 300-acre regional
open space along Alder Creek. Easton Place, consisting of
approximately 150 acres, is planned as a high-density mixed-use
urban hub connecting Glenborough and Westborough. Easton Place
will take full advantage of a new light rail station, the
existing Aerojet employment center and its location on the
Highway 50 corridor.
We expect the County to commence the EIR for Glenborough and
Easton Place during the first half of fiscal 2005. This project
has extensive habitat for an invertebrate on the Federal
Endangered Species List. We expect to be required to mitigate
for any incidental takings of habitat associated with the
development of the project. To that end, we are working with
federal agencies to develop a comprehensive mitigation plan that
will provide suitable alternative habitat. This mitigation plan
will be part of the approval of the application. We expect
County approval of this project to be granted in late fiscal
2007 or thereafter.
Portions of the land designated for this project totaling
approximately 330 acres are subject to state and federal
environmental restrictions, which must be released before
development of those acres can proceed. We are working with
state and federal agencies to determine and carry out the
actions necessary to ensure the successful delisting of those
portions of the project. We believe that restrictions covering
some areas of this project will be removed about the same time
as the Glenborough and Easton Place general plan amendment and
zoning application is approved by the County. Although we expect
that some areas will remain subject to environmental
restrictions for a period of time after receipt of County
approval, we do not expect any delays in our development
schedule as development of those portions of the project are not
expected to begin for several years.
Westborough and Easton Place In November
2004, we filed an application with Rancho Cordova for a general
plan amendment for a 1,665 acre project named Westborough at
Easton. We are currently working with Rancho Cordova to expand
the application to include the rezoning of the property. A
portion of this project will be a 150-acre expansion to Easton
Place (discussed above), and the balance will be known as
Westborough. The Easton Place expansion will be consistent with
the plans for the balance of Easton Place (as discussed above).
We intend Westborough to have a wide mix of residential,
business, community and recreational uses. We have granted a
regional homebuilder the right to purchase 100 acres of
Westborough at Easton.
11
During 2005, we will be working with Rancho Cordova to determine
the scope of the project so that Rancho Cordova may commence the
EIR for Westborough and Easton Place during 2006. Since the EIR
takes approximately one year to prepare, we do not expect that
Rancho Cordova will complete a first draft of the EIR for review
until 2007. This project has extensive habitat for an
invertebrate on the Federal Endangered Species List. We are
working with federal agencies to develop a comprehensive
mitigation plan that will provide suitable alternative habitat
in connection with any incidental taking of habitat associated
with the development of the project. This mitigation plan will
be part of the approval of the application. We expect Rancho
Cordova approval of this project during 2008.
Approximately 280 acres of this project are subject to federal
environmental restrictions which we do not expect to be removed
for several years. Although we expect that some areas will
remain subject to environmental restrictions for a period of
time after receipt of Rancho Cordova approval, we do not expect
any delays in our development schedule as development of those
portions of the project are not expected to begin for several
years.
Office Park and Auto Mall We are preparing a
subdivision application for submittal to the County for
approximately 55 acres of the Sacramento Land. We intend to
develop this land as an office park. The previously announced
joint venture in March 2003 with a local real estate developer
will be part of this subdivision.
We have submitted an application to the County for a conditional
use permit to allow the sale of new cars on approximately
30-acres of the land, a portion of which was sold to two
automobile dealers in fiscal 2003. We expect the County to
approve this application in 2005.
|
|
|
Land Available for Future Development |
We believe it will be several years before any of the 1,628
acres of our Sacramento Land will be ready for development.
Portions of such land are far from existing infrastructure,
making it uneconomical to develop at this time. Other parts of
such land will go through a lengthy annexation process and
development will not occur until that process is completed.
We believe that the Aerojet operations land is more than
adequate for Aerojets long-term needs, and as a result,
portions of this area may be available for development in the
future.
|
|
|
Other Projects and Fiscal 2004 Transactions |
In addition to the projects described above, we currently lease
to third parties approximately 330,000 square feet of office
space and 10 acres of land. These leasing activities generated
$6 million in revenue in fiscal 2004.
In fiscal 2004, we concluded a property usage agreement with
Sacramento Regional Transit and a mining agreement with Granite
Construction Company, both of which support our goal of
enhancing the value of our real estate assets. Initial proceeds
received in fiscal 2004 total $9 million for these
transactions.
As we work toward the development of the Sacramento Land, we
will continue to explore other alternatives to enhance the value
of our real estate assets, including outright sales, and/or
joint ventures with real estate developers or other third
parties.
Environmental Matters
Our operations are subject to and affected by federal, state,
local and foreign environmental laws and regulations relating to
the discharge, treatment, storage, disposal, investigation and
remediation of certain materials, substances and wastes. Our
policy is to conduct our businesses with due regard for the
preservation and protection of the environment. We continually
assess compliance with these regulations and management
12
of environmental matters. We believe our operations are in
substantial compliance with all applicable environmental laws
and regulations.
Operation and maintenance costs associated with environmental
compliance and management of contaminated sites are a normal,
recurring part of our operations. These costs are not
significant relative to total operating costs and most such
costs are incurred by our Aerospace and Defense segment and are
generally allowable costs under contracts with the U.S.
government.
Under existing U.S. environmental laws a Potentially Responsible
Party (PRP) is jointly and severally liable, and therefore
we are potentially liable to the government or third parties for
the full cost of remediating the contamination at our facilities
or former facilities or at third-party sites where we have been
designated as a PRP by the Environmental Protection Agency or a
state environmental agency. The nature of environmental
investigation and cleanup activities often makes it difficult to
determine the timing and amount of any estimated future costs
that may be required for remediation measures. However, we
review these matters and accrue for costs associated with
environmental remediation when it becomes probable that a
liability has been incurred and the amount of the liability,
usually based on proportionate sharing, can be reasonably
estimated. These liabilities have not been discounted to their
present value as the timing of cash payments is not fixed or
reliably determinable. See Managements Discussion and
Analysis in Part II, Item 7 of this Report for
additional information.
Employees
As of November 30, 2004, excluding employees of our
discontinued operations, approximately 17% of our 2,857
employees were covered by collective bargaining or similar
agreements all of which are due to expire within one year. We
believe that our relations with employees are good.
Executive Officers of the Registrant
See Part III, Item 10 of this Report for information
about Executive Officers of the Company.
13
Risk Factors
Set forth below are the risks that we believe are material to
our investors. This section contains forward-looking statements.
You should refer to the explanation of the qualifications and
limitations on forward-looking statements set forth in
Managements Discussion and Analysis in Part II,
Item 7 of this Report.
|
|
|
The cancellation or material modification of one or more
significant contracts could have a material adverse effect on
our ability to realize anticipated sales and profits. |
Sales, directly and indirectly, to the U.S. government and its
agencies accounted for approximately 85% of our Aerospace and
Defense segment net sales and 84% of our total net sales from
continuing operations in fiscal 2004. Our contracts typically
permit the U.S. government to unilaterally modify or terminate a
contract or to discontinue funding for a particular program at
any time. The cancellation of one or more significant contracts
could have a material adverse effect on our ability to realize
anticipated sales and profits. The cancellation of a contract,
if terminated for cause, could also subject us to liability for
the excess costs incurred by the U.S. government in procuring
undelivered items from another source. If terminated for
convenience, our recovery of costs would be limited to amounts
already incurred or committed, and our profit would be limited
to work completed prior to termination.
The Under Secretary of the Air Force has indicated that in 2005
the DoD intends to revise the Evolved Expendable Launch Vehicle
(EELV) program, under which we provide propulsion systems for
the Atlas V rocket, to address cost pressures resulting from
continued low commercial launch activity. Details of the form
and terms of the anticipated changes are unknown at this time;
however, we cannot assure you that any significant change to the
program will lead to a satisfactory resolution for launch
vehicle manufacturers. The cancellation or material modification
of the EELV program could adversely affect our revenues from
that program and our ability to recover the costs we have
incurred to date under the program.
|
|
|
Future reductions or changes in U.S. government spending
could negatively affect our revenues. |
Our primary aerospace and defense customers include the DoD and
its agencies, the government prime contractors that supply
products to these customers, and NASA. As a result, we rely on
particular levels of U.S. government spending on propulsion
systems for defense and space applications and armament systems
for precision tactical weapon systems and munitions
applications, and our backlog depends, in large part, on
continued funding by the U.S. government for the programs in
which we are involved. These spending levels are not generally
correlated with any specific economic cycle, but rather follow
the cycle of general political support for this type of
spending. The overall U.S. defense budget declined from the
mid-1980s through the early 1990s. Although the DoD currently
forecasts continued defense budget increases through its fiscal
year 2009, which is the remainder of the DoDs detailed
forecast period, future levels of defense spending may not
increase and could decrease. Moreover, although our contracts
often contemplate that our services will be performed over a
period of several years, Congress usually must approve funds for
a given program each government fiscal year and may
significantly reduce or eliminate funding for a program. A
decrease in U.S. military expenditures, or the elimination or
curtailment of a material program in which we are involved,
could negatively affect our revenues.
|
|
|
A significant percentage of our aerospace and defense
contracts are fixed-price contracts. If we experience cost
overruns on these contracts, we would have to absorb the excess
costs and our profitability would be adversely affected. |
Our aerospace and defense contracts generally can be categorized
as either fixed-price or
cost-reimbursable contracts. Under fixed-price
contracts, we agree to perform specified work for a fixed price
and realize all of the profit or loss resulting from variations
in the costs of performing the contract. As a result, all
fixed-price contracts involve the inherent risk of unreimbursed
cost overruns. To the extent we were to incur unanticipated cost
overruns on a program or platform subject to a fixed-price
contract, our profitability would be adversely affected. For
example, our Atlas V program contract is a fixed-price contract
that has not been profitable for us to date in part as a result
of unexpected costs of development and production. During fiscal
14
2004, we recorded an inventory write-down of $16 million
related to the Atlas V program. The write-down relates to
unanticipated transition costs from the development phase to the
production phase of the contract and the value of materials
rendered obsolete by a decision to proceed with qualification
and production of an enhanced motor configuration. As of
November 30, 2004, the Atlas V inventory balance was
$128 million. The current contract provides for production
of 44 motors over a number of years and for the order of an
additional 52 motors at the option of our prime contractor,
Lockheed Martin. Full recovery of our Atlas V investment is
subject to uncertainties, including: (i) our ability to
produce motors at our estimated average unit price,
(ii) final pricing of the enhanced motor configuration, and
(iii) a satisfactory renegotiation of contract terms with
Lockheed Martin, and Lockheed Martins exercise of its
option for additional motors. If we are unable to recover our
costs, we will be required to take additional write-downs
related to the Atlas V program. If the cost overruns associated
with our Atlas V program continue, the program may not become
profitable during the contract term and we may not be able to
fully recover our investment in the program.
During fiscal 2004, approximately 57% of Aerojets total
sales were achieved on fixed-price contracts, 41% on cost
reimbursable contracts, and 2% on other contract types.
|
|
|
Our success and growth in the aerospace and defense
industry depend on our ability to secure contracts. We face
significant competition, including from competitors with greater
resources than ours, which may adversely affect our market
share. |
We encounter intense competition in bidding for contracts. Many
of our competitors have financial, technical, production and
other resources substantially greater than ours. Although the
downsizing of the defense industry in the early 1990s has
resulted in a reduction in the aggregate number of competitors,
the consolidation has also strengthened the capabilities of some
of the remaining competitors resulting in an increasingly
competitive environment. The U.S. government also has its own
manufacturing capabilities in some areas. We may be unable to
compete successfully with our competitors and our inability to
do so could result in a decrease in revenues that we
historically have generated from these contracts. Further, the
U.S. government may open to competition programs on which we are
currently the sole supplier, which could also adversely affect
our revenues.
|
|
|
Our Aerospace and Defense segment is subject to
procurement and other related laws and regulations inherent in
contracting with the U.S. government, non-compliance with which
could have a material adverse effect on our business. |
In the performance of contracts with the U.S. government, we are
subject to complex and extensive procurement and other related
laws and regulations. Possible consequences of a failure to
comply, even inadvertently, with these laws and regulations
include civil and criminal fines and penalties, in some cases,
double or triple damages, and suspension or debarment from
future government contracts and exporting of goods for a
specified period of time.
These laws and regulations provide for ongoing audits and
reviews of incurred costs as well as contract procurement,
performance and administration. The U.S. government may, if
appropriate, conduct an investigation into possible illegal or
unethical activity in connection with these contracts.
Investigations of this nature are common in the aerospace and
defense industry, and lawsuits may result. In addition, the U.S.
government and its principal prime contractors periodically
investigate the financial viability of its contractors and
subcontractors as part of its risk assessment process associated
with the award of new contracts. If the U.S. government or one
or more prime contractors were to determine that we were not
financially viable, our ability to continue to act as a
government contractor or subcontractor would be impaired.
15
|
|
|
Our inability to adapt to rapid technological changes
could impair our ability to remain competitive. |
The aerospace and defense industry has undergone rapid and
significant technological development over the last few years.
Our competitors may implement new technologies before we are
able to, allowing them to provide more effective products at
more competitive prices. Future technological developments could:
|
|
|
|
|
adversely impact our competitive position if we are unable to
react to these developments in a timely or efficient manner; |
|
|
|
require us to write-down obsolete facilities, equipment and
technology; |
|
|
|
require us to discontinue production of obsolete products before
we can recover any or all of our related research, development
and commercialization expenses; or |
|
|
|
require significant capital expenditures for research,
development and launch of new products or processes. |
|
|
|
We may experience product failures, schedule delays or
other problems with existing or new products and systems, all of
which could result in increased costs and loss of sales. |
Many of the products we develop and manufacture are
technologically advanced systems that must function under
demanding operating conditions. Even though we believe that we
employ sophisticated and rigorous design, manufacturing and
testing processes and practices, we may not be able to
successfully launch or manufacture our products on schedule or
our products may not perform as intended.
Some of our contracts require us to forfeit a portion of our
expected profit, receive reduced payments, provide a replacement
product or service or reduce the price of subsequent sales to
the same customer if our products fail to perform adequately.
Performance penalties also may be imposed should we fail to meet
delivery schedules or other measures of contract performance. We
do not generally insure against potential costs resulting from
any required remedial actions or costs or loss of sales due to
postponement or cancellation of scheduled operations or product
deliveries.
|
|
|
Our operations and properties are currently the subject of
significant environmental claims, and the numerous environmental
and other government regulations to which we are subject may
become more stringent in the future and may reduce our
profitability and liquidity. |
We are subject to foreign, federal, state and local
environmental laws and regulations that, among other things,
require us to obtain permits to operate and install pollution
control equipment and regulate the generation, storage,
handling, transportation, treatment and disposal of hazardous
and solid wastes. We may also be subject to fines and penalties,
and are subject to toxic tort and asbestos suits as well as
other third-party lawsuits, due to either our past or present
use of hazardous substances or the alleged on-site or off-site
contamination of the environment through past or present
operations. We may incur material costs in defending these
proceedings or claims. Any unexpected adverse judgment or cash
outlay could reduce our profitability and leave us with less
cash available to service our debt.
In one matter, GenCorp Inc. v. Olin Corporation, we are
currently subject to a judgment order in the amount of
approximately $29 million entered November 21, 2002 by
the U.S. District Court for the Northern District of Ohio,
Eastern Division. On November 22, 2004, this judgment order
was upheld by the U.S. Sixth Circuit Court of Appeals. We have
filed a petition for rehearing with the Sixth Circuit. If the
petition is not granted and the offsets to which we believe we
are entitled are not realized, the judgment will have a material
adverse impact on our cash flow and financial condition.
For additional discussion of environmental and legal matters,
please see the environmental discussion in Note 13 to
Consolidated Financial Statements.
16
|
|
|
Although some of our environmental costs may be
recoverable and we have established reserves, given the many
uncertainties involved in assessing liability for environmental
claims, our reserves may not be sufficient. |
Under an agreement with the U.S. government, the U.S. government
recognizes as allowable for government contract cost purposes up
to 88% of environmental expenses at our Sacramento and former
Azusa sites. Aerojets mix of contracts can affect the
actual reimbursement made by the U.S. government. Because these
costs are recovered through forward pricing arrangements, our
ability to continue recovering these costs from the U.S.
government depends on Aerojets sustained business volume
under U.S. government contracts and programs and the relative
size of Aerojets commercial business. We also may seek
recovery of our environmental costs from insurers.
As of November 30, 2004, we had established reserves of
$304 million, which we believe to be sufficient to cover
our estimated share of the environmental remediation costs at
that time. However, given the many uncertainties involved in
assessing liability for environmental claims, our reserves may
prove to be insufficient. We continually evaluate the adequacy
of those reserves, and they could change. In addition, the
reserves are based only on known sites and the known
contamination at those sites. It is possible that additional
remediation sites will be identified in the future or that
unknown contamination at previously identified sites will be
discovered. This could lead us to have additional expenditures
for environmental remediation in the future and given the many
uncertainties involved in assessing liability for environmental
claims, our reserves may prove to be insufficient.
For additional discussion of environmental matters, please see
the environmental discussion in Note 13 to Consolidated
Financial Statements.
|
|
|
The release or explosion of dangerous materials used in
our business could disrupt our operations and cause us to incur
additional costs and liability. |
The operations of our Aerospace and Defense business involve the
handling and production of potentially explosive materials and
other dangerous chemicals, including materials used in rocket
propulsion. Despite our use of specialized facilities to handle
dangerous materials and intensive employee training programs,
the handling and production of hazardous materials could result
in incidents that temporarily shut down or otherwise disrupt our
manufacturing operations and could cause production delays. It
is possible that a release of these chemicals or an explosion
could result in death or significant injuries to employees and
others. Material property damage to us and third parties could
also occur. The use of these products in applications by our
customers could also result in liability if an explosion or fire
were to occur. Any release or explosion could expose us to
adverse publicity or liability for damages or cause production
delays, any of which could have a material adverse effect on our
reputation and profitability.
|
|
|
Disruptions in the supply of key raw materials and
difficulties in the supplier qualification process, as well as
increases in prices of raw materials, could adversely impact our
operations. |
We closely monitor sources of supply to assure that adequate raw
materials and other supplies needed in our manufacturing
processes are available. As a U.S. government contractor, we are
frequently limited to procuring materials and components from
sources of supply that can meet rigorous customer and/or
government specifications. In addition, as business conditions,
the DoD budget, and Congressional allocations change, suppliers
of specialty chemicals and materials sometimes consider dropping
low volume items from their product lines, which may require, as
it has in the past, qualification of new suppliers for raw
materials on key programs. The supply of ammonium perchlorate, a
principal raw material used in our operations, is limited to a
single source that supplies the entire domestic solid propellant
industry. This single source, however, maintains two separate
manufacturing lines a reasonable distance apart, which mitigates
the likelihood of a fire, explosion, or other problem impacting
all production. We also presently rely on one primary supplier
for graphite fiber, which is used in the production of composite
materials. This supplier has multiple manufacturing lines for
graphite fiber. Although other sources of graphite fiber exist,
the addition of a new supplier would require us to qualify the
new source for use.
17
Current suppliers of some insulation materials used in rocket
motors have announced plans to close manufacturing plants and
discontinue product lines. These materials include polymers used
in ethylene propylene diene monomer rubber insulation and
aerospace-grade rayon used in nozzles. We are in the process of
qualifying new replacement materials for some programs. For
other programs, we have produced sufficient inventory to cover
current program requirements and are in the process of
qualifying new replacement materials to be qualified in time to
meet future production needs.
We are also impacted by increases in the prices of raw materials
used in production on fixed-price contracts. Most recently, we
have seen an increase in the price of commodity metals,
primarily steel and aluminum.
Prolonged disruptions in the supply of any of our key raw
materials, difficulty completing qualification of new sources of
supply, implementing use of replacement materials or new sources
of supply, or a continuing increase in the prices of raw
materials could have a material adverse effect on our operating
results, financial condition or cash flows.
|
|
|
Substantially all of our real estate planned for
development is located in Sacramento County, California making
us vulnerable to changes in economic and other conditions in
that particular market. |
As a result of the geographic concentration of our properties,
our long-term performance and the value of our properties will
depend upon conditions in the Sacramento region, including:
|
|
|
|
|
the sustainability and growth of industries located in the
Sacramento region; |
|
|
|
the financial strength and spending of the State of California; |
|
|
|
local real estate market conditions; |
|
|
|
changes in neighborhood characteristics; and |
|
|
|
real estate tax rates. |
There can be no assurance that the Sacramento market will
continue to grow or that conditions will remain favorable. If
unfavorable economic or other conditions occur in the region,
our development plans and business strategy could be adversely
affected.
|
|
|
We have limited experience in real estate development
activities. |
While we have owned our real estate for over 50 years, we
have no significant real estate development experience.
Therefore, we do not have any real estate development history
from which you can draw conclusions about our ability to execute
our real estate business plan.
|
|
|
Real estate development is inherently risky. |
Our real estate development activities may subject us to the
following risks:
|
|
|
|
|
we may be unable to obtain, or suffer delays in obtaining,
necessary re-zoning, land use, building, occupancy and other
required governmental permits and authorizations, which could
result in increased costs or our abandonment of these projects; |
|
|
|
we may be unable to complete environmental remediation or to
lift state and federal environmental restrictions on our real
estate, which could cause a delay or abandonment of these
projects; |
|
|
|
we may be unable to obtain sufficient water sources to service
our development projects, which may prevent us from executing
our development plan; and |
|
|
|
we may not be able to obtain financing on favorable terms, which
may render us unable to proceed with our development activities. |
Additionally, the time frame required for development of these
properties means that we may have to wait years for a
significant cash return.
18
|
|
|
The value of our real estate assets could be adversely
affected by an increase in interest rates. |
For the past three years, interest rates in the U.S. have been
at historically low levels, which has facilitated the financing
and purchase of homes. Historical evidence has shown that
significant increases in interest rates have a negative impact
on housing demand. Since June 30, 2004, the federal funds
rate has increased from 1% to 2.50%. During that time, the
Federal Reserve Boards rate-setting committee has met six
times, and each time raised the federal funds rate by 0.25%. If
interest rates continue to increase, and the ability or
willingness of prospective buyers to finance home purchases is
diminished, the value of our real estate assets may decrease.
|
|
|
We have a substantial amount of debt, and the cost of
servicing that debt could adversely affect our ability to take
actions or our liquidity or financial condition. |
We have a substantial amount of debt for which we are required
to make interest and principal payments. As of November 30,
2004, we had total consolidated debt of $577 million.
Subject to the limits contained in some of the agreements
governing our outstanding debt, we may incur additional debt in
the future.
Our level of debt places significant demands on our cash
resources, which could:
|
|
|
|
|
make it more difficult for us to satisfy our outstanding debt
obligations; |
|
|
|
require us to dedicate a substantial portion of our cash flow
from operations to payments on our debt, reducing the amount of
our cash flow available for working capital, capital
expenditures, acquisitions, developing our real estate assets
and other general corporate purposes; |
|
|
|
limit our flexibility in planning for, or reacting to, changes
in the industries in which we compete; |
|
|
|
place us at a competitive disadvantage compared to our
competitors, some of which have lower debt service obligations
and greater financial resources than we do; |
|
|
|
limit our ability to borrow additional funds; or |
|
|
|
increase our vulnerability to general adverse economic and
industry conditions. |
Continuing operations generated $5 million of cash in
fiscal 2004, compared to negative cash flow from continuing
operations in fiscal 2003 and fiscal 2002. We may experience
negative net cash flow from continuing operations in the future.
Our ability to record positive cash flow from continuing
operations for the next fiscal year will depend in part on
positive cash flow from our Real Estate business. If we are
unable to generate sufficient cash flow to service our debt and
fund our operating costs, our liquidity may be adversely
affected.
|
|
|
We are obligated to comply with financial and other
covenants in our debt that could restrict our operating
activities, and the failure to comply could result in defaults
that accelerate the payment under our debt. |
Our outstanding debt generally contains various restrictive
covenants. These covenants include, among others, provisions
restricting our ability to:
|
|
|
|
|
incur additional debt; |
|
|
|
make certain distributions, investments and other restricted
payments; |
|
|
|
limit the ability of restricted subsidiaries to make payments to
us; |
|
|
|
enter into transactions with affiliates; |
|
|
|
create certain liens; |
|
|
|
sell assets; and |
|
|
|
consolidate, merge or sell all or substantially all of our
assets. |
19
Our secured debt also contains other customary covenants,
including, among others, provisions:
|
|
|
|
|
relating to the maintenance of the property securing the debt,
and |
|
|
|
restricting our ability to pledge assets or create other liens. |
In addition, certain covenants in our bank facilities require us
and our subsidiaries to maintain certain financial ratios. Any
of the covenants described in this risk factor may restrict our
operations and our ability to pursue potentially advantageous
business opportunities. Our failure to comply with these
covenants could also result in an event of default that, if not
cured or waived, could result in the acceleration of all or a
substantial portion of our debt.
|
|
|
If our operating subsidiaries do not generate sufficient
cash flow or if they are not able to pay dividends or otherwise
distribute their cash to us, or if we have insufficient funds on
hand, we may not be able to service our debt. |
All of the operations of our Aerospace and Defense and Real
Estate businesses are conducted through subsidiaries.
Consequently, our cash flow and ability to service our debt
obligations will be largely dependent upon the earnings of our
operating subsidiaries and the distribution of those earnings to
us, or upon loans, advances or other payments made by these
subsidiaries to us. The ability of our subsidiaries to pay
dividends or make other payments or advances to us will depend
upon their operating results and will be subject to applicable
laws and any contractual restrictions contained in the
agreements governing their debt, if any.
|
|
|
We expect to continue to expand our operations through
acquisitions, which may divert managements attention and
expose us to unanticipated liabilities and costs. We may
experience difficulties integrating the acquired operations, and
we may incur costs relating to acquisitions that are never
consummated. |
Our business strategy contemplates continued expansion of our
Aerospace and Defense operations, including growth through
future acquisitions. However, our ability to consummate and
integrate effectively any future acquisitions on terms that are
favorable to us may be limited by the number of attractive
acquisition targets, internal demands on our resources and our
ability to obtain financing. Our success in integrating newly
acquired businesses will depend upon our ability to retain key
personnel, avoid diversion of managements attention from
operational matters, integrate general and administrative
services and key information processing systems and, where
necessary, requalify our customer programs. In addition, future
acquisitions could result in the incurrence of additional debt,
costs and contingent liabilities. We may also incur costs and
divert management attention to acquisitions that are never
consummated. Integration of acquired operations may take longer,
or be more costly or disruptive to our business, than originally
anticipated. It is also possible that expected synergies from
past or future acquisitions may not materialize.
Although we undertake a diligence investigation of each business
that we acquire, there may be liabilities of the acquired
companies that we fail to or are unable to discover during the
diligence investigation and for which we, as a successor owner,
may be responsible. In connection with acquisitions, we
generally seek to minimize the impact of these types of
potential liabilities through indemnities and warranties from
the seller, which may in some instances be supported by
deferring payment of a portion of the purchase price. However,
these indemnities and warranties, if obtained, may not fully
cover the liabilities due to limitations in scope, amount or
duration, financial limitations of the indemnitor or warrantor
or other reasons.
|
|
|
We have recently focused our operations through
divestitures. We may incur delays in the timing of one of these
divestitures or we may incur costs related to this divestiture,
both of which may negatively impact our profitability and our
liquidity. |
We have announced that we intend to divest our Fine Chemicals
business. However, our ability to do so on favorable terms may
be limited by the availability of interested purchasers and
internal demand on our resources. We may not be able to identify
a purchaser and negotiate an acceptable agreement on a timely
basis or at all. In that event, we may be unable to complete our
strategy of focusing our operations in our Aerospace and Defense
and Real Estate businesses.
20
In connection with divestitures, including our recent sale of
our GDX business, we may incur costs, including costs related to
the closure of a manufacturing facility in Chartres, France.
This closure requires us to comply with certain procedures and
processes that are defined under local law and labor
regulations. These costs may require additional cash
expenditures, thereby reducing our profitability and our
liquidity.
|
|
|
A strike or other work stoppage, or our inability to renew
collective bargaining agreements on favorable terms, could have
a material adverse effect on our cost structure and ability to
run our facilities and produce our products. |
As of November 30, 2004, we had approximately 2,857
employees in our ongoing operations, of which approximately 17%
were covered by collective bargaining or similar agreements. Of
the covered employees, all are covered by collective bargaining
agreements that are due to expire within one year. If we are
unable to negotiate acceptable new agreements with the unions
representing our employees upon expiration of the existing
contracts, we could experience strikes or work stoppages. Even
if we are successful in negotiating new agreements, the new
agreements could call for higher wages or benefits paid to union
members, which would increase our operating costs and could
adversely affect our profitability. If our unionized workers
were to engage in a strike or other work stoppage, or other
non-unionized operations were to become unionized, we could
experience a significant disruption of operations at our
facilities or higher ongoing labor costs. A strike or other work
stoppage in the facilities of any of our major customers could
also have similar effects on us.
|
|
|
A loss of key personnel or highly skilled employees could
disrupt our operations. |
Our executive officers are critical to the management and
direction of our businesses. Our future success depends, in
large part, on our ability to retain these officers and other
capable management personnel. In general, we do not enter into
employment agreements with our executive officers. We have
entered into severance agreements with several of our officers
that allow those officers to terminate their employment under
particular circumstances, such as a change of control affecting
our company. Although we believe that we will be able to attract
and retain talented personnel and replace key personnel should
the need arise, our inability to do so could disrupt the
operations of the segment affected or our overall operations. In
addition, because of the complex nature of many of our products
and programs, we are generally dependent on an educated and
highly-skilled engineering staff and workforce. Our operations
could be disrupted by a shortage of available skilled employees.
|
|
|
Due to the nature of our business, our sales levels may
fluctuate causing our quarterly operating results to
fluctuate. |
Changes in our operating results from quarter to quarter could
result in volatility in our common stock price. Our quarterly
and annual sales are affected by a variety of factors that could
lead to significant variability in our operating results:
|
|
|
|
|
In our Aerospace and Defense business, sales earned under
long-term contracts are recognized either on a cost basis, when
deliveries are made, or when contractually defined performance
milestones are achieved. The timing of deliveries or milestones
may fluctuate from quarter to quarter. |
|
|
|
In our Real Estate business, sales of property will be made from
time to time, which will result in variability in our operating
results. |
21
|
|
|
We may be subject to risks associated with our Fine
Chemicals business until the sale of the business is
consummated, and these risks could make it more difficult to
sell that business. |
We have announced that we plan to sell our Fine Chemicals
business. We will continue to operate our Fine Chemicals
business in the ordinary course of business pending any sale.
This business is subject to the following operational risks:
|
|
|
|
|
The pharmaceutical fine chemicals market is highly fragmented
and competitive. As a result, the Fine Chemicals business may
not be successful in obtaining or renewing customer contracts on
commercially favorable terms, if at all. |
|
|
|
The pharmaceutical fine chemicals industry is a
capital-intensive industry that may consume our cash from our
operations and borrowings. If we cannot sell our Fine Chemicals
business and we further expand our operations, our capital
expenditures are expected to increase. Increases in expenditures
may result in low levels of working capital or require us to
finance working capital deficits. These factors could
substantially increase our operating costs and therefore impair
our ability to invest in our Fine Chemicals business. |
|
|
|
The lack of availability of certain raw materials used by our
Fine Chemicals business or a material increase in the price of
these raw materials, each of which is generally outside of our
control, could result in significantly increased operating costs
that the business may not be able to offset through price
increases to customers. |
|
|
|
Our Fine Chemicals business produces chemical compounds that are
difficult to manufacture, including highly-energetic and
highly-potent materials. The production of these chemicals
requires a high degree of precision and strict adherence to
safety standards. Regulatory agencies, such as the U.S. Food and
Drug Administration and the European Agency for the Evaluation
of Medical Products must approve the production process for many
of the products that our Fine Chemicals business manufactures. |
Any of these factors could have a material adverse effect on the
business and financial results of the Fine Chemicals business.
Item 2. Properties
Significant operating, manufacturing, research, design and/or
marketing facilities are set forth below.
Facilities
Corporate Headquarters
GenCorp Inc.
Highway 50 and Aerojet Road
Rancho Cordova, California 95670
Mailing address:
P.O. Box 537012
Sacramento, California 95853-7012
22
Manufacturing/ Research/ Design/ Marketing Locations
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
|
Design/ Manufacturing Facilities: |
|
|
|
Marketing/ Sales Offices: |
|
Aerojet-General Corporation
P.O. Box 13222
Sacramento, California 95813- 6000 |
|
Camden, Arkansas* Clearfield, Utah* El Segundo, California* Gainesville, Virginia* Jonesborough, Tennessee Orange, Virginia Rancho Cordova, California Redmond, Washington Socorro, New Mexico* Vernon, California* |
|
Huntsville, Alabama* Washington, DC* |
Real Estate
620 Coolidge Drive, Suite 165
Folsom, California 95630 |
|
|
|
|
|
Marketing/ Sales Office: Folsom, California* |
Discontinued Operations |
|
Processing Development/ Manufacturing Facilities: Rancho Cordova, California Chartres, France |
|
Marketing/ Sales Offices:
Rancho Cordova, California |
|
|
* |
An asterisk next to a facility listed above indicates that it is
a leased property. |
We believe each of the facilities is adequate for the business
conducted at that facility. The facilities are suitable and
adequate for their intended purpose and taking into account
current and future needs. A portion of Aerojets property
in California (approximately 3,900 acres of undeveloped land),
and its Redmond, Washington facility are encumbered by a deed of
trust or mortgage. In addition, we own and lease properties
(primarily machinery and warehouse and office facilities) in
various locations for use in the ordinary course of our business.
23
Item 3. Legal
Proceedings
The following information pertains to legal proceedings,
including proceedings relating to environmental matters, which
are discussed in detail in Notes 13(b) and 13(c) to the
Consolidated Financial Statements.
Groundwater Cases
Sacramento Cases
Aerojet-General Corporation, along with other industrial
Potentially Responsible Parties (PRPs) and area water purveyors,
was sued in three cases by approximately 500 individual
plaintiffs residing in the vicinity of Aerojets facilities
near Sacramento, California (the Sacramento cases). One of such
cases was voluntarily dismissed by the named plaintiff. As
discussed in detail in Notes 13(b) and 13(c) to the Consolidated
Financial Statements, through dismissals, the number of
plaintiffs has been reduced to 27. The remaining Sacramento
cases are denominated as follows:
Adams, Daphne, et al. v. Aerojet-General Corporation, et al.,
Case No. 98AS01025, Sacramento County Superior Court, served
April 30, 1998.
Allen, et al. v. Aerojet-General Corporation, et al.,
Case No. 97AS06295, Sacramento County Superior Court,
served January 14, 1998.
In the Sacramento cases, the plaintiffs allege that that
industrial defendants contaminated groundwater provided by the
water purveyors as drinking water, which plaintiffs consumed
causing illness, death and economic injury. Plaintiffs seek
judgment against defendants for unspecified general, special and
punitive damages.
As discussed in detail in Notes 13(b) and 13(c) to the
Consolidated Financial Statements, the regulated water entities
defendants were dismissed from the litigation, and following
plaintiffs tentative settlement against McDonnell Douglas
Corporation, Aerojet is the only remaining defendant in these
cases. Discovery is ongoing and the first phase of the trial has
been set for August 2005.
San Gabriel Valley
Cases
Aerojet, along with numerous other defendants, was also sued in
14 cases by approximately 1,100 individual plaintiffs residing
in the vicinity of Aerojets former facility in Azusa,
California (the San Gabriel Valley cases). The number of
plaintiffs involved in the San Gabriel Valley cases has been
reduced to approximately 500. The San Gabriel cases are
denominated as follows:
Adams, Robert G., et al. v. Aerojet-General Corporation, et
al., Case No. BC230185, Los Angeles County Superior Court,
served July 26, 2000.
Adler, Jeff, et al. v. Southern California Water Co. et al.,
Case No. BC169892, Los Angeles County Superior Court, served
on or about April 22, 1998.
Alexander, et al. v. Suburban Water Systems, et al., Case
No. KC031130, Los Angeles County Superior Court, served
June 22, 2000.
Alvarado, et al. v. Suburban Water Systems, et al., Case
No. KC034953, Los Angeles County Superior Court, served
May 7, 2001.
Anderson, Anthony et al. v. Suburban Water Systems, et al.,
Case No. KC02854, Los Angeles County Superior Court, served
November 23, 1998.
Arenas, et al. v. Suburban Water Systems, et al., Case
No. KC037559, Los Angeles County Superior Court, served
June 24, 2002.
Boswell, et al. v. Suburban Water Systems, et al., Case
No. KC027318, Los Angeles County Superior Court, served
April 28, 1998.
24
Bowers, et al. v. Aerojet-General Corporation, et al.,
Case No. BC250817, Los Angeles County Superior Court,
served July 17, 2001.
Brooks, et al. v. Suburban Water Systems et al., Case
No. KC032915, Los Angeles County Superior Court, served
October 17, 2000.
Celi, et al. v. San Gabriel Valley Water Company, et al.,
Case No. GC020622, Los Angeles County Superior Court, served
April 28, 1998.
Criner, et al. v. San Gabriel Valley Water Company, et al.,
Case No. GC021658, Los Angeles County Superior Court, served
September 16, 1998.
Criner, et al. v. San Gabriel Valley Water Company, et al.,
Case No. GC021658, Los Angeles County Superior Court, served
September 16, 1998.
Dominguez, et al. v. Southern California Water Company, et
al., Case No. GC021657, Los Angeles County Superior Court,
served September 16, 1998.
Santamaria, et al. v. Suburban Water Systems, et al.,
Case No. KC025995, Los Angeles County Superior Court,
served February 24, 1998.
In the San Gabriel Valley cases, the plaintiffs allege that that
industrial defendants contaminated groundwater provided by the
water purveyors as drinking water, which plaintiffs consumed
causing illness, death and economic injury. Plaintiffs seek
judgment against defendants for unspecified general, special and
punitive damages.
As discussed in detail in Notes 13(b) and 13(c) to the
Consolidated Financial Statements, the San Gabriel Valley cases
have been coordinated for trial in Los Angeles, California, and
are proceeding under two master complaints. The regulated water
entities defendants were dismissed from the litigation and
numerous industrial defendants have settled with the plaintiffs.
Currently, 162 of the remaining approximately 500 San Gabriel
Valley plaintiffs are subject to early trial most likely
in fiscal 2005.
SEMOU Related Cases
In October 2002, Aerojet, along with approximately 65 other
individual and corporate defendants, was served with four civil
suits filed in the U.S. District Court for the Central District
of California pursuant to which plaintiff water purveyors that
seek recovery of costs allegedly incurred in response to the
contamination present at the South El Monte Operable Unit
(SEMOU) of the San Gabriel Valley Superfund site. The cases
are denominated as follows:
San Gabriel Valley Water Company v. Aerojet-General
Corporation, et al.,Case No. CV-02-6346 ABC (RCx), U.
S. District Court, Central District of CA, served
October 30, 2002.
San Gabriel Basin Water Quality Authority v. Aerojet-General
Corporation, et al., Case No. CV-02-4565 ABC (RCx), U.
S. District Court, Central District of CA, served
October 30, 2002.
Southern California Water Company v. Aerojet-General
Corporation, et al.,Case No. CV-02-6340 ABC (RCx), U.
S. District Court, Central District of CA, served
October 30, 2002.
The City of Monterey Park v. Aerojet-General Corporation, et
al., Case No. CV-02-5909 ABC (RCx), U. S. District Court,
Central District of CA, served October 30, 2002.
The cases have been coordinated for ease of administration by
the court. Plaintiffs allege that groundwater in the SEMOU is
contaminated with chlorinated solvents and ammonium perchlorate
that were released into the environment by Aerojet and other
defendants, causing plaintiffs to incur unspecified response
costs and other damages.
Aerojet has filed third-party complaints against several water
entities on the basis that they introduced
perchlorate-containing Colorado River water to the basin. Those
water entities have filed motions to dismiss
25
Aerojets complaints. The motions as well as discovery have
been stayed pending efforts to resolve the litigation through
mediation. Aerojet has notified its insurers of these claims.
Other Ground Water
Case
Orange County Water District v. Northrop Corporation, et al.,
Case No. O4CC00715, Orange County (CA) Superior Court,
served December 29, 2004. Aerojet and other defendants were
sued by the Orange County Water District, a public entity with
jurisdiction over groundwater resources and water supplies in
Orange County. The plaintiff alleges that groundwater in Orange
County, California is contaminated with chlorinated solvents
that were allegedly released to the environment by Aerojet and
other industrial defendants causing it to incur unspecified
response costs and other damages. The plaintiff seeks
declaratory relief and recovery of past costs in connection with
investigation and remediation of groundwater resources. Aerojet
has filed its answer and discovery has commenced.
Air Pollution Cases
Chino Hills Cases
Aerojet and several other defendants have been sued by private
residents living in the vicinity of Chino and Chino Hills,
California. The cases have been consolidated and are pending in
the U.S. District Court for the Central District of California.
The cases are denominated as follows:
Baier, et al. v. Aerojet-General Corporation, et al.,
Case No. EDCV 00 618VAP (RNBx) U.S. District Court, Central
District, CA, served June 29, 2000.
Kerr, et al. v. Aerojet-General Corporation, Case
No. EDCV 01-19VAP (SGLx) U.S. District Court, Central
District, CA, served June 29, 2000.
Taylor, et al. v. Aerojet-General Corporation, et al.,
Case No. EDCV 01-106 VAP (RNBx) U.S. District Court,
Central District, CA, served January 31, 2001.
Yeh, et al. v. Aerojet-General Corporation, Case
No. RCV 083065 San Bernardino County Superior Court
(transferred to U.S. District Court, Central District, CA,
served October 24, 2004 and renumbered Case No. EDCV
04-1354-VAP(SHx) and coordinated with Baier, Kerr and Taylor
cases).
Plaintiffs generally allege that Aerojet released hazardous
chemicals into the air at its former manufacturing facility in
Chino Hills, California, which allegedly caused illness, death,
and economic injury. Various motions have reduced the number of
plaintiffs from 80 to 48. Discovery is proceeding in the cases.
Trial is likely to be scheduled for 2006.
Other Legal Proceedings
GenCorp Inc. v. Olin Corporation, Case
No. 5:93CV2269, U.S. District Court, N.D. Ohio, filed
October 25, 1993. GenCorp initiated civil proceedings
against Olin Corporation (Olin), the owner and operator of a
former chemical manufacturing facility located on land formerly
owned by the Company, seeking a declaratory judgment that the
Company was not liable to Olin for remedial costs. In the same
case, Olin filed a counterclaim against GenCorp alleging that
GenCorp was jointly and severally liable under CERCLA for
remediation costs estimated at $70 million due to its
contractual relationship with Olin, operational activities and
land ownership by GenCorp. The Company has filed a counterclaim
based on Olins breach of contractual obligations to
provide insurance protection for both the Company and Olin, as
required by the contract between the two companies.
The trial court ruled GenCorp liable based on theories of owner
and arranger liability under CERCLA. The trial court found
GenCorp 30% liable and Olin 70% liable for the Big D site, and
GenCorp 40% liable and Olin 60% liable for another site, for
CERCLA remediation costs. The Sixth Circuit Court of Appeals
denied GenCorps appeal regarding its CERCLA contribution
liability on the basis that it is not directly or indirectly
liable as an arranger for Olins waste disposal at the Big
D site and that GenCorp did not either actively control
Olins waste disposal choices or operate the plant on a
day-to-day basis. The Sixth Circuit Court of
26
Appeals also rejected GenCorps argument that the trial
courts decision did not constitute a final
judgment. GenCorp had argued that the trial court failed
to address GenCorps claims under the complaint, holding
such claims in abeyance. The decision of the three judge panel
of the Sixth Circuit Court of Appeals is that GenCorp is
responsible to Olin for costs and prejudgment interest in an
amount equal to approximately $29 million. GenCorp has
filed a petition for rehearing with the Sixth Circuit Court of
Appeals.
Wotus, et al. v. GenCorp Inc. and OMNOVA Solutions Inc.,
Case No. 5:00-CV-2604, U.S. District Court, N.D. Ohio
(Cleveland), served October 12, 2000. Plaintiffs are hourly
retirees six under the OMNOVA plan and three under the
GenCorp plan. Plaintiffs allege GenCorps and OMNOVAs
adoption and administration of new retiree medical plans
constitute a breach of labor contracts and violate alleged
obligations to provide lifetime medical benefits without
increased retiree contributions. Plaintiffs seek to reinstate
benefits under prior GenCorp Retiree Medical Plans, as
negotiated with their union at the time of retirement, as well
as the right to participate in improvements in subsequent plans
and the right to reimbursement of contributions paid in excess
of those required under prior medical benefit plans.
The trial court denied the plaintiffs motion for class
certification on December 2, 2003. The plaintiffs filed a
motion for reconsideration that was denied by the trial court.
Plaintiffs petitioned the Sixth Circuit Court of Appeals (Court
of Appeals) for the right to seek an interlocutory appeal of the
trial courts denial of class certification. The Court of
Appeals denied that petition in August 2004. Following the Court
of Appeals ruling on the interlocutory appeal, the trial court
denied a pending motion filed on behalf of 241 members of the
putative class who sought to intervene as individual plaintiffs.
The case will move forward with the nine named plaintiffs or
their estates. A trial in the Ohio federal court is not expected
until sometime after the summer of 2005.
A total of 294 individuals, including the 241 individuals who
sought to intervene in the Wotus matter, filed a separate
lawsuit against GenCorp and OMNOVA, also in the U.S. District
Court for the Northern District of Ohio, seeking the same claims
and relief (other than class certification) as in the Wotus
matter. Baumgardner, et al. v. GenCorp Inc. et al.,
U.S.D.C., N.D. OH (Cleveland, OH), Case No. 1:04 CV 1278.
The trial court dismissed their claims, ruling that the joinder
of the 294 individuals was improper. The trial court ordered
that the applicable statute of limitations would be tolled for
any individuals who filed individual claims until
February 28, 2005. On February 4, 2005, the former
Baumgardner plaintiffs filed individual complaints against the
Company and Omnova with the same allegations that were made in
the Baumgardner case.
Separately, on May 26, 2004, an arbitrator ruled that
GenCorp is required to defend and indemnify OMNOVA in the Wotus
matter. GenCorp has sought clarification, and possible
modification, of the ruling in Ohio state court.
Tolwin et al. v. GenCorp Inc. et al., Case
No. 04AS04580, Superior Court of the State of California,
County of Sacramento, served December 10, 2004. Plaintiff,
an alleged shareholder of GenCorp, alleges that the directors of
Company and one executive officer of the Company breached their
fiduciary duties by failing to give adequate consideration to
reasonable acquisition offers. Plaintiff seeks class action
status and on behalf of herself and other similarly situated
individuals and plaintiff seeks damages and injunctive relief.
27
Vinyl Chloride Cases. The following table sets forth
information related to our historical product liability costs
associated with our vinyl chloride litigation cases.
Vinyl Chloride Cases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(Dollars in thousands) | |
Claims filed
|
|
|
14 |
|
|
|
11 |
|
|
|
12 |
|
Claims dismissed
|
|
|
8 |
|
|
|
4 |
|
|
|
1 |
|
Claims settled
|
|
|
1 |
|
|
|
2 |
|
|
|
2 |
|
Claims pending
|
|
|
24 |
|
|
|
19 |
|
|
|
14 |
|
Aggregate settlement costs
|
|
$ |
425 |
|
|
$ |
55 |
|
|
$ |
58 |
|
Average settlement costs
|
|
$ |
425 |
|
|
$ |
27 |
|
|
$ |
29 |
|
Legal and administrative fees for the vinyl chloride cases for
fiscal 2004, fiscal 2003 and fiscal 2002 were approximately
$0.4 million, $0.4 million and $0.3 million,
respectively.
Asbestos Cases. The following table sets forth
information related to our historical product liability costs
associated with our asbestos litigation cases.
Asbestos Cases
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(Dollars in thousands) | |
Claims filed
|
|
|
63 |
|
|
|
40 |
|
|
|
14 |
|
Claims dismissed
|
|
|
27 |
|
|
|
21 |
|
|
|
16 |
|
Claims settled
|
|
|
8* |
|
|
|
6 |
|
|
|
7 |
|
Claims pending
|
|
|
70** |
|
|
|
42 |
|
|
|
29 |
|
Aggregate settlement costs
|
|
$ |
3,073* |
|
|
$ |
226 |
|
|
$ |
232 |
|
Average settlement costs
|
|
$ |
384* |
|
|
$ |
38 |
|
|
$ |
33 |
|
|
|
|
|
* |
Includes the Goede et al. v. Chesterton Inc. et al.
matter discussed in Note 13(b) to the Consolidated Financial
Statements. The aggregate settlement costs and average
settlement costs for fiscal 2004 include the Goede et al. v.
Chesterton Inc. et al. matter in which there was a judgment
of approximately $5.0 million against Aerojet, which was
reduced to approximately $2.0 million after setoff based on
plaintiffs settlements with other defendants. The total
amount paid, including interest accruing from the date of
judgment, was $2.0 million. |
|
|
** |
Does not include approximately 48 additional cases pending
against PCC Flow Technologies, Inc. and its affiliates
(PCC) for which we have agreed in principle to indemnify
PCC as discussed in greater detail in Note 13(b) to the
Consolidated Financial Statements under the heading
Asbestos Litigation. |
Legal and administrative fees for the asbestos cases for fiscal
2004, fiscal 2003, and fiscal 2002 were approximately
$1.0 million, $1.4 million, and $0.7 million,
respectively.
We are subject to other legal actions, governmental
investigations and proceedings relating to a wide range of
matters in addition to those discussed above. While there can be
no certainty regarding the outcome of any litigation,
investigation or proceeding, in the opinion of the our
management, after reviewing the information that is currently
available with respect to such matters, we believe that any
liability that may ultimately be incurred with respect to these
matters is not expected to materially affect our consolidated
financial condition. The effect of resolution of these matters
on our financial condition and results of operations cannot be
predicted because any such effect depends on future results of
operations, our liquidity
28
position and available financial resources, and the amount and
timing of the resolution of such matters. In addition, it is
possible that amounts incurred could be significant in any
particular reporting period.
Item 4. Submission of
Matters to a Vote of Security Holders
No matters were submitted to a vote of security holders, through
the solicitation of proxies or otherwise, during the quarter
ended November 30, 2004.
PART II
|
|
Item 5. |
Market for Registrants Common Equity, Related
Stockholders Matters and Issuer Purchases of Equity
Securities |
Our common stock is quoted on the New York Stock Exchange under
the trading symbol GY. The following table lists, on
a per share basis for the periods indicated, the high and low
sale prices for the common stock as reported by the New York
Stock Exchange:
|
|
|
|
|
|
|
|
|
|
|
|
Common Stock | |
|
|
Price | |
|
|
| |
Fiscal Year Ended November 30, |
|
High | |
|
Low | |
|
|
| |
|
| |
2003
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$ |
8.67 |
|
|
$ |
6.73 |
|
|
Second Quarter
|
|
$ |
8.45 |
|
|
$ |
6.00 |
|
|
Third Quarter
|
|
$ |
10.32 |
|
|
$ |
7.66 |
|
|
Fourth Quarter
|
|
$ |
10.49 |
|
|
$ |
8.75 |
|
2004
|
|
|
|
|
|
|
|
|
|
First Quarter
|
|
$ |
11.74 |
|
|
$ |
10.00 |
|
|
Second Quarter
|
|
$ |
11.82 |
|
|
$ |
10.18 |
|
|
Third Quarter
|
|
$ |
13.53 |
|
|
$ |
10.77 |
|
|
Fourth Quarter
|
|
$ |
17.70 |
|
|
$ |
12.03 |
|
As of January 31, 2005, there were 9,979 holders of record
of the common stock. On January 31, 2005, the last reported
sale price of our common stock on the New York Stock Exchange
was $18.58 per share.
During each quarter of fiscal 2002 and fiscal 2003 and during
the first two quarters of fiscal 2004, we paid a quarterly cash
dividend on our common stock of $0.03 per share. Our Board of
Directors has eliminated the payment of quarterly dividends
effective the third quarter of fiscal 2004. In December 2004,
the Company closed a new $180 million credit facility which
restricts the payment of dividends.
Information concerning long-term debt, including material
restrictions relating to payment of dividends on the our common
stock appears in Part II, Item 7 under the caption
Liquidity and Capital Resources and at Note 10
in Notes to Consolidated Financial Statements, which is
incorporated herein by reference. Information concerning
securities authorized for issuance under the our equity
compensation plans appears in Part III, Item 12 under
the caption Equity Compensation Plan Information
which is incorporated herein by reference.
|
|
|
Issuer Purchases of Equity Securities Made During the
Fourth Quarter of Fiscal 2004 |
On November 23, 2004, we used the net proceeds from the
offering of our
21/4%
Convertible Subordinated Debentures due 2024,
(21/4%
Debentures), to repurchase $70 million of our outstanding
53/4%
Convertible Subordinated Notes due 2007
(53/4%
Notes) and which are convertible into our common stock. At the
time of repurchase, the
53/4%
Notes were convertible, at the option of the holder, into the
Companys common stock at a conversion price of $18.42 per
share, for a total of 3.8 million shares of common stock.
29
In connection with the offering of the
21/4%
Debentures, we granted one of the initial purchasers an option
to purchase up to an additional $80 million aggregate
principal amount of the
21/4%
Debentures. A portion of this option was exercised during the
first quarter of fiscal 2005.
Item 6. Selected
Financial Data
The following selected financial data of the Company is
qualified by reference to and should be read in conjunction with
the consolidated financial statements of the Company, including
the notes thereto, and Managements Discussion and Analysis
of Financial Condition and Results of Operations.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2001 | |
|
2000 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except per share and dividend amounts) | |
Net sales(1)
|
|
$ |
499 |
|
|
$ |
348 |
|
|
$ |
277 |
|
|
$ |
640 |
|
|
$ |
534 |
|
Net income (loss):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations, net of income
taxes(2)
|
|
$ |
(86 |
) |
|
$ |
12 |
|
|
$ |
15 |
|
|
$ |
168 |
|
|
$ |
52 |
|
|
Income (loss) from discontinued operations, net of income
taxes(1)
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
|
|
(40 |
) |
|
|
|
|
|
Cumulative effect of change in accounting principle, net of
income taxes(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
74 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
|
$ |
128 |
|
|
$ |
126 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic earnings per share of Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations(2)
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.36 |
|
|
$ |
3.98 |
|
|
$ |
1.24 |
|
|
Income (loss) from discontinued operations(1)
|
|
|
(6.91 |
) |
|
|
0.24 |
|
|
|
0.35 |
|
|
|
(0.95 |
) |
|
|
|
|
|
Cumulative effect of change in accounting principle(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.76 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.71 |
|
|
$ |
3.03 |
|
|
$ |
3.00 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Diluted earnings per share of Common Stock
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations(2)
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.35 |
|
|
$ |
3.94 |
|
|
$ |
1.23 |
|
|
Income (loss) from discontinued operations(1)
|
|
|
(6.91 |
) |
|
|
0.24 |
|
|
|
0.35 |
|
|
|
(0.94 |
) |
|
|
|
|
|
Cumulative effect of change in accounting principle(3)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1.76 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.70 |
|
|
$ |
3.00 |
|
|
$ |
2.99 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash dividends paid per share of Common Stock
|
|
$ |
0.06 |
|
|
$ |
0.12 |
|
|
$ |
0.12 |
|
|
$ |
0.12 |
|
|
$ |
0.12 |
|
Other financial data:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
1,495 |
|
|
$ |
1,929 |
|
|
$ |
1,656 |
|
|
$ |
1,468 |
|
|
$ |
1,325 |
|
|
Long-term debt, including current maturities
|
|
$ |
577 |
|
|
$ |
538 |
|
|
$ |
387 |
|
|
$ |
214 |
|
|
$ |
190 |
|
|
|
(1) |
On August 31, 2004, the Company completed the sale of its
GDX Automotive (GDX) business. Also, in fiscal 2004,
management committed to a plan to sell the Companys Fine
Chemicals business. The GDX and Fine Chemicals businesses are
classified as discontinued operations in these Consolidated
Financial Statements and Notes to Consolidated Financial
Statements. |
|
(2) |
In October 2001, the Company sold its Electronics and
Information Systems (EIS) business to Northrop Grumman for
$315 million. The gain on the transaction was
$206 million. EIS contributed net sales of
$398 million and $323 million, respectively, for
fiscal 2001 and fiscal 2000. |
|
(3) |
Effective December 1, 1999, the Company changed its methods
for determining the market-related value of plan assets used in
determining the expected return-on-assets component of annual
net pension costs and the amortization of gains and losses for
both pension and postretirement benefit costs. |
30
|
|
Item 7. |
Managements Discussion and Analysis of Financial
Condition and Results of Operations |
We begin Managements Discussion and Analysis of Financial
Condition and Results of Operations with an overview of our
business and operations. This is followed by a discussion of our
results of operations, including results for our operating
segments, for the past two fiscal years. We then provide,
beginning on page 37, an analysis of our liquidity and
capital resources, including discussions of our cash flows, debt
arrangements, sources of capital and financial commitments. In
the next section, beginning on page 41, we discuss the
critical accounting policies that we believe are important to
understanding the assumptions and judgments incorporated in our
reported financial results. Finally, on page 47, we discuss
our use of certain forward looking statements that present our
expectations, beliefs, plans and objectives.
The following discussion should be read in conjunction with the
other sections of this Report, including the consolidated
financial statements and notes thereto appearing in Item 8
of this Report, the Risk Factors appearing in Item 1 of
this Report and the subsection captioned Forward-Looking
Statements below. Historical results set forth in
Item 6 and Item 8 of this Report should not be taken
as indicative of our future operations.
Overview
We are a technology-based manufacturer operating primarily in
the United States. Our continuing operations are organized into
two operating segments: Aerospace and Defense and Real Estate.
The Aerospace and Defense segment includes the operations of
Aerojet, which develops and manufactures propulsion systems for
space and defense applications, armament systems for precision
tactical weapon systems and munitions applications, and advanced
airframe structures. Primary customers served include major
prime contractors to the U.S. government, the DoD and NASA. The
Real Estate segment includes activities related to the
development, sale and leasing of our real estate assets.
During the second quarter of fiscal 2004, we announced plans to
sell our GDX business, which developed and manufactured vehicle
sealing systems for automotive original equipment manufacturers.
This decision was a result of declining volumes and continued
challenges in this market environment including adverse customer
pricing pressures, increased material costs, high development
and start-up costs and increased working capital requirements.
In accordance with our plan to sell the GDX business, we
classified our GDX business as a discontinued operation during
the second quarter of fiscal 2004. During the third quarter of
fiscal 2004, we completed the sale of GDX to Cerberus Capital
Management, L.P. for $147 million, subject to adjustment,
of which $140 million had been received as of
November 30, 2004. In addition, on October 15, 2004,
we announced our strategic decision to sell our Fine Chemicals
business, which, through Aerojet Fine Chemicals, is a custom
manufacturer of active pharmaceutical ingredients and registered
intermediates for pharmaceutical and biotechnology companies.
This plan was a result of managements decision to focus
our capital and resources on our Aerospace and Defense and Real
Estate businesses. We will continue to operate our Fine
Chemicals business in the ordinary course of business pending
any sale. We classified our Fine Chemicals business segment as a
discontinued operation as of the third quarter of fiscal 2004.
See additional discussion in Note 17 in Notes to
Consolidated Financial Statements. For all periods presented, we
have classified the results of operations of GDX and Fine
Chemicals as discontinued operations in the Consolidated
Statements of Income. The assets and liabilities of GDX have
been classified as Assets of Discontinued Operations and
Liabilities of Discontinued Operations in the Condensed
Consolidated Balance Sheets as of November 30, 2003. The
assets and liabilities of Fine Chemicals have been classified as
Assets of Discontinued Operations and Liabilities of
Discontinued Operations in the Consolidated Balance Sheets as of
November 30, 2004 and 2003.
31
Results of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
|
|
|
|
| |
|
2004 vs. | |
|
2003 vs. | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net Sales
|
|
$ |
499 |
|
|
$ |
348 |
|
|
$ |
277 |
|
|
$ |
151 |
|
|
$ |
71 |
|
Costs and Expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold
|
|
|
447 |
|
|
|
260 |
|
|
|
200 |
|
|
|
187 |
|
|
|
60 |
|
Selling, general and administrative
|
|
|
49 |
|
|
|
31 |
|
|
|
8 |
|
|
|
18 |
|
|
|
23 |
|
Depreciation and amortization
|
|
|
31 |
|
|
|
28 |
|
|
|
21 |
|
|
|
3 |
|
|
|
7 |
|
Interest expense
|
|
|
35 |
|
|
|
22 |
|
|
|
9 |
|
|
|
13 |
|
|
|
13 |
|
Other (income) expense, net
|
|
|
(15 |
) |
|
|
(9 |
) |
|
|
5 |
|
|
|
(6 |
) |
|
|
(14 |
) |
Unusual items, net
|
|
|
9 |
|
|
|
5 |
|
|
|
15 |
|
|
|
4 |
|
|
|
(10 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
|
556 |
|
|
|
337 |
|
|
|
258 |
|
|
|
219 |
|
|
|
79 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
|
|
(57 |
) |
|
|
11 |
|
|
|
19 |
|
|
|
(68 |
) |
|
|
(8 |
) |
Income tax (benefit) provision
|
|
|
29 |
|
|
|
(1 |
) |
|
|
4 |
|
|
|
30 |
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(86 |
) |
|
|
12 |
|
|
|
15 |
|
|
|
(98 |
) |
|
|
(3 |
) |
Income (loss) from discontinued operations, net of tax
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
|
|
(322 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
|
$ |
(420 |
) |
|
$ |
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Consolidated net sales increased to $499 million in fiscal
2004 compared to $348 million in fiscal 2003. The increase
in sales was primarily due to $156 million of sales
contributed by the propulsion business of ARC, which was
acquired in October 2003.
Consolidated net sales increased to $348 million in fiscal
2003 compared to $277 million in fiscal 2002. The increase
is primarily the effect of acquisitions at Aerojet and increased
real estate asset sales. The acquisition of the Redmond,
Washington operations in October 2002 and the ARC acquisition in
October 2003 contributed an additional $68 million in net
sales in fiscal 2003 as compared to fiscal 2002.
During fiscal 2004, Lockheed Martin and Raytheon accounted for
32% and 15%, respectively, of net sales. During fiscal 2003,
Lockheed Martin, Boeing, and Raytheon accounted for 28%, 15%,
and 10%, respectively, of net sales. During fiscal 2002,
Lockheed Martin, Boeing, Raytheon, and NASA accounted for 21%,
18%, 13%, and 13%, respectively, of net sales. Sales in fiscal
2004, fiscal 2003 and fiscal 2002 directly and indirectly to the
U.S. government and its agencies (principally the DoD),
including sales to our significant customers discussed above,
totaled $420 million, $263 million and
$243 million, respectively.
|
|
|
Income (Loss) from Continuing Operations Before Income
Taxes |
We reported a loss from continuing operations before income
taxes of $57 million during fiscal 2004 compared to
$11 million of income from continuing operations in fiscal
2003. This decrease is primarily due to the following:
|
|
|
|
|
We had declines in segment performance for our Aerospace and
Defense and Real Estate segments. See below for a more detailed
discussion of segment performance. |
|
|
|
Employee retirement benefit expense of $44 million in
fiscal 2004 compared to income of $1 million in fiscal
2003. See discussion under Employee Pension and
Postretirement Plans, below. |
32
|
|
|
|
|
Interest expense increased to $35 million in fiscal 2004
from $22 million in fiscal 2003. The increase is primarily
the result of higher debt levels and average interest rates.
Additional debt includes amounts incurred to finance the ARC
acquisition completed in October 2003, to fund working capital
in fiscal 2004, and to refinance a portion of the
53/4%
Convertible Subordinated Notes with the issuance of the
21/4%
Convertible Subordinated Debentures in November 2004. Net cash
proceeds from the sale of GDX received in August 2004 and the
Equity Offering in November 2004 were held as restricted cash as
of November 30, 2004 and were used to reduce debt balances
subsequent to the fiscal year-end. |
|
|
|
We had increased spending related to our corporate functions.
See below for a more detailed discussion. |
|
|
|
We recorded unusual charges of $9 million in fiscal 2004
versus $5 million in fiscal 2003. A discussion of unusual
items is included under Unusual Items following the
Companys discussion of segment results. |
The decrease in income from continuing operations before income
taxes of $8 million during fiscal 2003 compared to fiscal
2002 is primarily due to the following:
|
|
|
|
|
We recognized improvements in segment performance for our
Aerospace and Defense and Real Estate segments. See below for a
more detailed discussion of segment performance. |
|
|
|
Asset sales by the Real Estate segment resulted in gross profit
of $19 million in fiscal 2003. There were no asset sales in
fiscal 2002. |
|
|
|
Interest expense increased to $22 million in fiscal 2003
from $9 million in fiscal 2002 primarily due to the debt
incurred to finance the Redmond Washington acquisition completed
in October 2002 and the ARC acquisition completed in October
2003. |
|
|
|
Employee benefit plan income of $1 million in fiscal 2003
compared to income of $38 million in fiscal 2002. See
discussion under Employee Pension and Postretirement
Plans, below. |
|
|
|
We recorded unusual charges of $5 million in fiscal 2003
versus $15 million in fiscal 2002. A discussion of unusual
items is included under Unusual Items following the
Companys discussion of segment results. |
|
|
|
Income Tax (Benefit) Provision |
In fiscal 2004, a net income tax provision for continuing
operations of $29 million was recorded consisting of
$34 million primarily to reflect the uncertainty of
realizing tax benefits, given historical losses, offset by
$5 million benefit primarily related to research tax credit
refund claims. We recorded a net income tax benefit of
$1 million in fiscal 2003 resulting from $5 million in
domestic federal and state tax settlements. Our tax provision in
fiscal 2002 was favorably impacted by a reduction of
$4 million for federal and state income tax settlements and
$1 million for the tax benefit of a charitable gift of real
property.
|
|
|
Income (Loss) from Discontinued Operations |
During the second quarter of fiscal 2004, the GDX business net
assets were adjusted to managements estimate of proceeds
to be received on disposition less costs to sell. During the
third quarter of fiscal 2004, we signed a definitive agreement
to sell GDX, including substantially all of the assets of
GenCorp Inc. that were used in the GDX business and
substantially all of GenCorp Inc.s worldwide subsidiaries
that were engaged in the GDX business, to Cerberus for
$147 million, subject to adjustment, of which
$140 million has been received as of November 30,
2004. We closed the transaction on August 31, 2004. The
loss on the sale of the GDX business during fiscal 2004 was
$279 million. During the third quarter of fiscal 2004, we
classified the Fine Chemicals business as a discontinued
operation as a result of our plans to sell the business. This
plan was a result of managements decision to focus our
capital and resources on our Aerospace and Defense and Real
Estate operating segments.
33
In November 2003, we announced we were closing a GDX
manufacturing facility in Chartres, France. The decision
resulted primarily from declining sales volumes with French
automobile manufacturers. In June 2004, we completed the legal
process for closing the facility and establishing a social plan.
As a result, we recorded a pre-tax expense of approximately
$14 million during fiscal 2004 primarily related to
employee social costs. The charge is included as a component of
discontinued operations. We have not yet recorded expenses
associated with certain social benefits due to the uncertainty
of the benefit amount. These additional social costs are
expected to result in an additional pre-tax expense of
$1 million to $3 million and are anticipated to be
incurred over the next two years. We will recognize the related
costs once they are certain in accordance with accounting
principles generally accepted in the United States.
Summarized financial information for the GDX and Fine Chemicals
operations (discontinued operations) is set forth below (dollars
in millions):
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net sales
|
|
$ |
629 |
|
|
$ |
844 |
|
|
$ |
858 |
|
Income (loss) before income taxes
|
|
|
(308 |
) |
|
|
6 |
|
|
|
23 |
|
Income tax benefit (provision)
|
|
|
(4 |
) |
|
|
4 |
|
|
|
(8 |
) |
Net income (loss) from discontinued operations
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
Segment Results
We evaluate our operating segments based on several factors, of
which the primary financial measure is segment performance.
Segment performance, which is a non-GAAP financial measure,
represents net sales from continuing operations less applicable
costs, expenses and provisions for unusual items relating to
operations. Segment performance excludes corporate income and
expenses, provisions for unusual items not related to the
operations, interest expense and income taxes.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
|
|
|
|
November 30, | |
|
|
|
|
|
|
| |
|
2004 vs. | |
|
2003 vs. | |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net Sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
492 |
|
|
$ |
321 |
|
|
$ |
271 |
|
|
$ |
171 |
|
|
$ |
50 |
|
|
Real Estate
|
|
|
15 |
|
|
|
32 |
|
|
|
6 |
|
|
|
(17 |
) |
|
|
26 |
|
|
Intersegment sales elimination
|
|
|
(8 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
499 |
|
|
$ |
348 |
|
|
$ |
277 |
|
|
$ |
151 |
|
|
$ |
71 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Performance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
57 |
|
|
$ |
45 |
|
|
$ |
32 |
|
|
$ |
12 |
|
|
$ |
13 |
|
|
Benefit plan income (expense)(1)
|
|
|
(27 |
) |
|
|
3 |
|
|
|
24 |
|
|
|
(30 |
) |
|
|
(21 |
) |
|
Unusual items(2)
|
|
|
|
|
|
|
(5 |
) |
|
|
(12 |
) |
|
|
5 |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
|
30 |
|
|
|
43 |
|
|
|
44 |
|
|
|
(13 |
) |
|
|
(1 |
) |
|
|
Real Estate
|
|
|
12 |
|
|
|
23 |
|
|
|
3 |
|
|
|
(11 |
) |
|
|
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Performance
|
|
$ |
42 |
|
|
$ |
66 |
|
|
$ |
47 |
|
|
$ |
(24 |
) |
|
$ |
19 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
34
A reconciliation of segment performance to income from
continuing operations before income taxes is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Performance
|
|
$ |
42 |
|
|
$ |
66 |
|
|
$ |
47 |
|
|
$ |
(24 |
) |
|
$ |
19 |
|
|
Interest expense
|
|
|
(35 |
) |
|
|
(22 |
) |
|
|
(9 |
) |
|
|
(13 |
) |
|
|
(13 |
) |
|
Corporate benefit plan income (expense)(1)
|
|
|
(17 |
) |
|
|
(2 |
) |
|
|
14 |
|
|
|
(15 |
) |
|
|
(16 |
) |
|
Corporate and other expenses
|
|
|
(38 |
) |
|
|
(31 |
) |
|
|
(30 |
) |
|
|
(7 |
) |
|
|
(1 |
) |
|
Unusual items(2)
|
|
|
(9 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
(9 |
) |
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
|
$ |
(57 |
) |
|
$ |
11 |
|
|
$ |
19 |
|
|
$ |
(68 |
) |
|
$ |
(8 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
See discussion of benefit plan income (expense) under the
caption Employee Pension and Postretirement Benefit
Plans following the segment discussion. Discussions of the
individual operating segments results below exclude these
items. |
|
(2) |
See discussion of unusual charges under the caption
Unusual Items following the segment discussion.
Discussions of the individual operating segments results
below exclude these items. |
Aerospace and Defense
Net sales for the Aerospace and Defense segment totaled
$492 million for fiscal 2004, an increase of 53% compared
with sales of $321 million for fiscal 2003. The ARC
business acquired in October 2003 contributed $156 million
of the increase. Excluding sales increases attributable to the
ARC acquisition, programs contributing higher sales were as
follows: increased deliveries to Boeing on the F-22/ A program,
volume on the recently acquired THAAD program and higher sales
on programs utilizing electric and liquid thrusters for orbit
and attitude maintenance. The sales increases were offset by
lower volume on a variety of defense and armament programs.
Segment performance before unusual items and benefit plan
expense was $57 million and $45 million for fiscal
2004 and fiscal 2003, respectively. Operating income for fiscal
2004 increased over fiscal 2003 performance from higher sales
volume, and a $16 million favorable environmental reserve
adjustment. Segment performance for fiscal 2004 included an
inventory write down of $16 million on a contract to
design, develop, and produce solid rocket motors for Lockheed
Martins Atlas V Program. The write-down relates to
unanticipated transition costs from the development phase to the
production phase of the contract and the value of materials
rendered obsolete by a decision to proceed with qualification
and production of an enhanced motor configuration. In
managements judgment, these costs will not be recoverable
on the contract. The current Atlas V contract provides for
production of 44 motors over a number of years and for the order
of an additional 52 motors at Lockheed Martins option. At
November 30, 2004, Aerojets Atlas V inventory
balance was $126 million. Full recovery of this investment
is subject to uncertainties, including: (i) Aerojets
ability to produce motors at its estimated average unit price,
(ii) final pricing of the enhanced motor configuration, and
(iii) a satisfactory renegotiation of contract terms with
Lockheed Martin. Aerojet believes its Atlas V contract will
be restructured during 2005 when launch services contracts
between launch vehicle manufacturers and the
U.S. government are modified to reflect cost pressures
resulting from continued low commercial launch activity. Details
of the form and terms of the anticipated changes are unknown at
this time. Aerojet management believes that continued
improvements in operational efficiency and renegotiation of
contract terms will permit recovery of inventoried development
and production costs. However, if managements efforts are
unsuccessful, Aerojet may be required to recognize additional
material losses.
Contract backlog was $879 million at November 30, 2004
as compared to $830 million as of November 30, 2003.
Funded backlog, which includes only those contracts for which
money has been directly authorized by the U.S. Congress, or
for which a purchase order has been received by a commercial
customer, was $538 million at November 2004 compared to
$425 million as of November 30, 2003. Overall, backlog
growth reflects contract awards in excess of sales on both
production and development programs.
35
Net sales for the Aerospace and Defense segment totaled
$321 million for fiscal 2003, an increase of 18% compared
with fiscal 2002 sales of $271 million. The acquisition of
the Redmond, Washington operations in October 2002 and the ARC
acquisition in October 2003 contributed an additional
$68 million in net sales in fiscal 2003 as compared to
fiscal 2002. In addition to sales increases from recent
acquisitions, programs contributing higher sales were as
follows: Missile and Defense application programs, Boeings
HyFly program, deliveries of Atlas V solid rocket motors,
greater Titan IV volume, ordnance programs and increased
volumes on various technology programs. These increases were
offset by completion of the NASA X-38 De-Orbit Propulsion
Stage in 2002, cancellation of the COBRA booster engine program
in 2002 and lower volumes on other programs.
Before unusual items and benefit plan income, segment
performance for the Aerospace and Defense segment was
$45 million for fiscal 2003 as compared to $32 million
in fiscal 2002, an improvement of $13 million. Increased
segment performance reflects higher sales due to recent
acquisitions, improved profit margins on the Delta program, and
the effects of overall operational improvements.
In October 2003, Aerojet acquired the propulsion business of ARC
for $144 million, including estimated transaction costs and
purchase price adjustments. Aerojets 2003 operating
results include sales of $18 million and negligible
earnings from this acquired business (as described more fully in
Note 11 in Notes to Consolidated Financial Statements).
Real Estate
Real Estate sales and segment performance for fiscal 2004 were
$15 million and $12 million, respectively, compared to
$32 million and $23 million, respectively, for fiscal
2003. The fiscal 2003 results included sales of several real
estate assets. Results for fiscal 2004 do not include any sales
of real estate assets, but do include a property usage agreement
with the Sacramento Regional Transit for construction of a Light
Rail station adjacent to property we intend to develop. We also
finalized an agreement with Granite Construction Company for the
exclusive rights to mine excess aggregates from certain portions
of our Sacramento property.
Real Estate net sales and segment performance for fiscal 2003
were $32 million and $23 million, respectively,
compared to $6 million and $3 million, respectively,
for fiscal 2002. The fiscal 2003 net sales and segment
performance increases were driven by sales of real estate assets
while fiscal 2002 performance reflected only leasing activities.
Asset sales for fiscal 2003 included a 96,000 square foot
office complex on 11 acres in Sacramento County for
$15 million, 20 acres of undeveloped land for
$6 million, and other smaller property sales.
Corporate and Other Expenses
Corporate and other expenses increased to $38 million in
fiscal 2004 compared to $31 million in fiscal 2003. The
increase in spending was primarily due to the following:
(i) increases in professional accounting fees primarily
related to Sarbanes-Oxley compliance, (ii) a
$2 million environmental remediation charge related to a
former operating site, and (iii) increases in insurance
costs.
Corporate and other expenses increased to $31 million in
fiscal 2003 compared to $30 million in fiscal 2002.
Expenses for fiscal 2002 included $6 million in costs for
outside legal advisors and accounting consultants involved in
the special review of prior year accounting matters at GDX.
Corporate and other expenses included amortization of debt
financing costs of $5 million in fiscal 2003 and
$4 million in fiscal 2002.
36
Employee Pension and Postretirement Benefit Plans
Income (expense) from benefit plans is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Aerospace and Defense
|
|
$ |
(27 |
) |
|
$ |
3 |
|
|
$ |
24 |
|
Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
(17 |
) |
|
|
(2 |
) |
|
|
14 |
|
|
|
|
|
|
|
|
|
|
|
Benefit plan income (expense)
|
|
$ |
(44 |
) |
|
$ |
1 |
|
|
$ |
38 |
|
|
|
|
|
|
|
|
|
|
|
Benefit plan expense recognized in fiscal 2004 increased by
$45 million as compared to fiscal 2003, and benefit plan
income recognized in fiscal 2003 decreased by $37 million
as compared to fiscal 2002. The increased cost of benefit plans
is primarily due to the recognition of the underperformance of
the U.S. pension plan assets in prior years and is also
affected by our decision in fiscal 2003 and fiscal 2004 to
decrease the discount rate used to determine benefit
obligations, due to lower market interest rates.
Unusual Items
Charges associated with unusual items are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Aerospace and Defense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecoverable portion of legal settlement with local water
company
|
|
$ |
|
|
|
$ |
5 |
|
|
$ |
|
|
|
Write-off of the Redmond, Washington operations in-process
research and development
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
Final settlement on Aerojet sale of EIS business
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
12 |
|
Corporate Headquarters:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reacquisition of Fine Chemicals minority interest
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
Loss on repayment of convertible subordinated notes
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
Write-off of bank fees for Term Loan repayment
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Unusual expense
|
|
$ |
9 |
|
|
$ |
5 |
|
|
$ |
15 |
|
|
|
|
|
|
|
|
|
|
|
In fiscal 2004, we incurred a $9 million charge as a result
of the repayment of $70 million of principal of the
53/4% Convertible
Subordinated Notes.
In fiscal 2003, Aerojet recorded an unusual charge of
$5 million representing the unrecoverable portion of an
estimated legal settlement with a local water company related to
contaminated wells.
In fiscal 2002, Aerojet charged $6 million to expense for
acquired in-process research and development resulting from the
acquisition of the Redmond, Washington operations. In fiscal
2002, Aerojet reached an agreement on the purchase price
adjustments related to the sale of its EIS business whereby
Aerojet reduced the purchase price by $6 million. Also in
fiscal 2002, we reacquired the minority ownership interest in
our AFC subsidiary and certain agreements between AFC and
NextPharma were terminated, resulting in an expense of
$2 million.
37
Environmental Matters
Our policy is to conduct our businesses with due regard for the
preservation and protection of the environment. We devote a
significant amount of resources and management attention to
environmental matters and actively manage our ongoing processes
to comply with environmental laws and regulations. We are
involved in the remediation of environmental conditions that
resulted from generally accepted manufacturing and disposal
practices in the 1950s and 1960s followed at certain plants. In
addition, we have been designated a PRP with other companies at
third party sites undergoing investigation and remediation.
Estimating environmental remediation costs is difficult due to
the significant uncertainties inherent in these activities,
including the extent of the remediation required, changing
governmental regulations and legal standards regarding
liability, evolving technologies and the long periods of time
over which most remediation efforts take place. In accordance
with the American Institute of Certified Public
Accountants Statement of Position 96-1 (SOP 96-1),
Environmental Remediation Liabilities and Staff
Accounting Bulletin No. 92 (SAB 92), Accounting and
Disclosure Relating to Loss Contingencies, we:
|
|
|
|
|
accrue for costs associated with the remediation of
environmental pollution when it becomes probable that a
liability has been incurred and when our proportionate share of
the costs can be reasonably estimated. In some cases, only a
range of reasonably possible costs can be estimated. In
establishing our reserves, the most probable estimate is used
when determinable and the minimum estimate is used when no
single amount is more probable; and |
|
|
|
record related estimated recoveries when such recoveries are
deemed probable. |
Expenditures for recurring costs associated with managing
hazardous substances or pollutants in ongoing operations was
$13 million in fiscal 2004 compared to $7 million in
fiscal 2003 and $8 million in fiscal 2002.
We continually review estimated future remediation costs that we
could incur, which take into consideration the investigative
work and analysis of our engineers and the advice of our legal
staff regarding the status and anticipated results of various
administrative and legal proceedings. In most cases only a range
of reasonably possible costs can be estimated. In establishing
our reserves, the most probable estimated amount is used when
determinable and the minimum is used when no single amount is
more probable. The timing of payment for estimated future
environmental costs is subject to variability and depends on the
timing of regulatory approvals for planned remedies and the
construction and completion of the remedies.
Quarterly, we complete a review of estimated future
environmental costs which incorporates, but is not limited to,
the following: (i) status of work completed since the last
estimate; (ii) expected cost savings related to the
substitution of new remediation technology and to information
not available previously; (iii) obligations for
reimbursement of regulatory agency service costs;
(iv) updated cost estimates; (v) costs of complying
with the Western Groundwater Administrative Order, including
replacement water and remediation upgrades; (vi) estimated
costs related to the Inactive Rancho Cordova Test Site
(IRCTS) and Aerojets Sacramento site; (vii) new
information related to the extent and location of previously
unidentified contamination; and (viii) additional
construction costs. Our review of estimated future remediation
costs resulted in additions to our environmental reserves of
$25 million in fiscal 2004, $12 million in fiscal 2003
and $107 million in fiscal 2002.
The effect of the final resolution of environmental matters and
our obligations for environmental remediation and compliance
cannot be accurately predicted due to the uncertainty concerning
both the amount and timing of future expenditures and due to
regulatory or technological changes. We believe, on the basis of
presently available information, that the resolution of
environmental matters and our obligations for environmental
remediation and compliance will not have a material adverse
effect on our results of operations, liquidity or financial
condition. We will continue our efforts to mitigate past and
future costs through pursuit of claims for recoveries from
insurance coverage and other PRPs and continued investigation of
new and more cost effective remediation alternatives and
associated technologies.
38
A summary of our environmental reserve activity is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, | |
|
2002 | |
|
2002 | |
|
November 30, | |
|
2003 | |
|
2003 | |
|
November 30, | |
|
2004 | |
|
2004 | |
|
November 30, | |
|
|
2001 | |
|
Additions | |
|
Expenditures | |
|
2002 | |
|
Additions | |
|
Expenditures | |
|
2003 | |
|
Additions | |
|
Expenditures | |
|
2004 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Aerojet
|
|
$ |
252 |
|
|
$ |
107 |
|
|
$ |
(41 |
) |
|
$ |
318 |
|
|
$ |
12 |
|
|
$ |
(32 |
) |
|
$ |
298 |
|
|
$ |
23 |
|
|
$ |
(34 |
) |
|
$ |
287 |
|
Other Sites
|
|
|
27 |
|
|
|
|
|
|
|
(5 |
) |
|
|
22 |
|
|
|
|
|
|
|
(5 |
) |
|
|
17 |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Environmental Reserve
|
|
$ |
279 |
|
|
$ |
107 |
|
|
$ |
(46 |
) |
|
$ |
340 |
|
|
$ |
12 |
|
|
$ |
(37 |
) |
|
$ |
315 |
|
|
$ |
25 |
|
|
$ |
(36 |
) |
|
$ |
304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2004, the Aerojet reserves include
$170 million for the Sacramento site, $99 million for
BPOU, and $18 million for other Aerojet sites. The reserves
for Other Sites include $7 million for the Lawrence,
Massachusetts site.
On January 12, 1999, Aerojet and the U.S. government
implemented an Agreement in Principle (Global Settlement)
resolving certain prior environmental and facility
disagreements, with retroactive effect to December 1,
1998. The Global Settlement covered all environmental
contamination at the Sacramento and Azusa sites. Under the
Global Settlement, Aerojet and the U.S. government resolved
disagreements about an appropriate cost-sharing ratio. The
Global Settlement provides that the cost-sharing ratio will
continue for a number of years.
Pursuant to the Global Settlement covering environmental costs
associated with Aerojets Sacramento site and its former
Azusa site, the Company can recover up to 88% of its
environmental remediation costs for these sites through the
establishment of prices for Aerojets products and services
sold to the U.S. government. Allowable environmental costs
are charged to these contracts as the costs are incurred.
Aerojets mix of contracts can affect the actual
reimbursement made by the U.S. government. Because these
costs are recovered through forward pricing arrangements, the
ability of Aerojet to continue recovering these costs depends on
its sustained business volume under U.S. government
contracts and programs and the relative size of its commercial
business.
In conjunction with the sale of EIS, Aerojet entered into an
agreement with Northrop whereby Aerojet will be reimbursed by
Northrop for a portion of environmental expenditures eligible
for recovery under the Global Settlement. Amounts reimbursed are
subject to annual limitations, with excess amounts carrying over
to subsequent periods, the total of which will not exceed
$190 million over the term of the agreement, which ends in
2028. As of November 30, 2004, $158 million in
potential future reimbursements were available over the
remaining life of the agreement.
As part of the acquisition of the propulsion business of ARC,
Aerojet entered into an agreement with ARC pursuant to which
Aerojet is responsible for up to $20 million of costs
(Pre-Close Environmental Costs) associated with environmental
issues that arose prior to Aerojets acquisition of the ARC
propulsion business. Pursuant to an agreement with the
U.S. government which was entered into prior to the closing
of the ARC acquisition, these Pre-Close Environmental Costs will
be treated as allowable costs and combined with Aerojet
environmental costs under the Global Settlement, and will be
recovered through the establishment of prices for Aerojets
products and services sold to the U.S. government. These
costs will be allocable to all Aerojet operations (including the
previously excluded Redmond, Washington operations) beginning in
2005.
In conjunction with the ARC acquisition, Aerojet signed a
Memorandum of Understanding with the U.S. government
agreeing to key assumptions and conditions that will preserve
the original methodology to be used in recalculating the
percentage allocation between Aerojet and Northrop. Aerojet has
presented a proposal to the U.S. government based on the
Memorandum of Understanding and expects to complete an agreement
in the near term.
In conjunction with our review of our environmental reserves
discussed above, we revise our estimate quarterly of costs that
will be recovered under the Global Settlement based on business
expected to be conducted under contracts with the
U.S. government and our agencies in the future. The
adjustments to the
39
environmental remediation reserves and estimated future cost
recoveries did not affect operating results in 2002 as the
impact of increases to the reserves of $107 million was
offset by increased estimated future recoveries. In fiscal 2003,
due to the Global Settlement and Memorandum of Understanding
with the U.S. government, discussed above, which allows for
costs to be allocated to all Aerojet operations beginning in
2005 and decreases the costs allocated to Northrop annually,
Aerojet increased its environmental reserves by $12 million
and estimated recoveries by $13 million, which resulted in
other income of $1 million in our statement of operations.
The recovery of costs under the Global Settlement is based, in
part on the relative size of Aerojets commercial business
base, which has historically included the Fine Chemicals
operating segment because it was previously a division of
Aerojet. As a result of our plan to sell Fine Chemicals, Aerojet
revised its estimated recovery of costs under the Global
Settlement during fiscal 2004. As a result, Aerojet increased
its estimated recoveries by $38 million and recorded
$16 million of other income (expense), net in fiscal 2004.
For additional discussion of environmental and related legal
matters, see Note 13 in Notes to Consolidated Financial
Statements.
Liquidity and Capital Resources
Cash and cash equivalents increased by $4 million during
the year ended November 30, 2004. The change in cash and
cash equivalents is summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net Cash Provided by (Used in) Operating Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
$ |
5 |
|
|
$ |
(12 |
) |
|
$ |
(54 |
) |
|
Discontinued operations
|
|
|
(35 |
) |
|
|
56 |
|
|
|
37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(30 |
) |
|
|
44 |
|
|
|
(17 |
) |
Net Cash Used in Investing Activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Continuing operations
|
|
|
(78 |
) |
|
|
(149 |
) |
|
|
(121 |
) |
|
Discontinued operations
|
|
|
(41 |
) |
|
|
(31 |
) |
|
|
(20 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
(119 |
) |
|
|
(180 |
) |
|
|
(141 |
) |
Net Cash Provided by Financing Activities:
|
|
|
157 |
|
|
|
144 |
|
|
|
159 |
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
|
(4 |
) |
|
|
8 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Increase in cash and cash equivalents
|
|
$ |
4 |
|
|
$ |
16 |
|
|
$ |
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by (Used in) Operating Activities |
Net cash provided by continuing operations was $5 million
in fiscal 2004, compared to net cash used of $12 million in
fiscal 2003, and $54 million in fiscal 2002.
Cash flow from continuing operations in fiscal 2004 as compared
to fiscal 2003 reflects: (i) improved cash flow from the
Aerospace and Defense segment as a result of increased segment
performance before the non-cash impact of retirement benefit
plans, including positive cash flow from the ARC business
acquired in October 2003, partially offset by working capital
requirements for certain programs, primarily Atlas V;
(ii) cash flow from the Real Estate segment as a result of
real estate asset sales completed in fiscal 2004 plus the full
payment of a note receivable of $20 million; partially
offset by; (iii) increased interest costs as a result of
higher debt levels; and (iv) increased corporate expenses.
Cash flow from continuing operations in fiscal 2003 as compared
to fiscal 2002 reflects: (i) improved cash flow for the
Aerospace and Defense segment as a result of increased segment
performance before the non-cash impact of retirement benefit
plans and a reduction in working capital usage;
(ii) improved cash flows for the
40
Real Estate segment as a result of the real estate asset sales
completed in 2003 as compared to no asset sales in 2002;
partially offset by; (iii) increased interest costs as a
result of higher debt levels primarily related to the Aerospace
and Defense segment acquisitions.
Net cash used in discontinued operations was $35 million in
fiscal 2004, compared to net cash provided of $56 million
in fiscal 2003, and $37 million in fiscal 2002.
|
|
|
Net Cash Used In Investing Activities |
Net cash used in investing activities for continuing operations
was $78 million in fiscal 2004, $149 million for
fiscal 2003, and $121 million for fiscal 2002.
Investing activities for continuing operations included capital
expenditures of $21 million for fiscal 2004,
$11 million for fiscal 2003, and $14 million for
fiscal 2002. Capital expenditures directly support the
Companys contracts and customer requirements and are
primarily made for asset replacement, capacity expansion,
development of new projects, cost reduction initiatives and
safety and productivity improvements. The increase in capital
expenditures in fiscal 2004 as compared to fiscal 2003 is
primarily due to consolidation efforts associated with the ARC
acquisition, including capital investment for equipment and
facilities.
Investing activities for continuing operations in 2004 also
include $140 million in proceeds received from the sale of
GDX business in August 2004, $4 million in proceeds from
the sale of the certain assets acquired with the ARC
acquisition; offset by $70 million of GDX proceeds and
$131 million of the equity proceeds received in November
2004 designated as restricted cash in accordance with agreements
reached with the senior lenders under our senior credit facility
(see Note 10 in Notes to Consolidated Financial Statements).
Investing activities for continuing operations in fiscal 2003
include $138 million paid for the acquisition of the ARC
propulsion business, including transaction costs. Investing
activities for continuing operations in fiscal 2002 include
$93 million paid for the purchase of the Redmond,
Washington operations, $8 million related to our
reacquisition of the minority ownership interest in Fine
Chemicals, and $6 million related to a purchase price
adjustment for the sale of EIS.
Net cash used in investing activities for discontinued
operations was $41 million in fiscal 2004, $31 million
in fiscal 2003, and $20 million in fiscal 2002.
|
|
|
Net Cash Provided by Financing Activities |
Net cash provided by financing activities for fiscal 2004 was
$157 million compared with $144 million for fiscal
2003, and $159 million for fiscal 2002. Cash flows from
financing activities in fiscal 2004 reflect the proceeds of the
equity offering (see Note 14 in Notes to Consolidated
Financial Statements) and our borrowings, net of repayments.
Cash flows from financing activities in 2003 and 2002 relate
primarily to activities involving our borrowings, net of
repayments.
In November 2004, we initiated three financing transactions to
reduce net debt, extend debt maturities, improve financial
flexibility, and reduce interest costs going forward:
|
|
|
|
|
In November 2004, we issued 8,625,000 shares of common
stock for $16.00 per share (Equity Offering). Cash proceeds
from the Equity Offering, net of underwriting discounts and
transaction costs were $131 million. The net proceeds were
deposited in a restricted cash account as of November 30,
2004, and were used in the first quarter fiscal 2005 to redeem
$53 million aggregate principal amount of the outstanding
91/2% Senior
Subordinated Notes
(91/2% Notes)
at 109.5% and to repay $73 million of outstanding term
loans. |
41
|
|
|
|
|
In November 2004, we issued $80 million of our
21/4% Convertible
Subordinated Debentures
(21/4% Debentures).
The net proceeds were used to repurchase $70 million of the
53/4% Convertible
Subordinated Notes
(53/4% Notes),
plus premium, accrued interest, and transaction fees. In
December 2004, subsequent to our fiscal year-end, we issued an
additional $66 million of our
21/4% Debentures
under an option given to an initial purchaser. The net proceeds
were used to repurchase an additional $60 million of the
53/4% Notes,
plus premium, accrued interest, and transaction fees. |
|
|
|
In December 2004, subsequent to our fiscal year-end, we closed a
$180 million credit facility (New Credit Facility) that
replaces the previous credit facility (Restated Credit
Facility), which was terminated by us effective December 2004.
The outstanding term loans totaling $141 million plus
accrued interest under the Restated Credit Facility were repaid
in full using restricted cash from the proceeds of the GDX
Automotive sale completed in August 2004 and the Equity
Offering, discussed above. |
In fiscal 2004, we recorded a $9 million charge consisting
of the write-off of deferred financing fees and the premium
associated with the repurchase of the
53/4% Notes.
In the first quarter of fiscal 2005, we will record an
additional loss of approximately $19 million from the
write-off of deferred fees associated with the termination of
the Restated Credit Facility, the redemption of the
91/2% Notes,
and the write-off of deferred financing fees and the premium
associated with the repurchase of additional
53/4% Notes.
In fiscal 2004, we issued $80 million of
21/4% Debentures
and repaid $79 million of our
53/4% Notes
including premium (see discussion above). We also issued
$125 million of 4% Convertible Subordinated Notes
(4% Notes) in January 2004, with net proceeds of
approximately $120 million used to repay outstanding
borrowings under the Restated Credit Facility, to pre-pay the
next 12 months of scheduled maturities under the Term
Loan A, and for general corporate purposes. With the sale
of GDX Automotive effective August 31, 2004, the foreign
credit facilities in Europe and Canada, as well as other bank
loans and capitalized leases relating to the GDX Automotive
business, were paid in full.
In fiscal 2003, we issued $150 million of
91/2% Senior
Subordinated Notes
(91/2% Notes),
generating net proceeds of $145 million used to finance, in
part, the ARC acquisition.
We paid dividends on common stock of $3 million in fiscal
2004 and $5 million in both fiscal 2003 and fiscal 2002.
The payment of quarterly dividends was suspended after the
second quarter of fiscal 2004.
Our borrowing activity in fiscal 2004 was as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, | |
|
|
|
|
|
November 30, | |
|
|
2003 | |
|
Additions | |
|
(Payments) | |
|
2004 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Revolving Credit Facility
|
|
$ |
30 |
|
|
$ |
|
|
|
$ |
(30 |
) |
|
$ |
|
|
Term Loans
|
|
|
166 |
|
|
|
|
|
|
|
(25 |
) |
|
|
141 |
|
91/2% Senior
Subordinated Notes
|
|
|
150 |
|
|
|
|
|
|
|
|
|
|
|
150 |
|
53/4% Convertible
Subordinated Notes
|
|
|
150 |
|
|
|
|
|
|
|
(70 |
) |
|
|
80 |
|
4% Contingent Convertible Subordinated Notes
|
|
|
|
|
|
|
125 |
|
|
|
|
|
|
|
125 |
|
21/4% Convertible
Subordinated Debentures
|
|
|
|
|
|
|
80 |
|
|
|
|
|
|
|
80 |
|
Foreign Credit Facilities and Other
|
|
|
42 |
|
|
|
2 |
|
|
|
(43 |
) |
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt and Borrowing Activity
|
|
$ |
538 |
|
|
$ |
207 |
|
|
$ |
(168 |
) |
|
$ |
577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2004, the borrowing limit under the
revolving credit facility was $137 million, subject to
certain restrictions described in Note 10 in Notes to
Consolidated Financial Statements. We had letters of credit
outstanding of $58 million and had no borrowings
outstanding under that facility as of November 30, 2004. We
were in compliance with all debt covenants as of
November 30, 2004.
As a result of the termination of the Restated Credit Facility
and the repayment of the outstanding term loans effective in
December 2004, subsequent to our fiscal year end, we are no
longer subject to the restrictive
42
covenants and the financial ratios contained in that facility.
Under the New Credit Facility, which replaced the Restated
Credit Facility, we are subject to certain limitations including
the ability to: incur additional debt or sell assets, with
restrictions on the use of proceeds; make certain investments
and acquisitions; grant liens; and make restricted payments. We
also are subject to financial covenants effective for the period
ending February 28, 2005, which include an interest
coverage ratio, a leverage ratio, a senior leverage ratio, and a
fixed charge coverage ratio (as described more fully in
Note 21 in Notes to Consolidated Financial Statements). We
meet the initial financial ratios under the New Credit Facility
effective November 30, 2004. In addition, the indenture
governing the
91/2% Notes
contains customary covenants including limits on our ability to
incur additional indebtedness; make restricted payments; pay
dividends or make distributions on, or redeem or repurchase,
capital stock; make investments, or issue or sell capital stock
of restricted subsidiaries; create liens on assets to secure
indebtedness; enter into transactions with affiliates; and
consolidate, merge or transfer all or substantially all of our
assets. These covenants could restrict our ability to secure
additional debt and equity financing were we to need additional
capital in the future. Also, in order to maintain compliance
with these covenants, we could be required to curtail some of
our operations and growth plans in the future.
The outstanding debt had effective interest rates ranging from
2.25% to 9.50% as of November 30, 2004, with maturities as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Foreign | |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Credit | |
|
|
|
|
Credit |
|
Term | |
|
91/2% | |
|
53/4% | |
|
4% | |
|
21/4% | |
|
Facilities | |
|
|
|
|
Facility |
|
Loans | |
|
Notes | |
|
Notes | |
|
Notes | |
|
Debentures | |
|
and Other | |
|
Total | |
|
|
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
2005
|
|
$ |
|
|
|
$ |
22 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
1 |
|
|
$ |
23 |
|
2006
|
|
|
|
|
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 |
|
2007
|
|
|
|
|
|
|
88 |
|
|
|
|
|
|
|
80 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
168 |
|
2008
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2009
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Thereafter
|
|
|
|
|
|
|
|
|
|
|
150 |
|
|
|
|
|
|
|
125 |
|
|
|
80 |
|
|
|
|
|
|
|
355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Debt
|
|
$ |
|
|
|
$ |
141 |
|
|
$ |
150 |
|
|
$ |
80 |
|
|
$ |
125 |
|
|
$ |
80 |
|
|
$ |
1 |
|
|
$ |
577 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
With the completion of the transactions in November 2004 and the
first quarter of fiscal 2005 discussed above, we have reduced
debt and interest costs going forward and extended debt
maturities (as described more fully in Notes 10 and 21 in
Notes to Consolidated Financial Statements). The following table
reflects total debt as of November 30, 2004, adjusted on a
proforma basis to give effect to the financing transactions
completed in the first quarter of fiscal 2005, including the
partial redemption of the
91/2% Notes,
the closing of the New Credit Facility and termination of the
Restated Credit Facility, the issuance of additional
21/4% Notes,
and the repurchase of additional
53/4% Notes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Proforma | |
|
|
November 30, | |
|
November 30, | |
|
|
2004 | |
|
2004(1) | |
|
|
| |
|
| |
|
|
(In millions) | |
Term Loans
|
|
$ |
141 |
|
|
$ |
25 |
|
91/2% Senior
Subordinated Notes
|
|
|
150 |
|
|
|
97 |
|
53/4% Convertible
Subordinated Notes
|
|
|
80 |
|
|
|
20 |
|
4% Contingent Convertible Subordinated Notes
|
|
|
125 |
|
|
|
125 |
|
21/4% Convertible
Subordinated Debentures
|
|
|
80 |
|
|
|
146 |
|
Other
|
|
|
1 |
|
|
|
1 |
|
|
|
|
|
|
|
|
Total Debt
|
|
$ |
577 |
|
|
$ |
414 |
|
|
|
|
|
|
|
|
|
|
(1) |
Proforma information reflects the use of restricted cash for the
redemption of $53 million of principal of the
91/2% Notes
and repayment of $141 million of principal, plus accrued
interest, of the Term Loans |
43
|
|
|
under the Restated Credit Facility. Proforma also reflects the
issuance of $25 million term loan under the New Credit
Facility, issuance of additional $66 million of principle
of the
21/4% Debentures,
and repayment of additional $60 million of principal of the
53/4% Notes. |
As disclosed in Notes 13(b) and 13(c) in Notes to
Consolidated Financial Statements, we have exposure for certain
legal matters. We believe that it is currently not possible to
estimate the impact, if any, that the ultimate resolution of
these matters will have on our financial position or cash flows.
We currently believe that our existing cash and cash
equivalents, existing credit facilities, forecasted operating
cash flows, anticipated proceeds from the sale of our Fine
Chemicals business, and our ability to access capital markets
for debt or equity financing will provide sufficient funds to
meet our operating plan for the next twelve months. The
operating plan for this period provides for full operation of
our businesses, including the Fine Chemicals business until it
is sold, and interest and principal payments on our debt. We may
also access capital markets to raise debt or equity financing to
fund strategic acquisitions. The timing, terms, size and pricing
of any such financing will depend on investor interest and
market conditions, and there can be no assurance that we will be
able to obtain any such financing.
If we experience adverse economic developments and are not able
to raise debt or equity financing in the capital markets or to
obtain bank borrowings, we believe that we can generate
additional funds to meet our liquidity requirements for the next
twelve months by reducing working capital requirements,
deferring capital expenditures, implementing cost reduction
initiatives in addition to those already included in our
operating plan, selling assets or through a combination of these
means.
Major factors that could adversely impact our forecasted
operating cash and our financial condition are described in the
Risk Factors. In addition, our liquidity and
financial condition will continue to be affected by changes in
prevailing interest rates on the portion of debt that bears
interest at variable interest rates.
Other Information
|
|
|
Critical Accounting Policies |
Our financial statements are prepared in accordance with
accounting principles generally accepted in the United States
that offers acceptable alternative methods for accounting for
certain items affecting our financial results, such as
determining inventory cost, depreciating long-lived assets and
recognizing revenues.
The preparation of financial statements requires the use of
estimates, assumptions, judgments and interpretations that can
affect the reported amounts of assets, liabilities, revenues and
expenses, the disclosure of contingent assets and liabilities
and other supplemental disclosures. The development of
accounting estimates is the responsibility of our management.
Management discusses those areas that require significant
judgments with the audit committee of our board of directors.
The audit committee has reviewed all financial disclosures in
our filings with the SEC. Although we believe that the positions
we have taken with regard to uncertainties are reasonable,
others might reach different conclusions and our positions can
change over time as more information becomes available. If an
accounting estimate changes, its effects are accounted for
prospectively.
The areas most affected by our accounting policies and estimates
are revenue recognition for long-term contracts, goodwill and
other long-lived assets, employee pension and postretirement
benefit obligations, litigation, environmental remediation costs
and recoveries, and income taxes. Except for income taxes, which
are not allocated to our operating segments, these areas affect
the financial results of our business segment.
For a discussion of all of our accounting policies, including
the accounting policies discussed below, see Note 1 in
Notes to Consolidated Financial Statements.
44
|
|
|
Revenue Recognition/ Long-Term Contracts |
In the Aerospace and Defense segment, recognition of profit on
long-term contracts requires the use of assumptions and
estimates related to the contract value or total contract
revenue, the total cost at completion and the measurement of
progress towards completion. Due to the nature of the programs,
developing the estimated total cost at completion requires the
use of significant judgment. Estimates are continually evaluated
as work progresses and are revised as necessary. Factors that
must be considered in estimating the work to be completed
include labor productivity, the nature and technical complexity
of the work to be performed, availability and cost volatility of
materials, subcontractor and vendor performance, warranty costs,
volume assumptions, anticipated labor agreements and
inflationary trends, schedule and performance delays,
availability of funding from the customer, and the
recoverability of costs incurred outside the original contract
included in any estimates to complete. Aerojet reviews contract
performance and cost estimates for some contracts at least
monthly and for others at least quarterly and more frequently
when circumstances significantly change. When a change in
estimate is determined to have an impact on contract earnings,
Aerojet records a positive or negative adjustment to earnings
when identified. Changes in estimates and assumptions related to
the status of certain long-term contracts may have a material
effect on the amounts reported for net sales and segment
performance.
Our aerospace and defense business is derived from contracts
that are accounted for in conformity with the American Institute
of Certified Public Accountants (AICPA) audit and
accounting guide, Audits of Federal Government Contracts
and the AICPAs Statement of Position No. 81-1
(SOP 81-1), Accounting for Performance of
Construction-Type and Certain Production Type Contacts. We
consider the nature of the individual underlying contract and
the type of products and services provided in determining the
proper accounting for a particular contract. Each method is
applied consistently to all contracts having similar
characteristics, as described below. We typically account for
these contracts using the percentage-of-completion method, and
progress is measured on a cost-to-cost or units-of-delivery
basis. Sales are recognized using various measures of progress,
as allowed by SOP 81-1, depending on the contractual terms
and scope of work of the contract. We recognize revenue on a
units-of-delivery basis when contracts require unit deliveries
on a frequent and routine basis. Sales using this measure of
progress are recognized at the contractually agreed upon unit
price. Where the scope of work on contracts principally relates
to research and/or development efforts, or the contract is
predominantly a development effort with few deliverable units,
we recognize revenue on a cost-to-cost basis. In this case,
sales are recognized as costs are incurred and include estimated
earned fees or profits calculated on the basis of the
relationship between costs incurred and total estimated costs at
completion. Revenue on service or time and material contracts is
recognized when performed. For fixed-price and
fixed-price-incentive contracts, if at any time expected costs
exceed the value of the contract, the loss is recognized
immediately.
Certain government contracts contain cost or performance
incentive provisions that provide for increased or decreased
fees or profits based upon actual performance against
established targets or other criteria. Aerojet continually
evaluates its performance and incorporates any anticipated
penalties and cost incentives into its revenue and earnings
calculations. Performance incentives, which increase or decrease
earnings based solely on a single significant event, generally
are not recognized until an event occurs.
Revenue from real estate asset sales is recognized when a
sufficient down-payment has been received, financing has been
arranged and title, possession and other attributes of ownership
have been transferred to the buyer.
Revenue that is not derived from long-term development and
production contracts, or real estate asset transactions, is
generally recognized after products are shipped, all other
significant customer obligations have been met and collection is
reasonably assured. Sales are recorded net of provisions for
customer pricing allowances.
|
|
|
Goodwill and Intangible Assets |
All acquired long-term assets, including goodwill, are subject
to tests for impairment. Under Statement of Financial Accounting
Standards No. 141 (SFAS 141), Business
Combinations, all business combinations
45
initiated after June 30, 2001 are accounted for using the
purchase method of accounting. SFAS 141 provides criteria
for determining whether intangible assets acquired in a business
combination should be recognized separately from goodwill. The
purchase price of acquired companies is allocated to tangible
and intangible assets acquired and liabilities assumed, as well
as to in-process research and development based on their
estimated fair values. Consultants with expertise in performing
appraisals assist in determining the fair values of assets
acquired and liabilities assumed. Such valuations require
management to make significant estimates and assumptions,
especially with respect to intangible assets. Subsequent to the
initial recognition, goodwill is accounted for under Statement
of Financial Accounting Standards No. 142 (SFAS 142),
Goodwill and Other Intangible Assets. In accordance with
the requirements of this standard, goodwill must be tested for
impairment at least annually, or more frequently if indications
of possible impairment exist, by comparing the net assets of
each reporting unit (an organizational grouping)
with the current fair value of the reporting unit. If the
current fair value of the reporting unit is less than its
carrying amount, then a second test must be performed. Under the
second test, the current fair value of the reporting unit is
allocated to the assets and liabilities of the reporting unit,
including an amount for any implied goodwill. If
implied goodwill exceeds the net carrying amount of goodwill, no
impairment loss is recorded. Otherwise, an impairment loss is
recognized for the difference.
The evaluation of goodwill under SFAS 142 requires a
valuation of the underlying business. These valuations can be
significantly affected by estimates of future performance and
discount rates over a relatively long period of time, market
price valuation multiples and marketplace transactions in
related markets. These estimates will likely change over time.
Our businesses operate in cyclical industries and the valuation
of these businesses can be expected to fluctuate as a result. If
the annual review under SFAS 142 indicates impairment of
goodwill balances, that entire impairment must be recorded
immediately and reported as a component of current operations.
At November 30, 2004, our total assets included
$103 million of goodwill which relates to the Aerospace and
Defense segment.
|
|
|
Employee Pension and Postretirement Benefit Plans |
Employee pension and postretirement benefit plans are a
significant cost of doing business and represent obligations
that will be ultimately settled far in the future and therefore
are subject to estimates. Our pension and postretirement benefit
obligations and related costs are calculated using actuarial
concepts in accordance with Statement of Financial Accounting
Standards No. 87 (SFAS 87), Employers
Accounting for Pensions, and Statement of Financial
Accounting Standards No. 106 (SFAS 106),
Employers Accounting for Postretirement Benefits Other
Than Pensions, respectively. Pension accounting is intended
to reflect the recognition of future benefit costs over the
employees approximate service period based on the terms of
the plans and the investment and funding decisions made by us.
We are required to make assumptions regarding such variables as
the expected long-term rate of return on assets and the discount
rate applied to determine service cost and interest cost to
arrive at pension income or expense for the year.
The discount rate is determined at the annual measurement date
of August 31 for our pension plans, and is subject to
change each year based on changes in the overall market interest
rates. The assumed rate reflects the market rate for
high-quality fixed income debt instruments on the measurement
date. This rate is used to discount the future cash flows of
benefit obligations back to the measurement date. The discount
rate used to determine benefit obligations for both continuing
and discontinued operations decreased from 6.50% for fiscal 2003
to 6.25% for fiscal 2004. This 25 basis point decline in
the discount rate resulted in an increase in the present value
of pension benefit obligations as of November 30, 2004 and
is a component of pension expense for fiscal 2005.
The expected long-term rate of return on plan assets is also
determined at the annual measurement date of August 31 for
our pension plans. The expected long-term rate of return used to
determine benefit obligations was 8.75% for both fiscal 2004 and
fiscal 2003. We have analyzed the expected rates of return on
assets and determined that these rates are reasonable based on
the current and expected asset allocations and on the
plans historical investment performance and best estimates
for future investment performance. Our
46
asset managers regularly review actual asset allocations and
periodically rebalance investments to targeted allocations when
considered appropriate. At November 30, 2004, the actual
asset allocation was consistent with the asset allocation
assumptions used in determining the expected long-term rate of
return. Management will continue to assess the expected
long-term rate of return on assets for each plan based on
relevant market conditions and will make adjustments to the
assumptions as appropriate.
Market conditions and interest rates significantly affect assets
and liabilities of our pension plans. Pension accounting
requires that market gains and losses be deferred and recognized
over a period of years. This smoothing results in
the creation of assets or liabilities which will be amortized to
pension costs in future years. The accounting method we utilize
recognizes gains and losses in the market value of pension
assets and changes in the discount rate used to calculate
benefit costs over a period of five years. Investment gains or
losses for this purpose are the difference between the expected
return and the actual return on the market-related value of
assets. Although the smoothing period mitigates some volatility
in the calculation of annual pension costs, future pension costs
are impacted by changes in the market value of pension plan
assets and changes in interest rates.
In addition, we maintain postretirement benefit plans other than
pensions that are not funded. A one percentage point increase in
the assumed trend rate for healthcare costs would have increased
the postretirement accumulated benefit obligation recorded as of
November 30, 2004 by $3 million and the effect on the
service and interest cost components of expense for fiscal 2004
would not have been significant. A one percentage point decrease
in the assumed trend rate for healthcare costs would have
decreased the postretirement accumulated benefit obligation
recorded as of November 30, 2004 by $2 million and the
effect on the service and interest cost components of expense
for fiscal 2004 would not have been significant.
|
|
|
Contingencies and Litigation |
We are currently involved in certain legal proceedings and, as
required, have accrued our estimate of the probable costs for
resolution of these claims. These estimates are based upon an
analysis of potential results, assuming a combination of
litigation and settlement strategies. It is possible, however,
that future results of operations for any particular quarterly
or annual period could be materially affected by changes in
assumptions or the effectiveness of strategies related to these
proceedings. See Note 13 in Notes to Consolidated Financial
Statements for more detailed information on litigation exposure.
|
|
|
Reserves for Environmental Remediation and Recoverable
from the U.S. Government and Other Third Parties for
Environmental Remediation Costs |
For a discussion of our accounting for environmental remediation
obligations and costs and related legal matters, see
Environmental Matters above and Note 13 in
Notes to Consolidated Financial Statements.
We accrue for costs associated with the remediation of
environmental pollution when it becomes probable that a
liability has been incurred, and when its proportionate share of
the costs can be reasonably estimated. Management has a
well-established process in place to identify and monitor our
environmental exposures. In most cases only a range of
reasonably possible costs can be estimated. In establishing the
reserves, the most probable estimated amount is used when
determinable, and the minimum amount is used when no single
amount in the range is more probable. Environmental reserves
include the costs of completing remedial investigation and
feasibility studies, remedial and corrective actions, regulatory
oversight costs, the cost of operation and maintenance of the
remedial action plan, and employee compensation costs for
employees who are expected to devote a significant amount of
time to remediation efforts. Measurement of environmental
reserves is based on the evaluation of currently available
information with respect to each individual environmental site
and considers factors such as existing technology, presently
enacted laws and regulations, and prior experience in
remediation of contaminated sites. Such estimates are based on
the expected costs of investigation and remediation and the
likelihood that other potentially responsible parties will be
able to fulfill their commitments at sites where we may be
jointly or severally liable.
As of November 30, 2004, we had accrued environmental
remediation liabilities of $304 million. Environmental
remediation cost estimation involves significant uncertainties,
including the extent of the
47
remediation required, changing governmental regulations and
legal standards regarding liability, evolving technologies and
the long periods of time over which most remediation efforts
take place. A number of factors could substantially change
environmental remediation cost estimates, examples of which
include: regulatory changes reducing the allowable levels of
contaminants such as perchlorate, nitrosodimethylamine or
others; enhanced monitoring and testing technology or protocols
which could result in the discovery of previously undetected
contaminants; and the implementation of new remediation
technologies which could reduce future remediation costs.
On January 12, 1999, Aerojet and the U.S. government
implemented the October 1997 Agreement in Principle resolving
certain prior environmental and facility disagreements, with
retroactive effect to December 1, 1998. The Global
Settlement covered all environmental contamination at the
Sacramento and Azusa sites. Under the Global Settlement, Aerojet
and the U.S. government resolved disagreements about an
appropriate cost-sharing ratio. The Global Settlement provides
that the cost-sharing ratio will continue for a number of years.
Pursuant to the Global Settlement covering environmental costs
associated with Aerojets Sacramento site and its former
Azusa site, Aerojet can recover up to 88% of its environmental
remediation costs for these sites through the establishment of
prices for Aerojets products and services sold to the
U.S. government. Allowable environmental costs are charged
to these contracts as the costs are incurred. Aerojets mix
of contracts can affect the actual reimbursement made by the
U.S. government. Because these costs are recovered through
forward-pricing arrangements, the ability to continue recovering
these costs depends on Aerojets sustained business volume
under U.S. government contracts and programs and the
relative size of Aerojets commercial business.
Based on Aerojets projected business volume and the
proportion of its business expected to be covered by the Global
Settlement, Aerojet currently believes that, as of
November 30, 2004, approximately $233 million of its
estimated future environmental costs will be recoverable.
Significant estimates and assumptions that could affect the
future recovery of environmental remediation costs include: the
proportion of Aerojets future business base and total
business volume which will be subject to the Global Settlement;
limitations on the amount of recoveries available under the
Northrop agreement; the ability of Aerojet to competitively bid
and win future contracts if estimated environmental costs
significantly increase; the relative size of Aerojets
commercial business base; the timing of environmental
expenditures; and uncertainties inherent in long-term cost
projections of environmental remediation projects.
We file a consolidated U.S. income tax return for ourselves
and our wholly-owned consolidated subsidiaries. We account for
income taxes in accordance with Statement of Financial
Accounting Standards No. 109 (SFAS 109), Accounting
for Income Taxes. The deferred tax assets and/or liabilities
are determined by multiplying the differences between the
financial reporting and tax reporting bases for assets and
liabilities by the enacted tax rates expected to be in effect
when such differences are recovered or settled. The effect on
deferred taxes of a change in tax rates is recognized in income
in the period that includes the enactment date of the change.
The carrying value of our deferred tax assets is dependent upon
our ability to generate sufficient future taxable income. We
have established a full valuation allowance against our net
deferred tax assets for continuing operations to reflect the
uncertainty of realizing the deferred tax benefits, given
historical losses. A valuation allowance is required when it is
more likely than not that all or a portion of a deferred tax
asset will not be realized. A review of all available positive
and negative evidence needs to be considered, including our past
and future performance, the market environment in which we
operate, the utilization of tax attributes in the past, and the
length of carryback and carryforward periods and evaluation of
potential tax planning strategies. We expect to continue to
maintain a full valuation allowance until an appropriate level
of profitability is sustained or we are able to develop tax
strategies that would enable us to conclude that it is more
likely than not that a portion of our deferred tax assets would
be realizable.
48
Income taxes can be affected by estimates of whether, and within
which jurisdictions, future earnings will occur combined with
other aspects of an overall income tax strategy. Additionally,
taxing jurisdictions could retroactively disagree with our tax
treatment of certain items, and some historical transactions
have income tax effects going forward. Accounting rules require
these future effects be evaluated using current laws, rules and
regulations, each of which can change at any time and in an
unpredictable manner. We establish tax reserves when, despite
our belief that our tax return positions are fully supportable,
we believe that certain positions are likely to be challenged
and that we may not succeed. We adjust these reserves in light
of changing facts and circumstances, such as the progress of a
tax audit. We believe we have adequately provided for any
reasonably foreseeable outcome related to these matters, and we
do not anticipate any material earnings impact from their
ultimate resolutions.
At November 30, 2004, we had tax basis net operating loss
(NOL) carry-forwards attributable to continuing operations
of approximately $43 million that are available to reduce
future taxable income which expire in 2024, as well as a capital
loss carryforward of $228 million which expires in 2009.
$4 million of the net operating loss relates to the
exercise of stock options, the benefit of which will be credited
to equity when realized. We also have research credit
carry-forwards of $4 million which expire beginning in
2011; and, manufacturing investment credit carryforwards of
$2 million which expire beginning in 2008; and foreign tax
credit carryforwards of $6 million which expire beginning
in 2005, if not utilized. These tax carryforwards are subject to
examination by the tax authorities.
|
|
|
Recently Issued Accounting Standards |
In August 2004, the FASB issued Staff Position No. 106-2
(FSP 106-2), Accounting and Disclosure Requirements Related
to the Medicare Prescription Drug, Improvement and Modernization
Act of 2003 (the Act). The Act introduces a prescription
drug benefit under Medicare (Medicare Part D) as well as a
federal subsidy to sponsors of post-retirement health care
benefit plans that provide a benefit that is at least
actuarially equivalent to Medicare Part D. FSP 106-2
provides authoritative guidance on the accounting for the
federal subsidy and specifies the disclosure requirements for
employers who have adopted FSP 106-2, including those who are
unable to determine whether benefits provided under its plan are
actuarially equivalent to Medicare Part D. FSP 106-2 was
effective for our fourth quarter of fiscal 2004. The adoption of
FSP 106-2 reduced our accumulated plan benefit obligation by
$3 million related to the Act.
In September 2004, Emerging Issues Task Force
(EITF) reached a consensus on EITF Issue No. 04-08
(EITF 04-08), The Effect of Contingently Convertible
Debt on Diluted Earnings per Share. Under current
interpretations of FASB No. 128, Earnings per Share,
issuers of contingently convertible debt instruments (Co-Cos)
generally exclude the potential common shares underlying the
Co-Cos from the calculation of diluted earnings per share until
the underlying common stock achieves a specified price target,
or other contingency is met. EITF 04-08 requires that
Co-Cos should be included in diluted earnings per share
computations, if dilutive, regardless of whether the market
price trigger has been met. We will adopt the requirements of
EITF 04-08 beginning with the quarter ending
February 28, 2005. The application of EITF 04-08 will
require us to include our 4% Contingent Convertible Subordinated
Notes due 2024 (4% Notes) which were issued in January 2004
in our calculation of diluted earnings per share, if dilutive.
The diluted earnings per share computations for fiscal 2004
would exclude the impact of the 4% Notes as the effect
would be antidilutive.
On October 13, 2004, the FASB concluded that
Statement 123R, Share-Based Payment, which would
require all companies to measure compensation cost for all
share-based payments (including employee stock options) at fair
value, would be effective for public companies for interim or
annual periods beginning after June 15, 2005. We could
adopt the new standard in one of two ways the
modified prospective transition method or the modified
retrospective transition method. We will adopt
Statement 123R in our fourth quarter of fiscal 2005 and are
currently evaluating the effect that the adoption of
Statement 123R will have on our financial position and
results of operations.
In November 2004, the FASB issued Statement 151,
Inventory Costs, an amendment of ARB No. 43,
Chapter 4, which would be effective for inventory costs
incurred during fiscal years beginning after June 15,
49
2005. The amendments made by Statement 151 will improve
financial reporting by clarifying that abnormal amounts of idle
facility expense, freight, handling costs, and wasted materials
(spoilage) should be recognized as current-period charges
and by requiring the allocation of fixed production overheads to
inventory based on the normal capacity of the production
facilities. We do not anticipate that the adoption of the
Statement 151 will have a significant effect on our
earnings or financial position.
Forward-Looking Statements
Certain information contained in this report should be
considered forward-looking statements as defined by
Section 21E of the Private Securities Litigation Reform Act
of 1995. All statements in this report other than historical
information may be deemed forward-looking statements. These
statements present (without limitation) the expectations,
beliefs, plans and objectives of management and future financial
performance and assumptions underlying, or judgments concerning,
the matters discussed in the statements. The words
believe, estimate,
anticipate, project and
expect, and similar expressions, are intended to
identify forward-looking statements. Forward-looking statements
involve certain risks, estimates, assumptions and uncertainties,
including with respect to future sales and activity levels, cash
flows, contract performance, the outcome of litigation and
contingencies, environmental remediation and anticipated costs
of capital. A variety of factors could cause actual results or
outcomes to differ materially from those expected and expressed
in our forward-looking statements. Some important risk factors
that could cause actual results or outcomes to differ from those
expressed in the forward-looking statements are described in the
section Risk Factors in Item 1 of this report
and include, but are not limited to, the following:
|
|
|
|
|
the cancellation or material modification of one or more
significant contracts or future reductions or changes in
U.S. government spending; |
|
|
|
product failures, schedule delays or other problems with
existing or new products and systems or cost-overruns on our
fixed-price contracts; |
|
|
|
significant competition and our inability to adapt to rapid
technological changes; |
|
|
|
failure to comply with regulations applicable to contracts with
the U.S. government; |
|
|
|
environmental claims related to our business and operations,
including any costs we may incur if our petition for rehearing
to the Sixth Circuit Court of Appeals regarding the affirmation
by a three judge panel of the Sixth Circuit on November 22,
2004 of the judgment order in the amount of approximately
$29 million entered November 21, 2002 against GenCorp
in GenCorp Inc. v. Olin Corporation
(U.S. District Court for the Northern District of Ohio,
Eastern Division) is not granted, and the offsets to which we
believe are entitled are not realized; |
|
|
|
the environmental and other government regulations we are
subject to becoming more stringent or subjecting us to material
liability in excess of our established reserves; |
|
|
|
the release or explosion of dangerous materials used in our
businesses; |
|
|
|
disruptions in the supply of key raw materials and difficulties
in the supplier qualification process, as well as increases in
the prices of raw materials; |
|
|
|
changes in economic and other conditions in the Sacramento
County, California, real estate market or changes in interest
rates affecting real estate values in that market; |
|
|
|
our limited experience in real estate development and the
ability to execute our real estate business plan, including our
ability to obtain all necessary zoning, land use and
environmental approvals; |
|
|
|
the cost of servicing our debt and compliance with financial and
other covenants; |
|
|
|
costs and time commitment related to acquisition activities; |
|
|
|
recent changes in our operating strategies, such as the recent
decisions to divest the GDX Automotive and Fine Chemicals
businesses, which result in changes in the types or mix of
business in which we are involved; |
50
|
|
|
|
|
delay in identifying a buyer and negotiating the sale of the
Fine Chemicals operations on terms acceptable to us; |
|
|
|
a strike or other work stoppage or our inability to renew
collective bargaining agreements on favorable terms; |
|
|
|
the loss of key employees; |
|
|
|
fluctuations in sales levels causing our quarterly operating
results to fluctuate; |
|
|
|
risks related to the Fine Chemicals business prior to its sale,
including competition in the pharmaceutical fine chemicals
market, capital intensive nature of operations, lack of
availability of raw materials and highly energetic and potent
nature of chemical compounds used on production; and |
|
|
|
those risks detailed from time to time in our SEC reports. |
This list of factors that may affect future performance and the
accuracy of forward-looking statements is illustrative, but by
no means exhaustive. Additional risk factors may be described
from time to time in our future filings with the
U.S. Securities and Exchange Commission. Accordingly, all
forward-looking statements should be evaluated with the
understanding of their inherent uncertainty. All such risk
factors are difficult to predict, contain material uncertainties
that may affect actual results and may be beyond our control.
|
|
Item 7A. |
Quantitative and Qualitative Disclosures about Market
Risk |
Policies and Procedures
As an element of the Companys normal business practice, it
has established policies and procedures for managing its
exposure to changes in interest rates.
The objective in managing exposure to interest rate changes is
to limit the impact of interest rate changes on earnings and
cash flow and to make overall borrowing costs more predictable.
To achieve this objective, the Company may use interest rate
hedge transactions (Swaps) or other interest rate hedge
instruments to manage the net exposure to interest rate changes
related to the Companys portfolio of borrowings and to
balance its fixed rate compared to floating rate debt.
Interest Rate Risk
We are exposed to market risk principally due to changes in
domestic interest rates. Debt with interest rate risk includes
borrowings under our credit facilities. Other than pension
assets, we do not have any significant exposure to interest rate
risk related to our investments.
We use interest rate swaps and a combination of fixed and
variable rate debt to reduce our exposure to interest rate risk.
As of November 30, 2004, our debt totaled
$577 million: $549 million, or 95% was at an average
fixed rate of 5.93%; and $28 million, or 5% was at an
average variable rate of 5.13%.
In December 2002, we entered into Swaps on $100 million of
Term Loan variable rate debt for a two-year period as required
by the Restated Credit Facility. Our fixed interest rate under
these Swaps including the Eurocurrency margin was 6.02% for the
two-year period.
The estimated fair value of our total debt was $638 million
as of November 30, 2004 compared to a carrying value of
$577 million. The fair value of the convertible
subordinated notes and the senior subordinated notes was
determined based on quoted market prices as of November 30,
2004. The fair value of the remaining debt was determined to
approximate carrying value as the interest rates are generally
variable based on market interest rates and reflect current
market rates available us.
51
Financing Obligations and Other Commitments
Our financing obligations and other commitments include
primarily outstanding notes, senior credit facilities and
operating leases. The following table summarizes these
obligations as of November 30, 2004 and their expected
effect on our liquidity and cash flow in future periods:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Scheduled Payment Dates For the | |
|
|
|
|
Years Ended November 30, | |
|
|
|
|
| |
|
|
Total | |
|
2005 | |
|
2006 | |
|
2007 | |
|
2008 |
|
2009 |
|
Thereafter | |
|
|
| |
|
| |
|
| |
|
| |
|
|
|
|
|
| |
|
|
|
|
(In millions) | |
Financing Obligations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Long-term debt
|
|
$ |
577 |
|
|
$ |
23 |
|
|
$ |
31 |
|
|
$ |
168 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
355 |
|
Operating leases
|
|
|
13 |
|
|
|
6 |
|
|
|
4 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
590 |
|
|
$ |
29 |
|
|
$ |
35 |
|
|
$ |
171 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
355 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company also issues purchase orders and makes other
commitments to suppliers for equipment, materials and supplies
in the normal course of business. These purchase commitments are
generally for volumes consistent with anticipated requirements
to fulfill purchase orders or contracts for product deliveries
received, or expected to be received, from customers.
|
|
Item 8. |
Consolidated Financial Statements and Supplementary
Data |
Information called for by this item is set forth beginning on
page 50 of this report.
52
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders of GenCorp Inc.
We have audited the accompanying consolidated balance sheets of
GenCorp Inc. as of November 30, 2004 and 2003, and the
related consolidated statements of income, shareholders
equity, and cash flows for each of the three years in the period
ended November 30, 2004. These financial statements are the
responsibility of the Companys management. Our
responsibility is to express an opinion on these financial
statements based on our audits.
We conducted our audits in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are
free of material misstatement. An audit includes examining, on a
test basis, evidence supporting the amounts and disclosures in
the financial statements. An audit also includes assessing the
accounting principles used and significant estimates made by
management, as well as evaluating the overall financial
statement presentation. We believe that our audits provide a
reasonable basis for our opinion.
In our opinion, the financial statements referred to above
present fairly, in all material respects, the consolidated
financial position of GenCorp Inc. at November 30, 2004 and
2003, and the consolidated results of its operations and its
cash flows for each of the three years in the period ended
November 30, 2004, in conformity with U.S. generally
accepted accounting principles.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
effectiveness of GenCorp Inc.s internal control over
financial reporting as of November 30, 2004, based on
criteria established in Internal Control Integrated
Framework issued by the Committee of Sponsoring Organizations of
the Treadway Commission and our report dated February 9,
2005 expressed an unqualified opinion thereon.
Sacramento, California
February 9, 2005
53
GENCORP INC.
CONSOLIDATED STATEMENTS OF INCOME
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions, except per share | |
|
|
amounts) | |
Net sales
|
|
$ |
499 |
|
|
$ |
348 |
|
|
$ |
277 |
|
Costs and expenses
|
|
|
|
|
|
|
|
|
|
|
|
|
Cost of products sold
|
|
|
447 |
|
|
|
260 |
|
|
|
200 |
|
Selling, general and administrative
|
|
|
49 |
|
|
|
31 |
|
|
|
8 |
|
Depreciation and amortization
|
|
|
31 |
|
|
|
28 |
|
|
|
21 |
|
Interest expense
|
|
|
35 |
|
|
|
22 |
|
|
|
9 |
|
Other (income) expense, net
|
|
|
(15 |
) |
|
|
(9 |
) |
|
|
5 |
|
Unusual items, net
|
|
|
9 |
|
|
|
5 |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
|
Total costs and expenses
|
|
|
556 |
|
|
|
337 |
|
|
|
258 |
|
Income (loss) from continuing operations before income taxes
|
|
|
(57 |
) |
|
|
11 |
|
|
|
19 |
|
Income tax (benefit) provision
|
|
|
29 |
|
|
|
(1 |
) |
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(86 |
) |
|
|
12 |
|
|
|
15 |
|
Income (loss) from discontinued operations, net of tax
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
|
|
|
|
|
|
|
|
|
|
Earnings (loss) per share of common stock
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share from continuing operations
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.36 |
|
Income (loss) per share from discontinued operations
|
|
|
(6.91 |
) |
|
|
0.24 |
|
|
|
0.35 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.71 |
|
|
|
|
|
|
|
|
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per share from continuing operations
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.35 |
|
Income (loss) per share from discontinued operations
|
|
|
(6.91 |
) |
|
|
0.24 |
|
|
|
0.35 |
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.70 |
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock outstanding
|
|
|
45.1 |
|
|
|
43.3 |
|
|
|
42.8 |
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock outstanding, assuming
dilution
|
|
|
45.1 |
|
|
|
43.4 |
|
|
|
43.1 |
|
|
|
|
|
|
|
|
|
|
|
Dividends declared per share of common stock
|
|
$ |
0.06 |
|
|
$ |
0.12 |
|
|
$ |
0.12 |
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
54
GENCORP INC.
CONSOLIDATED BALANCE SHEETS
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions, except | |
|
|
per share amounts) | |
ASSETS |
Current Assets
|
|
|
|
|
|
|
|
|
Cash and cash equivalents
|
|
$ |
68 |
|
|
$ |
64 |
|
Restricted cash
|
|
|
23 |
|
|
|
|
|
Accounts receivable, net
|
|
|
88 |
|
|
|
88 |
|
Inventories, net
|
|
|
159 |
|
|
|
142 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
36 |
|
|
|
37 |
|
Prepaid expenses and other
|
|
|
6 |
|
|
|
13 |
|
Assets of discontinued operations
|
|
|
94 |
|
|
|
692 |
|
|
|
|
|
|
|
|
|
Total Current Assets
|
|
|
474 |
|
|
|
1,036 |
|
Noncurrent Assets
|
|
|
|
|
|
|
|
|
Restricted cash
|
|
|
178 |
|
|
|
|
|
Property, plant and equipment, net
|
|
|
145 |
|
|
|
148 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
197 |
|
|
|
183 |
|
Deferred income taxes
|
|
|
|
|
|
|
28 |
|
Prepaid pension asset
|
|
|
278 |
|
|
|
314 |
|
Goodwill
|
|
|
103 |
|
|
|
100 |
|
Intangible assets
|
|
|
28 |
|
|
|
30 |
|
Other noncurrent assets
|
|
|
92 |
|
|
|
90 |
|
|
|
|
|
|
|
|
|
Total Noncurrent Assets
|
|
|
1,021 |
|
|
|
893 |
|
|
|
|
|
|
|
|
|
Total Assets
|
|
$ |
1,495 |
|
|
$ |
1,929 |
|
|
|
|
|
|
|
|
LIABILITIES AND SHAREHOLDERS EQUITY |
Current Liabilities
|
|
|
|
|
|
|
|
|
Short-term borrowings and current portion of long-term debt
|
|
$ |
23 |
|
|
$ |
52 |
|
Accounts payable
|
|
|
55 |
|
|
|
37 |
|
Reserves for environmental remediation
|
|
|
51 |
|
|
|
53 |
|
Income taxes payable
|
|
|
35 |
|
|
|
36 |
|
Current deferred income taxes
|
|
|
|
|
|
|
1 |
|
Postretirement benefits other than pensions
|
|
|
15 |
|
|
|
26 |
|
Other current liabilities
|
|
|
141 |
|
|
|
138 |
|
Liabilities of discontinued operations
|
|
|
18 |
|
|
|
189 |
|
|
|
|
|
|
|
|
|
Total Current Liabilities
|
|
|
338 |
|
|
|
532 |
|
Noncurrent Liabilities
|
|
|
|
|
|
|
|
|
Convertible subordinated notes
|
|
|
285 |
|
|
|
150 |
|
Senior subordinated notes
|
|
|
150 |
|
|
|
150 |
|
Other long-term debt, net of current portion
|
|
|
119 |
|
|
|
186 |
|
Reserves for environmental remediation
|
|
|
253 |
|
|
|
262 |
|
Postretirement benefits other than pensions
|
|
|
149 |
|
|
|
148 |
|
Other noncurrent liabilities
|
|
|
60 |
|
|
|
73 |
|
|
|
|
|
|
|
|
|
Total Noncurrent Liabilities
|
|
|
1,016 |
|
|
|
969 |
|
|
|
|
|
|
|
|
|
Total Liabilities
|
|
|
1,354 |
|
|
|
1,501 |
|
Commitments and Contingencies
|
|
|
|
|
|
|
|
|
Shareholders Equity
|
|
|
|
|
|
|
|
|
Preference stock, par value of $1.00; 15 million shares
authorized; none issued or outstanding
|
|
|
|
|
|
|
|
|
Common stock, par value of $0.10; 150 million shares
authorized; 54.6 million shares issued, 54.0 million
outstanding in 2004; 44.3 million shares issued,
43.8 million shares outstanding in 2003
|
|
|
5 |
|
|
|
4 |
|
Other capital
|
|
|
167 |
|
|
|
19 |
|
(Accumulated deficit) retained earnings
|
|
|
(28 |
) |
|
|
373 |
|
Accumulated other comprehensive income (loss), net of income
taxes
|
|
|
(3 |
) |
|
|
32 |
|
|
|
|
|
|
|
|
|
Total Shareholders Equity
|
|
|
141 |
|
|
|
428 |
|
|
|
|
|
|
|
|
|
Total Liabilities and Shareholders Equity
|
|
$ |
1,495 |
|
|
$ |
1,929 |
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
55
GENCORP INC.
CONSOLIDATED STATEMENTS OF SHAREHOLDERS EQUITY
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accumulated | |
|
|
|
|
Comprehensive | |
|
Common Stock | |
|
|
|
Accumulated | |
|
Other | |
|
Total | |
|
|
Income | |
|
| |
|
Other | |
|
Deficit/Retained | |
|
Comprehensive | |
|
Shareholders | |
|
|
(Loss) | |
|
Shares | |
|
Amount | |
|
Capital | |
|
Earnings | |
|
Income (Loss) | |
|
Equity | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except share and per share amounts) | |
November 30, 2001
|
|
|
|
|
|
|
42,628,167 |
|
|
$ |
4 |
|
|
$ |
9 |
|
|
$ |
331 |
|
|
$ |
(34 |
) |
|
$ |
310 |
|
Net income
|
|
$ |
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
30 |
|
|
|
|
|
|
|
30 |
|
Currency translation adjustments and other, net of taxes
|
|
|
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
21 |
|
|
|
21 |
|
Cash dividends of $0.12 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
|
|
|
|
(5 |
) |
Shares issued under stock option and stock incentive plans
|
|
|
|
|
|
|
339,927 |
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, 2002
|
|
$ |
51 |
|
|
|
42,968,094 |
|
|
|
4 |
|
|
|
13 |
|
|
|
356 |
|
|
|
(13 |
) |
|
|
360 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income
|
|
$ |
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
22 |
|
|
|
|
|
|
|
22 |
|
Currency translation adjustments and other, net of taxes
|
|
|
45 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45 |
|
|
|
45 |
|
Cash dividends of $0.12 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(5 |
) |
|
|
|
|
|
|
(5 |
) |
Shares issued under stock option and stock incentive plans
|
|
|
|
|
|
|
812,963 |
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, 2003
|
|
$ |
67 |
|
|
|
43,781,057 |
|
|
|
4 |
|
|
|
19 |
|
|
|
373 |
|
|
|
32 |
|
|
|
428 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss
|
|
$ |
(398 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(398 |
) |
|
|
|
|
|
|
(398 |
) |
Reclassifications and other, net of taxes
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(35 |
) |
|
|
(35 |
) |
Cash dividends of $0.06 per share
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(3 |
) |
|
|
|
|
|
|
(3 |
) |
Proceeds from issuance of common stock (net of offering expenses
of $7 million)
|
|
|
|
|
|
|
8,625,000 |
|
|
|
1 |
|
|
|
130 |
|
|
|
|
|
|
|
|
|
|
|
131 |
|
Shares issued under stock option and stock incentive plans
|
|
|
|
|
|
|
1,596,110 |
|
|
|
|
|
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, 2004
|
|
$ |
(433 |
) |
|
|
54,002,167 |
|
|
$ |
5 |
|
|
$ |
167 |
|
|
$ |
(28 |
) |
|
$ |
(3 |
) |
|
$ |
141 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
See Notes to Consolidated Financial Statements.
56
GENCORP INC.
CONSOLIDATED STATEMENTS OF CASH FLOWS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Operating Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$ |
(86 |
) |
|
$ |
12 |
|
|
$ |
15 |
|
Adjustments to reconcile net income (loss) to net cash
provided by (used in) continuing operations:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net loss on reacquisition of minority ownership interest in
subsidiary
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
Gain on sale of EIS business
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
Loss on repayment of convertible notes
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
Foreign currency gain
|
|
|
|
|
|
|
(3 |
) |
|
|
|
|
|
Depreciation and amortization
|
|
|
31 |
|
|
|
28 |
|
|
|
21 |
|
|
Stock compensation and savings plan expense
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
Deferred income taxes
|
|
|
28 |
|
|
|
(17 |
) |
|
|
11 |
|
|
|
Changes in operating assets and liabilities, net of effects of
acquisitions and divestiture of businesses:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, net
|
|
|
2 |
|
|
|
4 |
|
|
|
7 |
|
|
|
|
Inventories, net
|
|
|
(17 |
) |
|
|
(16 |
) |
|
|
(3 |
) |
|
|
|
Other current assets
|
|
|
7 |
|
|
|
(9 |
) |
|
|
(1 |
) |
|
|
|
Other noncurrent assets
|
|
|
31 |
|
|
|
(2 |
) |
|
|
(94 |
) |
|
|
|
Current liabilities
|
|
|
6 |
|
|
|
53 |
|
|
|
(46 |
) |
|
|
|
Other noncurrent liabilities
|
|
|
(14 |
) |
|
|
(62 |
) |
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) continuing operations
|
|
|
5 |
|
|
|
(12 |
) |
|
|
(54 |
) |
Net cash provided by (used in) discontinued operations
|
|
|
(35 |
) |
|
|
56 |
|
|
|
37 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by (Used in) Operating Activities
|
|
|
(30 |
) |
|
|
44 |
|
|
|
(17 |
) |
Investing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
(21 |
) |
|
|
(11 |
) |
|
|
(14 |
) |
Proceeds from business dispositions
|
|
|
144 |
|
|
|
|
|
|
|
(6 |
) |
Restricted cash
|
|
|
(201 |
) |
|
|
|
|
|
|
|
|
Acquisition of businesses, net of cash acquired
|
|
|
|
|
|
|
(138 |
) |
|
|
(101 |
) |
Investing activities of discontinued operations
|
|
|
(41 |
) |
|
|
(31 |
) |
|
|
(20 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Used in Investing Activities
|
|
|
(119 |
) |
|
|
(180 |
) |
|
|
(141 |
) |
Financing Activities
|
|
|
|
|
|
|
|
|
|
|
|
|
Proceeds from issuance of convertible notes
|
|
|
205 |
|
|
|
150 |
|
|
|
150 |
|
Repayment of convertible notes
|
|
|
(79 |
) |
|
|
|
|
|
|
|
|
Net proceeds from issuance of common stock
|
|
|
131 |
|
|
|
|
|
|
|
|
|
Repayments, net of borrowings on revolving credit facility
|
|
|
(30 |
) |
|
|
(15 |
) |
|
|
(75 |
) |
Net short-term debt (repaid) incurred
|
|
|
(28 |
) |
|
|
27 |
|
|
|
(7 |
) |
Proceeds from the issuance of other long-term debt
|
|
|
2 |
|
|
|
6 |
|
|
|
140 |
|
Repayments on long-term debt
|
|
|
(40 |
) |
|
|
(20 |
) |
|
|
(42 |
) |
Debt issuance costs
|
|
|
(9 |
) |
|
|
(5 |
) |
|
|
(6 |
) |
Dividends paid
|
|
|
(3 |
) |
|
|
(5 |
) |
|
|
(5 |
) |
Other equity transactions
|
|
|
8 |
|
|
|
6 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Cash Provided by Financing Activities
|
|
|
157 |
|
|
|
144 |
|
|
|
159 |
|
|
|
|
|
|
|
|
|
|
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
|
(4 |
) |
|
|
8 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
Increase in Cash and Cash Equivalents
|
|
|
4 |
|
|
|
16 |
|
|
|
4 |
|
Cash and Cash Equivalents at Beginning of Year
|
|
|
64 |
|
|
|
48 |
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and Cash Equivalents at End of Year
|
|
$ |
68 |
|
|
$ |
64 |
|
|
$ |
48 |
|
|
|
|
|
|
|
|
|
|
|
57
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
1. Summary of Significant
Accounting Policies
|
|
|
a. Basis of Presentation and Nature of
Operations |
The consolidated financial statements of GenCorp Inc. (GenCorp
or the Company) include the accounts of the parent company and
its wholly owned and majority owned subsidiaries. All
significant intercompany accounts and transactions have been
eliminated in consolidation. Certain reclassifications have been
made to financial information for prior years to conform to the
current years presentation.
The Company is a technology-based manufacturer operating
primarily in the United States. The Companys continuing
operations are organized into two operating segments: Aerospace
and Defense and Real Estate. The Aerospace and Defense segment
includes the operations of Aerojet-General Corporation
(Aerojet), which develops and manufactures propulsion systems
for space and defense applications, armament systems for
precision tactical weapon systems and munitions applications,
and advanced airframe structures. Primary customers served
include major prime contractors to the U.S. government, the
Department of Defense (DoD) and the National Aeronautics and
Space Administration (NASA). The Real Estate segment includes
activities related to the development, sale and leasing of the
Companys real estate assets (see Note 15).
On August 31, 2004, the Company completed the sale of its
GDX Automotive (GDX) business. Also in fiscal 2004,
management committed to a plan to sell the Companys Fine
Chemicals business. The GDX and Fine Chemicals businesses are
classified as discontinued operations in these Consolidated
Financial Statements and Notes to Consolidated Financial
Statements (see Note 17).
The preparation of the consolidated financial statements in
conformity with accounting principles generally accepted in the
United States requires the Company to make estimates and
assumptions that affect the amounts reported in the consolidated
financial statements and accompanying notes. Actual results
could differ from those estimates.
As of November 30, 2004, excluding employees of the
Companys discontinued operations, approximately 17% of the
Companys 2,857 employees were covered by collective
bargaining or similar agreements all of which are due to expire
within one year.
|
|
|
c. Cash and Cash Equivalents |
All highly liquid debt instruments purchased with a remaining
maturity at the date of purchase of three months or less are
considered to be cash equivalents. The Company classifies
securities underlying its cash equivalents as
available-for-sale in accordance with the Financial
Accounting Standards Board (FASB) Statement of Financial
Accounting Standards (SFAS) No. 115 (SFAS 115),
Accounting for Certain Investments in Debt and Equity
Securities. Cash equivalents are stated at cost, which
approximates fair value, due to the highly liquid nature and
short duration of the underlying securities.
As of November 30, 2004, the Company has designated
$201 million as restricted cash in accordance with
agreements reached with the senior lenders under our senior
credit facility. The components of the restricted cash are (i)
$70 million of the proceeds from the sale of GDX and (ii)
$131 million of the proceeds from the November 2004 equity
offering of the Companys common stock (see Note 10).
58
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Inventories are stated at the lower of cost or market value.
Cost is determined using the average cost method.
|
|
|
f. Property, Plant and Equipment |
Property, plant and equipment are recorded at cost.
Refurbishment costs are capitalized in the property accounts,
whereas ordinary maintenance and repair costs are expensed as
incurred. Depreciation is computed principally by accelerated
methods. Depreciable lives on buildings and improvements, and
machinery and equipment, range from five years to 45 years,
and three years to 14 years, respectively.
Impairment of long-lived assets is recognized when events or
circumstances indicate that the carrying amount of the asset, or
related groups of assets, may not be recoverable. A long-lived
asset classified as held for sale is initially
measured at the lower of its carrying amount or fair value less
costs to sell. In the period that the held for sale
criteria are met, the Company recognizes an impairment charge
for any initial adjustment of the long-lived asset amount. Gains
or losses not previously recognized resulting from the sale of a
long-lived asset is recognized on the date of sale.
During fiscal 2003, the Companys GDX Automotive business
recognized impairment charges of $6 million to write-down
assets at one of its plants in France to their estimated net
realizable value upon plant closure (see Note 17). The
impaired assets included buildings and machinery and equipment
with a net book value prior to impairment of $10 million
and an estimated net realizable value of $4 million as of
November 30, 2003. During fiscal 2004, the Company
recognized impairment charges of $2 million to write-down
the remaining value of the assets down to zero. The impairment
charges in fiscal 2004 and fiscal 2003 are included as a
component of discontinued operations.
|
|
|
g. Goodwill and Other Intangible Assets |
Goodwill represents the excess of the purchase price of an
acquired enterprise or assets over the fair values of the
identifiable assets acquired and liabilities assumed. Tests for
impairment of goodwill are performed on an annual basis, or at
any other time, if events occur or circumstances indicate that
the carrying amount of goodwill may not be recoverable. The
Company performed the annual impairment tests for goodwill as of
September 1, 2004 and 2003 and determined that goodwill was
not impaired as of those dates.
Circumstances that could trigger an impairment test include but
are not limited to: a significant adverse change in the business
climate or legal factors; an adverse action or assessment by a
regulator; unanticipated competition; loss of key personnel; and
results of testing for recoverability of a significant asset
group within a reporting unit.
If the carrying amount of the reporting unit goodwill exceeds
the implied fair value of that goodwill, an impairment loss is
recorded. Measurement of the fair value of a reporting unit is
based on one or more of the following fair value measures
including: amounts at which the unit as a whole could be bought
or sold in a current transaction between willing parties; using
present value techniques of estimated future cash flows; or
using valuation techniques based on multiples of earnings or
revenue, or a similar performance measure.
Identifiable intangible assets, such as patents, trademarks and
licenses, are recorded at cost or when acquired as part of a
business combination at estimated fair value. Identifiable
intangible assets are amortized based on when they provide the
Company economic benefit, or using the straight-line method,
over their estimated useful life. Amortization periods for
identifiable intangible assets range from two to 27 years.
59
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
h. Revenue Recognition/ Long-Term Contracts |
The Company accounts for sales derived from long-term
development and production contracts in conformity with the
American Institute of Certified Public Accountants
(AICPA) Audit and Accounting guide, Audits of Federal
Government Contracts and the AICPAs Statement of Position
No. 81-1 (SOP 81-1), Accounting for Performance of
Construction-Type and Certain Production Type Contracts. The
Company considers the nature of the individual underlying
contract and the type of products and services provided in
determining the proper accounting for a particular contract.
Each method is applied consistently to all contracts having
similar characteristics, as described below. The Company
typically accounts for these contracts using the
percentage-of-completion method, and progress is measured on a
cost-to-cost or units-of-delivery basis. Sales are recognized
using various measures of progress, as allowed by SOP 81-1,
depending on the contractual terms and scope of work of the
contract. The Company recognizes revenue on a units-of-delivery
basis when contracts require unit deliveries on a frequent and
routine basis. Sales using this measure of progress are
recognized at the contractually agreed upon unit price. Where
the scope of work on contracts principally relates to research
and/or development efforts, or the contract is predominantly a
development effort with few deliverable units, the Company
recognizes revenue on a cost-to-cost basis. In this case, sales
are recognized as costs are incurred and include estimated
earned fees or profits calculated on the basis of the
relationship between costs incurred and total estimated costs at
completion. Revenue on service or time and material contracts is
recognized when performed. For fixed-price and
fixed-price-incentive contracts, if at any time expected costs
exceed the value of the contract, the loss is recognized
immediately.
Certain government contracts contain cost or performance
incentive provisions that provide for increased or decreased
fees or profits based upon actual performance against
established targets or other criteria. The Company continually
evaluates its performance and incorporates any anticipated
penalties and cost incentives into its revenue and earnings
calculations. Performance incentives, which increase or decrease
earnings based solely on a single significant event generally,
are not recognized until an event occurs.
Revenue from real estate asset sales is recognized primarily
when a sufficient down-payment has been received, financing has
been arranged, title, possession, and other attributes of
ownership have been transferred to the buyer.
Revenue that is not derived from long-term development and
production contracts, or real estate transactions, typically
revenues from the Companys discontinued operations, is
generally recognized after products are shipped, all other
significant customer obligations have been met and collection is
reasonably assured. Sales are recorded net of provisions for
customer pricing allowances.
|
|
|
i. Research and Development Expenses |
Company-sponsored research and development (R&D) expenses
were $8 million in fiscal 2004, $7 million in fiscal
2003 and $5 million in fiscal 2002. Company-sponsored
R&D expenses include the costs of technical activities that
are useful in developing new products, services, processes or
techniques, as well as expenses for technical activities that
may significantly improve existing products or processes.
Customer-sponsored R&D expenditures, which are funded under
government contracts, totaled $130 million in fiscal 2004,
$92 million in fiscal 2003 and $99 million in fiscal
2002.
|
|
|
j. Environmental Remediation Costs |
The Company accounts for identified or potential environmental
remediation liabilities in accordance with the AICPAs
Statement of Position 96-1 (SOP 96-1), Environmental Remediation
Liabilities and Security and Exchange Commission
(SEC) Staff Accounting Bulletin No. 92,
Accounting and Disclosures Relating to Loss Contingencies. Under
this guidance, the Company expenses, on a current basis,
recurring costs associated with managing hazardous substances
and pollution in ongoing operations. The Company
60
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
accrues for costs associated with the remediation of
environmental pollution when it becomes probable that a
liability has been incurred, and its proportionate share of the
amount can be reasonably estimated. In most cases only a range
of reasonably possible costs can be estimated. In establishing
the Companys reserves, the most probable estimated amount
is used when determinable, and the minimum amount is used when
no single amount in the range is more probable. The
Companys environmental reserves include the costs of
completing remedial investigation and feasibility studies,
remedial and corrective actions, regulatory oversight costs, the
cost of operation and maintenance of the remedial action plan,
and employee compensation costs for employees who are expected
to devote a significant amount of time to remediation efforts.
Measurement of environmental reserves is based on the evaluation
of currently available information with respect to each
individual environmental site and considers factors such as
existing technology, presently enacted laws and regulations, and
prior experience in remediation of contaminated sites. Such
estimates are based on the expected costs of investigation and
remediation and the likelihood that other potentially
responsible parties will be able to fulfill their commitments at
sites where the Company may be jointly or severally liable. The
Company recognizes amounts recoverable from insurance carriers,
the U.S. government or other third parties, when the collection
of such amounts is probable. Pursuant to U.S. government
agreements or regulations, the Company can recover a substantial
portion of its environmental costs for its Aerospace and Defense
segment through the establishment of prices of the
Companys products and services sold to the U.S.
government. The ability of the Company to continue recovering
these costs from the U.S. government depends on Aerojets
sustained business volume under U.S. government contracts and
programs (see Note 13).
|
|
|
k. Stock-Based Compensation |
The Company applies the provisions of Accounting Principles
Board Opinion No. 25 (APB 25), Accounting for Stock Issued
to Employees, and related interpretations to account for awards
of stock-based compensation granted to employees.
|
|
|
l. Derivative Financial Instruments |
Forward contracts are marked-to-market each quarter and the
unrealized gains or losses are included in other income and
expense. Foreign currency transaction gains totaled less than
$1 million, $4 million, and $1 million in fiscal
2004, fiscal 2003 and fiscal 2002, respectively, including gains
and losses on foreign currency forward and option contracts. The
Companys foreign currency transaction and forward
contracts were primarily associated with the Companys GDX
business, which was classified as discontinued operations and
sold effective August 31, 2004 (see Note 17). The
Company did not have any forward contracts outstanding as of
November 30, 2004.
61
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
2. Earnings Per Share
A reconciliation of the numerator and denominator used to
calculate basic and diluted earnings per share of common stock
(EPS) is presented in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions, except per | |
|
|
share amounts; shares in thousands) | |
Numerator for Basic and Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
$ |
(86 |
) |
|
$ |
12 |
|
|
$ |
15 |
|
|
Income (loss) from discontinued operations, net of tax
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) available to common shareholders
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
|
|
|
|
|
|
|
|
|
|
Denominator for Basic EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock outstanding
|
|
|
45,097 |
|
|
|
43,347 |
|
|
|
42,830 |
|
|
|
|
|
|
|
|
|
|
|
Denominator for Diluted EPS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Weighted average shares of common stock outstanding
|
|
|
45,097 |
|
|
|
43,347 |
|
|
|
42,830 |
|
|
Employee stock options
|
|
|
|
|
|
|
59 |
|
|
|
303 |
|
|
Other
|
|
|
|
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
45,097 |
|
|
|
43,408 |
|
|
|
43,133 |
|
|
|
|
|
|
|
|
|
|
|
Basic:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per basic share from continuing operations
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.36 |
|
|
Income (loss) per basic share from discontinued operations
|
|
$ |
(6.91 |
) |
|
$ |
0.24 |
|
|
$ |
0.35 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share Basic
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.71 |
|
|
|
|
|
|
|
|
|
|
|
Diluted:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) per diluted share from continuing operations
|
|
$ |
(1.91 |
) |
|
$ |
0.26 |
|
|
$ |
0.35 |
|
|
Income (loss) per diluted share from discontinued operations
|
|
$ |
(6.91 |
) |
|
$ |
0.24 |
|
|
$ |
0.35 |
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss) per share Diluted
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.70 |
|
|
|
|
|
|
|
|
|
|
|
The effect of a conversion of the Companys
$150 million aggregate principal amount of its
53/4%
Convertible Subordinated Notes due 2007 issued in April 2002
(53/4%
Notes) into common stock was not included in the computation of
diluted earnings (loss) per share for fiscal 2004, fiscal
2003, and fiscal 2002 because the effect would have been
antidilutive for these periods. The Companys
$125 million aggregate principal amount of its 4%
Contingent Convertible Subordinated Notes due 2024, issued in
January 2004 (4% Notes) were not convertible into common
stock as of November 30, 2004; accordingly, the 4% Notes
were not included in the computation of diluted loss per share
for fiscal 2004. The Companys $80 million aggregate
principal amount of its
21/4%
Convertible Subordinated Debentures due 2024
(21/4%
Debentures) were not convertible into common stock as of
November 30, 2004; accordingly, the
21/4%
Debentures were not included in the computation of diluted loss
per share for fiscal 2004. The
53/4%
Notes are convertible at an initial conversion rate of 54.29
shares per $1,000 outstanding. The 4% Notes are convertible at
an initial conversion rate of 64.8088 shares per $1,000
outstanding. The
21/4%
Debentures are convertible into cash and, if applicable, shares
of the Companys common stock at an initial conversion rate
of 50 shares per $1,000 outstanding. Potentially dilutive
securities that are not included in the diluted EPS calculation
because they
62
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
would be antidilutive are employee stock options of 2,388,785 as
of November 30, 2004, 2,693,000 as of November 30,
2003, and 825,000 as of November 30, 2002.
In September 2004, Emerging Issues Task Force
(EITF) reached a consensus on EITF Issue No. 04-08,
The Effect of Contingently Convertible Debt on Diluted
Earnings per Share will require the Company to include the
4% Notes which were issued in January 2004 in its calculation of
diluted earnings per share, if dilutive (see Note 20), in
fiscal 2005.
As permitted by Statement of Financial Accounting Standards
No. 123 (SFAS 123), Accounting for Stock-Based
Compensation and Statement of Financial Accounting Standards
No. 148 (SFAS 148), Accounting for Stock-Based
Compensation Transition and Disclosure, the
Company applies the existing accounting rules under APB Opinion
No. 25, Accounting for Stock Issued to Employees,
which provides that no compensation expense is charged for
options granted at an exercise price equal to the market value
of the underlying common stock on the date of grant. Had
compensation expense for the Companys stock option plans
been determined based upon the fair value at the grant date for
awards under these plans using market-based option valuation
models, net income (loss) and the effect on net income
(loss) per share would have been as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions, except | |
|
|
per share amounts) | |
Net income (loss), as reported
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
Add: Stock based compensation expense reported, net of related
tax effects
|
|
|
1 |
|
|
|
1 |
|
|
|
1 |
|
Deduct: Stock based compensation expense determined under fair
value based method for all awards, net of related tax effects
|
|
|
(1 |
) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
Net income (loss), pro forma
|
|
$ |
(398 |
) |
|
$ |
21 |
|
|
$ |
29 |
|
|
|
|
|
|
|
|
|
|
|
As reported
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.71 |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$ |
(8.82 |
) |
|
$ |
0.50 |
|
|
$ |
0.70 |
|
|
|
|
|
|
|
|
|
|
|
Pro forma
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Basic
|
|
$ |
(8.82 |
) |
|
$ |
0.48 |
|
|
$ |
0.69 |
|
|
|
|
|
|
|
|
|
|
|
|
Diluted
|
|
$ |
(8.82 |
) |
|
$ |
0.48 |
|
|
$ |
0.68 |
|
|
|
|
|
|
|
|
|
|
|
Option valuation models require the input of highly subjective
assumptions including the expected stock price volatility.
Because the Companys employee stock options have
characteristics significantly different from those of traded
options and because changes in the input assumptions can
materially affect the fair value estimate, it is the
Companys opinion that the existing models do not
necessarily provide a reliable single measure of the fair value
of the employee stock options.
The fair value of stock options was estimated at the date of
grant using a Black-Scholes stock option pricing model with the
following weighted-average assumptions: risk free interest rates
of 3.07% for fiscal 2004, risk free interest rates of 3.3% for
fiscal 2003 and 3.1% for fiscal 2002; dividend yield of 0.0% in
fiscal 2004; dividend yield of 1.5% for fiscal 2003 and 1.0% for
fiscal 2002; volatility factor of the expected market price of
the Companys common stock of 0.42 for fiscal 2004, 0.44
for fiscal 2003 and 0.47 for fiscal 2002; and a weighted-average
expected life of the options of five years for all periods.
Discontinued operations earnings (loss) per share would not
have changed as a result of stock based compensation expense.
63
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
3. Inventories
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Long-term contracts at average cost
|
|
$ |
235 |
|
|
$ |
196 |
|
Raw materials and supplies
|
|
|
2 |
|
|
|
7 |
|
Progress payments
|
|
|
(78 |
) |
|
|
(61 |
) |
|
|
|
|
|
|
|
|
Inventories, net
|
|
$ |
159 |
|
|
$ |
142 |
|
|
|
|
|
|
|
|
Inventories applicable to contracts, related to the
Companys Aerospace and Defense segment, include general
and administrative costs. The total of such costs incurred in
fiscal 2004 and fiscal 2003 were $50 million and
$42 million, respectively, and the cumulative amount of
general and administrative costs in inventory is estimated to be
$35 million and $32 million at November 30, 2004
and 2003, respectively.
During fiscal 2004, Aerojet recorded an inventory write-down of
$16 million on a contract to design, develop and produce a
solid rocket motor for Lockheed Martins Atlas V program.
This write-down relates to unanticipated transition costs from
the development phase to the production phase of the contract
and the value of materials rendered obsolete by a decision to
proceed with qualification and production of an enhanced motor
configuration. In managements judgment, these costs will
not be recoverable on the contract.
The current contract with Lockheed provides for production of 44
motors over a number of years and for the order of an additional
52 motors at Lockheed Martins option. At November 30,
2004, the Atlas V inventory balance was $126 million. Full
recovery of this investment is subject to uncertainties,
including: (i) Aerojets ability to produce motors at
its estimated average unit price, (ii) final pricing of the
enhanced motor configuration, and (iii) a satisfactory
renegotiation of contract terms with Lockheed Martin. Aerojet
believes its Atlas V contract will be restructured during fiscal
2005 when launch services contracts between launch vehicle
manufacturers and the U.S. government are modified to reflect
cost pressures resulting from continued low commercial launch
activity. Details of the form and terms of the anticipated
changes are unknown at this time. Aerojet management believes
that continued improvements in operational efficiency and
renegotiation of contract terms will permit recovery of
inventoried development and production costs. However, if
managements efforts are unsuccessful, Aerojet may be
required to recognize additional material losses.
4. Income Taxes
The Company accounts for income taxes in accordance with the
provisions of Statement of Financial Accounting Standards
No. 109 (SFAS 109), Accounting for Income Taxes. The
Company files a consolidated federal income tax return with its
wholly-owned subsidiaries.
64
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of the Companys income tax
(benefit) provision from continuing operations are as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Current
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States federal
|
|
$ |
(3 |
) |
|
$ |
9 |
|
|
$ |
(8 |
) |
|
State and local
|
|
|
1 |
|
|
|
3 |
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
(2 |
) |
|
|
12 |
|
|
|
(13 |
) |
Deferred
|
|
|
|
|
|
|
|
|
|
|
|
|
|
United States federal
|
|
|
28 |
|
|
|
(12 |
) |
|
|
9 |
|
|
State and local
|
|
|
3 |
|
|
|
(1 |
) |
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
31 |
|
|
|
(13 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
Income tax (benefit) provision
|
|
$ |
29 |
|
|
$ |
(1 |
) |
|
$ |
4 |
|
|
|
|
|
|
|
|
|
|
|
A reconciliation of the U.S. federal statutory income tax rate
to the Companys effective income tax rate on book earnings
from continuing operations is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
Statutory federal income tax rate
|
|
|
35.0 |
% |
|
|
35.0 |
% |
|
|
35.0 |
% |
State and local income taxes, net of federal income tax benefit
|
|
|
(2.1 |
) |
|
|
5.3 |
|
|
|
8.2 |
|
Tax settlements, refund claims, and reserve adjustments,
including interest
|
|
|
8.5 |
|
|
|
(50.1 |
) |
|
|
(21.5 |
) |
Valuation allowance
|
|
|
(91.1 |
) |
|
|
|
|
|
|
|
|
Benefit of charitable gift
|
|
|
|
|
|
|
|
|
|
|
(3.2 |
) |
Other, net
|
|
|
(1.2 |
) |
|
|
0.7 |
|
|
|
2.6 |
|
|
|
|
|
|
|
|
|
|
|
|
Effective income tax rate
|
|
|
(50.9 |
)% |
|
|
(9.1 |
)% |
|
|
21.1 |
% |
|
|
|
|
|
|
|
|
|
|
The Company reduced its fiscal 2004 income tax expense from
continuing operations by $5 million for domestic, federal
and state income tax settlements, research tax credit refund
claims, and tax reserve adjustments for fiscal years 1997 through
2002. The Company is under routine examinations by domestic and
foreign tax authorities. While it is difficult to predict the
outcome or timing of a particular tax matter, the Company
believes it has adequately provided for any reasonable
foreseeable outcome related to these matters, and it does not
anticipate any material earnings impact from their ultimate
resolutions.
The Company did not record an income tax benefit for the fiscal 2004
net operating loss from continuing operations, given the uncertainty
of realizing the tax benefit. A valuation allowance is
required when it is more likely than not that all or a portion
of net deferred tax asset will not be realized. A review of all
available positive and negative evidence needs to be considered,
including a Companys past and future performance, the
market environment in which the Company operates, the
utilization of tax attributes in the past, the length of
carryback and carryforward periods, and evaluation of potential
tax planning strategies.
Forming a conclusion that a valuation allowance is not needed is
difficult when there is negative evidence such as cumulative
losses in recent years. The Company determines cumulative losses
on a rolling twelve-
65
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
quarter basis. Accordingly, as of May 31, 2004, the Company
concluded that it was appropriate to establish a full valuation
allowance for its net deferred tax assets. Subsequent to
May 31, 2004, the Company has maintained a full valuation
allowance on all of its net deferred tax assets. The Company
expects to continue to maintain a full valuation allowance until
circumstances change.
The Company reduced its fiscal 2003 income tax expense from
continuing operations by $5 million for domestic, federal
and state income tax settlements for 1994 through 2001.
The Company reduced its fiscal 2002 income tax expense for
continuing operations by $1 million for the tax benefit of
a charitable gift of land to the County of Muskegon in Michigan
and by $4 million due to tax reserve adjustments.
The tax effects of temporary differences that give rise to
significant portions of the deferred tax assets and liabilities
for continuing operations are as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Deferred Tax Assets
|
|
|
|
|
|
|
|
|
Accrued estimated costs
|
|
$ |
59 |
|
|
$ |
67 |
|
Tax losses and credit carry-forwards
|
|
|
120 |
|
|
|
2 |
|
Depreciation
|
|
|
21 |
|
|
|
19 |
|
Other postretirement and employee benefits
|
|
|
66 |
|
|
|
70 |
|
Valuation allowance
|
|
|
(150 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Total deferred tax assets
|
|
|
116 |
|
|
|
158 |
|
Deferred Tax Liabilities
|
|
|
|
|
|
|
|
|
Pensions
|
|
|
105 |
|
|
|
125 |
|
Other
|
|
|
11 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
Total deferred tax liabilities
|
|
|
116 |
|
|
|
131 |
|
|
|
|
|
|
|
|
|
|
Total net deferred tax assets
|
|
|
|
|
|
|
27 |
|
|
|
Less: current deferred tax assets/(liabilities)
|
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
Noncurrent deferred tax assets
|
|
$ |
|
|
|
$ |
28 |
|
|
|
|
|
|
|
|
At November 30, 2004, the Company had tax basis net
operating loss carryforwards attributable to continuing
operations of approximately $43 million that are available
to reduce future taxable income which expire in 2024, as well as
a capital loss carryforward of approximately $228 million
which expires in 2009. $4 million of the net operating loss
carryforward relates to the exercise of stock options, the
benefit of which will be credited to equity when realized. The
Company also has research credit carry-forwards of
$4 million which expire beginning in 2011; and,
manufacturing investment credit carryforwards of $2 million
from continuing operations which expire beginning in 2008; and
foreign tax credit carryforwards of $6 million which
expire beginning in 2005, if not utilized. These tax
carryforwards are subject to examination by the tax
authorities.
Cash paid during the year for income taxes of both
continuing and discontinued operations was $10 million in
fiscal 2004, $8 million in fiscal 2003, and
$14 million in fiscal 2002.
Certain deferred tax assets of $4 million for continuing
operations as of November 30, 2003 were included in income
taxes payable and are included in the deferred tax provision for
continuing operations for the year ended November 30, 2004.
66
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Income taxes payable includes tax reserves for income tax
exposure in foreign jurisdictions including those related to the
period prior to the Companys purchase of the Draftex group
in December 2000. The reserve is net of the reimbursement to be
received by the Laird Group in accordance with the tax
indemnification agreement executed at the time of the
acquisition.
5. Property, Plant and
Equipment
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Land
|
|
$ |
29 |
|
|
$ |
29 |
|
Buildings and improvements
|
|
|
128 |
|
|
|
119 |
|
Machinery and equipment
|
|
|
333 |
|
|
|
327 |
|
Construction-in-progress
|
|
|
15 |
|
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
505 |
|
|
|
486 |
|
Less: accumulated depreciation
|
|
|
(360 |
) |
|
|
(338 |
) |
|
|
|
|
|
|
|
|
Property and equipment, net
|
|
$ |
145 |
|
|
$ |
148 |
|
|
|
|
|
|
|
|
Depreciation expense for fiscal 2004, fiscal 2003 and fiscal
2002 was $23 million, $21 million and
$16 million, respectively.
6. Goodwill
The goodwill balance at November 30, 2004 and 2003 relates
to the Companys Aerospace and Defense segment. The changes
in the carrying amount of goodwill for the year ended
November 30, 2004 and 2003 were as follows (in millions):
|
|
|
|
|
Balance as of November 30, 2002
|
|
$ |
42 |
|
ARC acquisition (see Note 11)
|
|
|
60 |
|
Purchase price adjustment (see Note 11)
|
|
|
(2 |
) |
|
|
|
|
Balance as of November 30, 2003
|
|
|
100 |
|
Purchase accounting adjustments
|
|
|
3 |
|
|
|
|
|
Balance as of November 30, 2004
|
|
$ |
103 |
|
|
|
|
|
During fiscal 2004, goodwill of $3 million was recorded as
a result of corrections to the valuation of assets and
liabilities associated with the ARC acquisition completed in
October 2003 and the acquisition of the General Dynamics
Ordnance and Tactical Systems Space Propulsion and Fire
Suppression business (Redmond, Washington operations) completed
in October 2002. The adjustments reflect the use of more
accurate data in valuing certain operations acquired as part of
the transaction with Sequa which were required by the Federal
Trade Commission to be disposed of as a condition to approving
the ARC acquisition and in recording our post-retirement
obligation associated with our acquired Redmond, Washington
operations employees.
67
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
7. Intangible Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross | |
|
|
|
|
|
|
Carrying | |
|
Accumulated | |
|
Net Carrying | |
As of November 30, 2004: |
|
Amount | |
|
Amortization | |
|
Amount | |
|
|
| |
|
| |
|
| |
|
|
|
|
(In millions) | |
|
|
Customer related
|
|
$ |
14 |
|
|
$ |
3 |
|
|
$ |
11 |
|
Acquired technology
|
|
|
18 |
|
|
|
2 |
|
|
|
16 |
|
Other
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Other intangible assets
|
|
$ |
33 |
|
|
$ |
5 |
|
|
$ |
28 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Gross | |
|
|
|
|
|
|
Carrying | |
|
Accumulated | |
|
Net Carrying | |
As of November 30, 2003: |
|
Amount | |
|
Amortization | |
|
Amount | |
|
|
| |
|
| |
|
| |
|
|
|
|
(In millions) | |
|
|
Customer related
|
|
$ |
14 |
|
|
$ |
2 |
|
|
$ |
12 |
|
Acquired technology
|
|
|
18 |
|
|
|
1 |
|
|
|
17 |
|
Other
|
|
|
1 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
Other intangible assets
|
|
$ |
33 |
|
|
$ |
3 |
|
|
$ |
30 |
|
|
|
|
|
|
|
|
|
|
|
Amortization expense related to other intangible assets was
$2 million in fiscal 2004, $2 million in fiscal 2003,
and less than $1 million in fiscal 2002. Amortization
expense for each of the five succeeding years related to other
intangible assets recorded in the Consolidated Balance Sheet at
November 30, 2004 is estimated to be $2 million
annually.
8. Other Noncurrent Assets
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Note and other receivables
|
|
$ |
23 |
|
|
$ |
34 |
|
Deferred financing costs
|
|
|
21 |
|
|
|
20 |
|
Real estate held for development and leasing
|
|
|
27 |
|
|
|
19 |
|
Other
|
|
|
21 |
|
|
|
17 |
|
|
|
|
|
|
|
|
|
Other noncurrent assets
|
|
$ |
92 |
|
|
$ |
90 |
|
|
|
|
|
|
|
|
As of November 30, 2004 and 2003, the Company had a
receivable of $23 million and $14 million from
Northrop Grumman Corporation related to amounts due related to
environmental remediation (see Note 13(d)). In addition, as
of November 30, 2003, the Company had a note receivable of
$20 million due from a regional home builder as a result of
the sale of approximately 100 acres of land that was paid in
full during fiscal 2004.
The Company amortizes deferred financing costs over the term of
the related debt. Amortization of financing costs was
$6 million, $5 million, and $4 million in fiscal
2004, fiscal 2003 and fiscal 2002, respectively.
68
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
9. Other Current Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Accrued goods and services
|
|
$ |
11 |
|
|
$ |
25 |
|
Contract loss provisions
|
|
|
15 |
|
|
|
14 |
|
Advanced payments on contracts
|
|
|
22 |
|
|
|
14 |
|
Accrued compensation and employee benefits
|
|
|
37 |
|
|
|
34 |
|
Interest payable
|
|
|
8 |
|
|
|
7 |
|
Other
|
|
|
48 |
|
|
|
44 |
|
|
|
|
|
|
|
|
|
Other current liabilities
|
|
$ |
141 |
|
|
$ |
138 |
|
|
|
|
|
|
|
|
10. Long-Term Debt
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Convertible subordinated notes
|
|
$ |
285 |
|
|
$ |
150 |
|
Senior subordinated notes
|
|
|
150 |
|
|
|
150 |
|
Other debt
|
|
|
142 |
|
|
|
238 |
|
|
|
|
|
|
|
|
Total debt
|
|
|
577 |
|
|
|
538 |
|
Less: Amounts due within one year
|
|
|
(23 |
) |
|
|
(52 |
) |
|
|
|
|
|
|
|
Total long-term debt
|
|
$ |
554 |
|
|
$ |
486 |
|
|
|
|
|
|
|
|
As of November 30, 2004, the Companys annual fiscal
year debt maturities are summarized as follows (in millions):
|
|
|
|
|
2005
|
|
$ |
23 |
|
2006
|
|
|
31 |
|
2007
|
|
|
168 |
|
2008
|
|
|
|
|
2009
|
|
|
|
|
Thereafter
|
|
|
355 |
|
|
|
|
|
Total Debt
|
|
$ |
577 |
|
|
|
|
|
Subsequent to year-end, the Company completed certain financing
transactions which resulted in reducing debt and extending debt
maturities (see Note 21).
The estimated fair value of the Companys total debt was
$638 million as of November 30, 2004 compared to a
carrying value of $577 million. The fair value of the
convertible subordinated notes and the senior subordinated notes
was determined based on quoted market prices as of
November 30, 2004. The fair value of the remaining debt
approximates the carrying value as the interest rates are
generally variable based on market interest rates and reflect
current market rates available to the Company.
Cash paid for interest for continuing and discontinued
operations was $39 million, $24 million, and
$15 million in fiscal 2004, fiscal 2003, and fiscal 2002,
respectively.
69
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
a. Convertible Subordinated Notes: |
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Convertible subordinated notes, bearing interest at 5.75% per
annum, interest payments due in April and October, maturing in
April 2007
(53/4%
Notes)(1)
|
|
$ |
80 |
|
|
$ |
150 |
|
Contingent convertible subordinated notes, bearing interest at
4.00% per annum, interest payments due in January and July,
maturing in 2024 (4% Notes)
|
|
|
125 |
|
|
|
|
|
Convertible subordinated debentures, bearing interest at 2.25%
per annum, interest payments due in May and November, maturing
in 2024
(21/4%
Debentures)(1)
|
|
|
80 |
|
|
|
|
|
|
|
|
|
|
|
|
Total convertible subordinated notes
|
|
$ |
285 |
|
|
$ |
150 |
|
|
|
|
|
|
|
|
|
|
(1) |
In December 2004, an additional $66 million of aggregate
principal amount of the
21/4% Debentures
was issued with the net proceeds used to repurchase an
additional $60 million of the
53/4% Notes
(see Note 21). |
|
|
|
53/4%
Convertible Subordinated Notes |
In April 2002, the Company issued $150 million aggregate
principal amount of its
53/4% Notes.
The
53/4% Notes
mature in April 2007. Interest on the
53/4% Notes
accrues at a rate of 5.75% per annum and is payable on April 15
and October 15, beginning in October 2002. The
53/4% Notes
are initially convertible into 54.29 shares of the
Companys common stock per $1,000 principal amount of the
53/4% Notes,
implying a conversion price of $18.42 per share, at any time
until the close of business on the business day immediately
preceding the maturity date unless previously redeemed or
repurchased. The
53/4% Notes
are redeemable in whole or in part at the option of the holder
upon a change of control at 100% of the principal amount of the
53/4% Notes
to be repurchased, plus accrued and unpaid interest, if any, to
the date of repurchase, and at the option of the Company at any
time on or after April 22, 2005 if the closing price of the
Companys common stock exceeds 125% of the conversion price
then in effect for at least 20 trading days within a period
of 30 consecutive trading days ending on the trading day
before the day of the mailing of the optional redemption notice
at specified redemption prices, plus accrued and unpaid
interest, if any.
The
53/4% Notes
are general unsecured obligations of the Company and rank equal
in right of payment to all of the Companys other existing
and future subordinated indebtedness including the 4% Notes and
the
21/4%
Debentures. The
53/4% Notes
rank junior in right of payment to all of the Companys
existing and future senior indebtedness, including all of its
obligations under its senior credit facilities, and all of its
existing and future senior subordinated indebtedness, including
the outstanding
91/2%
Senior Subordinated Notes. In addition, the
53/4% Notes
are effectively subordinated to any of the Companys
secured debt and to any and all debt and liabilities, including
trade debt of its subsidiaries.
The indenture governing the
53/4% Notes
limits the Companys ability to, among other things,
consolidate with or merge into any other person or convey,
transfer or lease its properties and assets substantially as an
entirety to any other person unless certain conditions are
satisfied. The indenture also contains customary events of
default, including failure to pay principal or interest when
due, cross-acceleration to other specified indebtedness, failure
to deliver shares of common stock as required, failure to comply
with covenants and certain events of bankruptcy, insolvency and
reorganization, subject in some cases to notice and applicable
grace periods.
Issuance of the
53/4% Notes
generated net proceeds of approximately $144 million, which
were used to repay debt outstanding under the senior credit
facilities.
70
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
In November 2004, the Company used the net proceeds from the
issuance of the
21/4%
Debentures to repurchase $70 million aggregate principal
amount of
53/4% Notes,
resulting in a pretax loss totaling $9 million. The
aggregate outstanding principal amount of
53/4% Notes
at November 30, 2004 was $80 million. Subsequent to
November 30, 2004, an additional $60 million in
aggregate principal amount of
53/4% Notes
was repurchased with net proceeds from the exercise by an
initial purchaser of the
21/4%
Debentures of its option to purchase additional debentures (see
Note 21).
|
|
|
4% Contingent Convertible Subordinated Notes |
In January 2004, the Company issued $125 million aggregate
principal amount of its 4% Notes in a private placement pursuant
to Section 4(2) and Rule 144A under the Securities Act
of 1933. The 4% Notes have been registered for resell for the
purchasers who requested registration. The 4% Notes mature in
January 2024. Interest on the 4% Notes accrues at a rate of 4%
per annum and is payable on January 16 and July 16,
beginning July 16, 2004. In addition, contingent interest
is payable during any six-month period, commencing with the
six-month period, beginning January 16, 2008, if the
average market price of a 4% Note for the five trading days
ending on the third trading day immediately preceding the
relevant six-month period equals 120% or more of the principal
amount of the notes.
Each $1,000 principal amount of the 4% Notes is convertible
at each holders option into 64.81 shares of the
Companys common stock (subject to adjustment as provided
in the indenture governing the 4% Notes) only if:
(i) during any calendar quarter the closing price of the
common stock for at least 20 trading days in the 30 trading-day
period ending on the last trading day of the preceding calendar
quarter exceeds 120% of the conversion price; (ii) the
Company has called the 4% Notes for redemption and
redemption has not yet occurred; (iii) during the five
trading day period after any five consecutive trading day period
in which the average trading price of the 4% Notes for each
day of such period is less than 95% of the product of the common
stock price on that day multiplied by the number of shares of
common stock issuable upon conversion of $1,000 principal amount
of the 4% Notes; or (iv) certain corporate events have
occurred. The initial conversion rate of 64.81 shares for each
$1,000 principal amount of the 4% Notes is equivalent to a
conversion price of $15.43 per share subject to certain
adjustments. None of these events have occurred subsequent to
the issuance of the 4% Notes.
The Company may redeem, at its option, some or all of its
4% Notes for cash on or after January 19, 2010. In
addition, the Company may, at its option, redeem some or all of
its 4% Notes for cash on or after January 19, 2008 and
prior to January 19, 2010, if the closing price of its
common stock for at least 20 trading days in the 30 trading-day
period ending on the last trading day of the preceding calendar
month is more than 125% of the conversion price of $15.43. Each
holder may require the Company to repurchase for cash all or a
portion of its 4% Notes on January 16, 2010, 2014, and
2019, or, subject to certain exceptions, upon a change of
control. In all cases for either redemption of the 4% Notes
or repurchase of the 4% Notes at the option of the holder,
the price is equal to 100% of the principal amount of the
4% Notes, plus accrued and unpaid interest, including
contingent interest and liquidated damages, if any.
The 4% Notes are general unsecured obligations and rank
equal in right of payment to all of the Companys other
existing and future subordinated indebtedness, including the
53/4%
Notes and the
21/4%
Debentures. The 4% Notes rank junior in right of payment to
all of the Companys existing and future senior
indebtedness, including all of its obligations under its senior
credit facilities, and all of its existing and future senior
subordinated indebtedness, including the Companys
outstanding
91/2%
Senior Subordinated Notes. In addition, the 4% Notes are
effectively subordinated to any of the Companys secured
debt and to any and all debt and liabilities, including trade
debt of its subsidiaries.
The indenture governing the 4% Notes limits the
Companys ability to, among other things, consolidate with
or merge into any other person, or convey, transfer or lease its
properties and assets substantially as an entirety to any other
person unless certain conditions are satisfied. The indenture
also contains customary
71
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
events of default, including failure to pay principal or
interest when due, cross-acceleration to other specified
indebtedness, failure to deliver shares of common stock as
required, failure to comply with covenants and certain events of
bankruptcy, insolvency and reorganization, subject in some cases
to notice and applicable grace periods.
Issuance of the 4% Notes generated net proceeds of
approximately $120 million, which were first used to repay
outstanding borrowings under the revolving credit facility and
to prepay the next 12 months of scheduled principal
amortization under Term Loan A. The remaining net proceeds were
available to be used for general corporate purposes.
|
|
|
21/4%
Convertible Subordinated Debentures |
In November 2004, the Company issued $80 million in
aggregate principal amount of its
21/4%
Debentures in a private placement pursuant to Section 4(2)
and Rule 144A under the Securities Act of 1933. The Company
has filed with the SEC to register the
21/4%
Debentures for resell for the purchasers who have requested
registration. The registration is not yet effective, however the
Company expects the registration will be declared effective as
soon as practical following the filing of this Annual Report on
Form 10-K. The
21/4%
Debentures mature in November 2024. Interest on the
21/4%
Debentures accrues at a rate of
21/4%
per annum and is payable on May 15 and November 15,
beginning May 15, 2005. The Company granted an initial
purchaser of the
21/4%
Debentures an option to purchase up to an additional
$80 million aggregate principal amount of the debentures
(see Note 21).
Each $1,000 principal of the
21/4%
Debentures is convertible at each holders option, into
cash and, if applicable, the Companys common stock at an
initial conversion price of $20 per share (subject to adjustment
as provided in the indenture governing the
21/4%
Debentures) only if: (i) during any fiscal quarter the
closing price of the common stock for at least 20 trading days
in the 30 consecutive trading day period ending on the last
trading day of the preceding fiscal quarter exceeds 130% of the
conversion price; (ii) the Company has called the
21/4%
Debentures for redemption and redemption has not yet occurred;
(iii) subject to certain exceptions, during the five
business days after any five consecutive trading day period in
which the trading price per $1,000 principal amount of the
21/4%
Debentures for each day of such period is less than 95% of the
product of the common stock price on that day multiplied by the
conversion rate then in effect; (iv) specified corporate
transactions have occurred; or (v) occurrence of a
transaction or event constituting a designated event. The
Company may be required to pay a make-whole premium in shares of
common stock and accrued but unpaid interest if the
21/4%
Debentures are converted in connection with certain specified
designated events occurring on or prior to November 20,
2011. The initial conversion rate of 50 shares for each $1,000
principal amount of the
21/4%
Debentures is equivalent to a conversion price of $20 per share,
subject to certain adjustments. None of these events have
occurred subsequent to the issuance of the debentures.
The Company may, at its option, redeem some or all of its
21/4%
Debentures for cash on or after November 15, 2014, at a
redemption price equal to 100% of the principal amount to be
redeemed, plus accrued and unpaid interest, including liquidated
damages, if any, to but not including the redemption date. In
addition, the Company may, at its option, redeem some or all of
its
21/4%
Debentures on or after November 20, 2011 and prior to
November 15, 2014, if the closing price of its common stock
for at least 20 trading days in any 30 consecutive trading-day
period is more than 140% of the conversion price of $20, at a
redemption price equal to 100% of the principal amount to be
redeemed, plus accrued and unpaid interest, including liquidated
damages, if any, payable in cash. If the Company so redeems the
21/4%
Debentures, it will make an additional payment in cash, Company
common stock or a combination thereof, at its option, equal to
the present value of all remaining scheduled payments of
interest on the redeemed debentures through November 15,
2014.
Each holder may require the Company to repurchase all or part of
their
21/4%
Debentures on November 20, 2011, November 15, 2014 and
November 15, 2019, or upon the occurrence of certain
events, at a price equal to 100% of the principal amount of the
21/4%
Debentures plus accrued and unpaid interest,
72
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
including liquidated damages, if any, payable in cash, to but
not including the repurchase date, plus, in certain
circumstances, a make-whole premium, payable in Company common
stock.
The
21/4%
Debentures are general unsecured obligations and rank equal in
right of payment to all of the Companys other existing and
future subordinated indebtedness, including the
53/4% Notes
and the 4% Notes. The
21/4%
Debentures rank junior in right of payment to all of the
Companys existing and future senior indebtedness,
including all of its obligations under its senior credit
facilities and all of its existing and future senior
subordinated indebtedness, including the Companys
outstanding
91/2%
Senior Subordinated Notes. In addition, the
21/4%
Debentures are effectively subordinated to any of the
Companys secured debt and to any and all debt and
liabilities, including trade debt of its subsidiaries.
The indenture governing the
21/4%
Debentures limits the Companys ability to, among other
things, consolidate with or merge into any other person, or
convey, transfer or lease its properties and assets
substantially as an entirety to any other person unless certain
conditions are satisfied. The indenture also contains customary
events of default, including failure to pay principal or
interest when due, cross-acceleration to other specified
indebtedness, failure to deliver cash or shares of common stock
as required, failure to comply with covenants and certain events
of bankruptcy, insolvency and reorganization, subject in some
cases to notice and applicable grace periods.
Issuance of the
21/4%
Debentures generated net proceeds of approximately
$77 million, which were used to repurchase
53/4% Notes.
Subsequent to November 30, 2004, the initial purchaser
exercised its option to purchase an additional $66 million
of
21/4%
Debentures. The net proceeds were used to repurchase additional
53/4% Notes
(see Note 21).
|
|
|
b. Senior Subordinated Notes: |
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Senior subordinated notes, bearing interest at 9.50% per annum,
interest payments due in February and August, maturing in August
2013
(91/2% Notes)(1)
|
|
$ |
150 |
|
|
$ |
150 |
|
|
|
|
|
|
|
|
|
|
(1) |
The Company redeemed $53 million of its
91/2% Notes
in February 2005 (see Note 21). |
|
|
|
91/2%
Senior Subordinated Notes |
In August 2003, the Company issued $150 million aggregate
principal amount of its
91/2% Notes
due 2013 in a private placement pursuant to Section 4(2)
and Rule 144A under the Securities Act of 1933. The
91/2%
Notes have been exchanged for registered, publicly tradable
notes with substantially identical terms. The
91/2%
Notes mature in August 2013. All or any portion of the
91/2% Notes
may be redeemed by the Company at any time on or after
August 15, 2008 at redemption prices beginning at 104.75%
and reducing to 100% by August 15, 2011. In addition, at
any time prior to August 15, 2006, the Company may redeem
up to 35% of the
91/2% Notes
with the net offering proceeds of one or more qualified equity
offerings. If the Company undergoes a change of control or sells
all or substantially all of its assets, it may be required to
offer to purchase the
91/2% Notes
from the holders of such notes.
The
91/2% Notes
are unsecured and subordinated to all of the Companys
existing and future senior indebtedness, including borrowings
under its senior credit facilities. The
91/2% Notes
rank senior to the
53/4%
Notes, the 4% Notes and the
21/4%
Debentures. The
91/2% Notes
are guaranteed by the Companys material domestic
subsidiaries. Each subsidiary guarantee is unsecured and
subordinated to the respective subsidiarys existing and
future senior indebtedness, including guarantees of borrowings
under the senior credit facilities.
73
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The
91/2% Notes
and related guarantees are effectively subordinated to the
Companys and the subsidiary guarantors secured debt
and to any and all debt and liabilities, including trade debt of
the Companys non-guarantor subsidiaries.
The indenture governing the
91/2% Notes
limits the Companys ability and the ability of the
Companys restricted subsidiaries, as defined in the
indenture, to incur or guarantee additional indebtedness, make
restricted payments, pay dividends or distributions on, or
redeem or repurchase, its capital stock, make investments, issue
or sell capital stock of restricted subsidiaries, create liens
on assets to secure indebtedness, enter into transactions with
affiliates and consolidate, merge or transfer all or
substantially all of the assets of the Company. The indenture
also contains customary events of default, including failure to
pay principal or interest when due, cross-acceleration to other
specified indebtedness, failure of any of the guarantees to be
in full force and effect, failure to comply with covenants and
certain events of bankruptcy, insolvency and reorganization,
subject in some cases to notice and applicable grace periods.
Issuance of the
91/2%
Notes generated net proceeds of approximately $145 million.
The Company used a portion of the net proceeds to repay
outstanding revolving loans under its senior credit facilities,
and the balance of the net proceeds to finance a portion of the
purchase price of the acquisition of substantially all of the
assets of the propulsion business of Atlantic Research
Corporation and to pay related fees and expenses (see
Note 11).
In October 2004, the Company entered into a supplemental
indenture to amend the indenture dated August 11, 2003 to
(i) permit the refinancing of its outstanding
53/4%
Notes with new subordinated debt having a final maturity or
redemption date later than the final maturity or redemption date
of the
53/4%
Notes being refinanced, and (ii) provide that the Company
will have up to ten business days to apply the proceeds of
refinancing indebtedness toward the redemption or repurchase of
outstanding indebtedness. The supplemental indenture also
amended the definition of refinancing indebtedness to include
indebtedness, the proceeds of which are used to pay a premium
necessary to accomplish a refinancing.
In February 2005, the Company redeemed $53 million
principal amount of its
91/2%
Notes, representing 35% of the $150 million aggregate
principal outstanding (see Note 21).
74
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
As of | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Revolving credit facility, bearing interest on borrowed amounts,
if any, at various rates, expires December 2005(1)
|
|
$ |
|
|
|
$ |
30 |
|
|
Term loan A, bearing interest at various rates (5.1% as of
November 30, 2004), payable in quarterly installments of
approximately $5 million plus interest through December
2004 and then four quarterly installments of approximately
$7 million plus interest through December 2005, with the
2004 quarterly installments prepaid in January 2004(1)
|
|
|
28 |
|
|
|
52 |
|
|
Term loan B, bearing interest at various rates (average rate of
6.02% as of November 30, 2004), payable in quarterly
installments of approximately $300,000 plus interest through
December 2005 and then four quarterly installments of
approximately $8 million plus interest through December
2006, final payment of approximately $79 million due in
March 2007(1)
|
|
|
113 |
|
|
|
114 |
|
|
|
Foreign credit facilities and other
|
|
|
1 |
|
|
|
42 |
|
|
|
|
|
|
|
|
Total other debt
|
|
|
142 |
|
|
|
238 |
|
Less: Amounts due within one year
|
|
|
(23 |
) |
|
|
(52 |
) |
|
|
|
|
|
|
|
Other long-term debt, net of current portion
|
|
$ |
119 |
|
|
$ |
186 |
|
|
|
|
|
|
|
|
|
|
|
Revolving Credit Facility and Term Loans |
In December 2004, the Company entered into a new
$180 million credit facility and terminated the credit
facility existing as of November 30, 2004. The outstanding
term loans totaling $141 million at November 30, 2004
plus accrued interest were repaid in full using restricted cash
from the proceeds of the GDX Automotive sale in August 2004 (see
Note 17) and the equity offering in November 2004 (see
Note 14). See Note 21, including a description of the
terms of the $180 million credit facility.
The credit facility existing as of November 30, 2004 was
originally a $500 million facility entered into in December
2000 to finance an acquisition and to refinance a former credit
facility. As a result of amendments in 2001 and repayment of
debt using proceeds from the sale of Aerojets EIS
business, the credit facility was restructured to consist of a
$137 million revolving credit facility (Revolver) and a
Term Loan A maturing in December 2005. In October 2002, the
Company amended and restated the credit facility (Restated
Credit Facility) to provide for a new Term Loan B in the amount
of $115 million maturing in March 2007. Proceeds of the
Term Loan B were used to finance the acquisition of the Redmond,
Washington operations and repay outstanding revolving loans. The
amendment allowed for extension of the Term Loan B maturity to
June 2009 if the
53/4%
Notes were repaid or otherwise redeemed. Once repaid, term loans
under the Restated Credit Facility may not be reborrowed. As of
November 30, 2004, the Restated Credit Facility consisted
of a Term Loan A maturing in December 2005 with $28 million
outstanding, a Term Loan B maturing in March 2007 with
$113 million outstanding, and a $137 million Revolver
maturing in December 2005. As of November 30, 2004, the
borrowing limit under the Revolver was $137 million subject
to certain restrictions described below. The Company had
outstanding letters of credit of $58 million, primarily
securing environmental and insurance obligations, which reduced
the available borrowing limit, and no borrowings were
outstanding under that facility as of November 30, 2004.
75
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company entered into amendments, consents and waivers
(Amendments) with the lenders of the Restated Credit Facility as
follows:
July, August, and December 2003: among other things,
permitted the issuance of the
91/2%
Notes and the 4% Notes. The Amendments provided, subject to
certain limitations, for the use of the net proceeds received
from the sale of these notes, and excluded these net proceeds
from the mandatory prepayment provisions of the Restated Credit
Facility. The Amendments also amended certain covenants
contained in the Restated Credit Facility.
August 2004: allowed the net proceeds from the sale of
the GDX business to be made available to the Company and be
applied as follows: (i) repay outstanding revolving loans
without a permanent reduction in the revolver commitment, and
(ii) deposit $70 million in a designated account with
one of its lenders. The Company was required to obtain senior
lender approval for the use of the net proceeds from the sale of
GDX on or prior to March 1, 2005, unless these proceeds
were used to repay loans. These Amendments also provided that as
long as the Company had not used the net proceeds from the sale
of GDX to repay term loans or otherwise received lender consent
for the use of these proceeds and the Company had
$50 million or more of cash on hand (including cash in the
designated account), the Company could not borrow from its
Revolver, except that it could issue letters of credit in
accordance with the terms of the Restated Credit Facility. These
Amendments also relaxed certain financial covenants contained in
the credit agreement going forward. The Companys interest
coverage ratio was reduced to 2.25 to 1.00 for the quarter ended
August 31, 2004, to 1.50 to 1.00 for the quarter ending
November 30, 2004 and to 1.65 to 1.00 for the quarter
ending February 28, 2005. The maximum leverage ratio was
increased to 7.00 to 1.00 for the quarter ended August 31,
2004, and 8.25 to 1.00 for the quarters ending November 30,
2004 and February 28, 2005. The fixed charge coverage ratio
was reduced to 0.90 to 1.00 for the quarter ended
August 31, 2004, and 0.65 to 1.00 for the quarters ending
November 30, 2004 and February 28, 2005. The minimum
net worth covenant was waived through the period ending
February 28, 2006. In addition, the Amendments permitted
the sale of the GDX business, including the release of all
collateral associated with the GDX business, the release of two
subsidiary guarantors and the release of the security interests
in the subsidiaries being sold. Under these Amendments, the
approval necessary for the consummation by the Company or any of
its subsidiaries of an acquisition involving total consideration
given and indebtedness assumed in excess of $50 million was
increased from 51% of the lenders to 100% of the lenders.
November 2004: allowed the net proceeds from the issuance
of common stock in the public offering discussed in Note 14
to be deposited into a designated account with one of its
lenders. The Company was required to obtain senior lender
approval for the use of the net proceeds on or prior to
March 1, 2005, unless these proceeds were used to repay
term loans. This Amendment also provided that the net proceeds
from the
21/4%
Debentures be used to repay existing subordinated notes plus
costs, expenses and premium associated therewith. The lenders
also consented to the recording of certain restrictions against
portions of certain real property owned by Aerojet and located
in California.
The Company paid a commitment fee between 0.375% and 0.50%
(based on the most recent leverage ratio) on the unused balance
of the Revolver. Borrowings under the Restated Credit Facility
bore interest at the borrowers option, at various rates of
interest, based on an adjusted base rate (defined as the prime
lending rate or federal funds rate plus 0.50%) or Eurocurrency
rate plus, in each case, an incremental margin. For the Revolver
and Term Loan A borrowings, the incremental margin was based on
the most recent leverage ratio. For base rate loans, the margin
ranged between 0.75% and 2.00%, and for the Eurocurrency loans,
the margin ranged between 1.75% and 3.00%. For Term Loan B
borrowings the margins for base rate loans and Eurocurrency rate
loans were 2.75% and 3.75%, respectively.
The Companys obligations under the Restated Credit
Facility were secured by substantially all of the capital stock
of its material domestic subsidiaries and 65% of the stock of
certain of its foreign subsidiaries, to the extent owned by the
Company and its subsidiaries, and by substantially all of the
material domestic
76
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
subsidiaries tangible and intangible personal property.
The Restated Credit Facility contained certain restrictive
covenants that required the Company to meet specific financial
ratios and also subjected the Company and its subsidiaries to
restrictions on capital expenditures, the ability to incur
additional debt, the disposition of assets including real
estate, and prohibited certain other types of transactions. The
Restated Credit Facility permitted dividend payments as long as
there was no event of default. The Restated Credit
Facilitys three financial covenants were: an interest
coverage ratio, a leverage ratio and a fixed charge coverage
ratio, all as defined in the Restated Credit Facility, as
amended. The Company was in compliance with all financial
covenants as of November 30, 2004. The actual ratios are as
follows:
|
|
|
|
|
|
|
Actual Ratio or | |
|
|
Amount | |
|
|
| |
Interest coverage ratio, not less than: 1.50 to 1.00
|
|
|
1.62 to 1.00 |
|
Leverage ratio, not greater than: 8.25 to 1.00
|
|
|
4.62 to 1.00 |
|
Fixed charges coverage ratio, not less than:0.65 to 1.00
|
|
|
0.84 to 1.00 |
|
|
|
|
Foreign Credit Facilities and Other Debt |
Prior to the sale of GDX, the Company had credit facilities in
Europe and Canada, as well as other bank loans and capitalized
leases relating to its discontinued operations. With the sale of
GDX effective August 31, 2004 (see Note 17), the
outstanding debt relating to its GDX business was paid in full
or assumed by Cerberus and the foreign credit facilities were
terminated. The remaining balance of other debt of
$1 million as of November 30, 2004, represents a
capitalized equipment lease for continuing operations.
Effective January 2003, the Company entered into interest rate
swap agreements on $100 million of its variable rate term
loan debt for a two-year period. Under the swap agreements, the
Company made payments based on a fixed rate of 6.02% and receive
a London InterBank Offered Rate (LIBOR) based variable rate
(5.81% as of November 30, 2004). The Company accounts for
the interest rate swaps pursuant to SFAS No. 133,
Accounting for Derivative Instruments and Hedging Activities,
and there was no material ineffectiveness recognized in
earnings. As of November 30, 2004, the fair value of these
swaps was immaterial and the swaps were terminated in December
2004 concurrent with the repayment of the terms loans (see
Note 21).
11. Acquisitions
On October 17, 2003, the Companys Aerospace and
Defense segment completed the acquisition of substantially all
of the assets of the propulsion business of Atlantic Research
Corporation (ARC), a subsidiary of Sequa Corporation (Sequa), at
a purchase price of $144 million, comprised of
$133 million in cash and estimated direct acquisition costs
and purchase price adjustments of $11 million. This
acquisition makes Aerojet a leading supplier of solid rocket
motors for tactical and missile defense applications and
complements Aerojets capabilities for air breathing and
strategic systems.
77
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The table presented below summarizes the allocation of the fair
value of ARCs assets acquired and liabilities assumed as
of the acquisition date:
|
|
|
|
|
|
|
|
|
October 17, 2003 | |
|
|
| |
|
|
(In millions) | |
Current assets
|
|
$ |
51 |
|
Noncurrent assets
|
|
|
53 |
|
Intangible assets subject to amortization(1)
|
|
|
|
|
|
Customer related(2)
|
|
|
12 |
|
|
Process technology(3)
|
|
|
7 |
|
Goodwill
|
|
|
62 |
|
|
|
|
|
|
Total assets acquired
|
|
|
185 |
|
|
|
|
|
Current liabilities
|
|
|
23 |
|
Noncurrent liabilities
|
|
|
18 |
|
|
|
|
|
|
|
Total liabilities assumed
|
|
|
41 |
|
|
|
|
|
|
|
Net assets acquired
|
|
$ |
144 |
|
|
|
|
|
|
|
(1) |
25 year weighted average useful life. |
|
(2) |
27 year life on customer related intangibles. |
|
(3) |
22 year life on process technology. |
The Company recorded $62 million of goodwill in its
Aerospace and Defense segment and expects $32 million of
goodwill to be deductible for tax purposes. As a condition to
the Federal Trade Commissions approval of the acquisition
of the propulsion business from ARC, Aerojet was required to
divest the former ARC in-space propulsion business operated out
of facilities located in New York and the United Kingdom. As
such, $6 million of assets and $2 million of
liabilities at these locations were recorded as held for sale
and were included in assets and liabilities of discontinued
operations, respectively, as of November 30, 2003. During
fiscal 2004, the Company adjusted the valuation of the assets
and liabilities held for sale by $2 million as a result of
more accurate data and sold the business to American Pacific
Corporation for approximately $4 million in cash and the
assumption of certain liabilities.
|
|
|
Redmond, Washington Operations |
In October 2002, Aerojet acquired the assets of the General
Dynamics Ordnance and Tactical Systems Space Propulsion and Fire
Suppression business (Redmond, Washington operations) for
$93 million, including cash of $90 million and
transaction costs of $5 million, net of a purchase price
adjustment due back to the Company in the amount of
$2 million. During fiscal 2004, the Company recorded an
adjustment of $1 million as the result of recording the
post retirement obligation associated with the acquired Redmond,
Washington operations employees.
12. Employee Pension and Other
Postretirement Benefit Plans
|
|
|
a. Defined Benefit and Other Postretirement Benefit
Plans |
The Company has defined benefit pension plans covering
substantially all salaried and hourly domestic employees. Normal
retirement age is 65, but certain plan provisions allow for
earlier retirement. The Companys funding policy complies
with the funding requirements under applicable laws and
regulations. Pension benefits are calculated under formulas
principally based on average earnings and length of service for
78
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
salaried employees and under negotiated non-wage based formulas
for hourly employees. Pension plan assets are invested primarily
in listed stocks and bonds.
In addition to providing pension benefits, the Company provides
healthcare and life insurance benefits (postretirement benefits)
to most domestic retired employees, with varied coverage by
employee group. Aerojet employees hired after January 1,
1997 are not eligible for postretirement healthcare and life
insurance benefits. All other employees hired after
January 1, 1995 are not eligible for postretirement
healthcare benefits. The healthcare plans generally provide for
cost sharing between the Company and its retirees in the form of
retiree contributions, deductibles and coinsurance.
Postretirement benefit obligations are unfunded and the costs
are accrued based on the date the employees become eligible for
the benefits.
The following information summarizes the balance sheet impacts
of the Companys defined benefit pension plans and other
postretirement benefit plans. The plan assets, benefit
obligations and the funded status of the plans are determined at
the annual measurement date of August 31 for each year
presented below.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
|
Defined Benefit | |
|
Postretirement | |
|
|
Pension Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Change in fair value of plan assets:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair value beginning of year
|
|
$ |
1,624 |
|
|
$ |
1,589 |
|
|
$ |
|
|
|
$ |
|
|
|
|
Actual return on plan assets
|
|
|
191 |
|
|
|
159 |
|
|
|
|
|
|
|
|
|
|
|
Divestiture(3)
|
|
|
(52 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Employer contributions
|
|
|
2 |
|
|
|
1 |
|
|
|
20 |
|
|
|
25 |
|
|
|
Benefits paid
|
|
|
(129 |
) |
|
|
(125 |
) |
|
|
(20 |
) |
|
|
(25 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Fair Value end of year
|
|
$ |
1,636 |
|
|
$ |
1,624 |
|
|
$ |
|
|
|
$ |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Change in benefit obligation:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit obligation beginning of year
|
|
$ |
1,603 |
|
|
$ |
1,510 |
|
|
$ |
190 |
|
|
$ |
181 |
|
|
|
Service cost(1)
|
|
|
17 |
|
|
|
13 |
|
|
|
1 |
|
|
|
1 |
|
|
|
Interest cost(1)
|
|
|
115 |
|
|
|
109 |
|
|
|
11 |
|
|
|
12 |
|
|
|
Amendments
|
|
|
1 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
Acquisition(2)
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
Divestiture(3)
|
|
|
(44 |
) |
|
|
|
|
|
|
(8 |
) |
|
|
|
|
|
|
Medicare Act(4)
|
|
|
|
|
|
|
|
|
|
|
(3 |
) |
|
|
|
|
|
|
Actuarial (gain) loss
|
|
|
54 |
|
|
|
81 |
|
|
|
(44 |
) |
|
|
12 |
|
|
|
Benefits paid
|
|
|
(129 |
) |
|
|
(125 |
) |
|
|
(20 |
) |
|
|
(25 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Benefit Obligation end of year(5)
|
|
$ |
1,617 |
|
|
$ |
1,603 |
|
|
$ |
127 |
|
|
$ |
181 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
79
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
|
Defined Benefit | |
|
Postretirement | |
|
|
Pension Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Funded status of the plans
|
|
$ |
19 |
|
|
$ |
21 |
|
|
$ |
(127 |
) |
|
$ |
(188 |
) |
|
Unrecognized actuarial loss
|
|
|
246 |
|
|
|
281 |
|
|
|
(32 |
) |
|
|
13 |
|
|
Unrecognized prior service cost
|
|
|
9 |
|
|
|
8 |
|
|
|
(8 |
) |
|
|
(12 |
) |
|
Unrecognized transition amount
|
|
|
|
|
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
Minimum funding liability
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Employer contributions/benefit payments August 31 through
November 30
|
|
|
1 |
|
|
|
1 |
|
|
|
3 |
|
|
|
6 |
|
|
Discontinued Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Asset (Liability) Recognized in the Consolidated Balance
Sheets(6)
|
|
$ |
274 |
|
|
$ |
309 |
|
|
$ |
(164 |
) |
|
$ |
(174 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Represents service and interest costs for continuing and
discontinued operations. |
|
(2) |
As discussed in Note 11, the Company acquired the
propulsion business of ARC in October 2003. |
|
(3) |
As discussed in Note 17, the Company sold the GDX business
effective August 31, 2004. |
|
(4) |
As discussed in Note 20, the Company reduced its
accumulated plan benefit obligation by $3 million related
to the Medicare Prescription Drug, Improvement and Modernization
Act of 2003. |
|
(5) |
Pension amounts include $14 million in fiscal 2004 and
$22 million in fiscal 2003 for unfunded plans. |
|
(6) |
Pension amounts include $13 million in fiscal 2004 and
$22 million in fiscal 2003 for unfunded plans. |
As of the August 31, 2004 and 2003 measurement dates, the
accumulated benefit obligation for the defined benefit pension
plans was $1.6 billion.
Components of the amounts recognized in the Companys
Consolidated Balance Sheets are detailed below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
|
Defined Benefit | |
|
Postretirement | |
|
|
Pension Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
As of November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Prepaid pension asset
|
|
$ |
278 |
|
|
$ |
314 |
|
|
$ |
|
|
|
$ |
|
|
Postretirement benefits other than pensions, current
|
|
|
|
|
|
|
|
|
|
|
(15 |
) |
|
|
(26 |
) |
Other current liabilities
|
|
|
(2 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
Postretirement benefits other than pensions, long term
|
|
|
|
|
|
|
|
|
|
|
(149 |
) |
|
|
(148 |
) |
Other noncurrent liabilities
|
|
|
(2 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
Intangible assets
|
|
|
1 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
Accumulated other comprehensive loss
|
|
|
1 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
Minimum funding liability
|
|
|
(2 |
) |
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net Asset (Liability) Recognized in the Consolidated Balance
Sheets
|
|
$ |
274 |
|
|
$ |
309 |
|
|
$ |
(164 |
) |
|
$ |
(174 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
80
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company used the following assumptions, calculated based on
a weighted-average, to measure the benefit obligations and to
compute the expected long-term return on assets for the
Companys employee pension and postretirement benefit plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined | |
|
Other | |
|
|
Benefit | |
|
Postretirement | |
|
|
Pension Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
2004 | |
|
2003 | |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
| |
|
| |
Discount rate
|
|
|
6.25 |
% |
|
|
6.50 |
% |
|
|
6.00 |
% |
|
|
6.25 |
% |
Expected long-term rate of return on plan assets
|
|
|
8.75 |
% |
|
|
8.75 |
% |
|
|
* |
|
|
|
* |
|
Rate of compensation increase
|
|
|
4.50 |
% |
|
|
4.50 |
% |
|
|
* |
|
|
|
* |
|
Initial healthcare trend rate
|
|
|
* |
|
|
|
* |
|
|
|
10.00 |
% |
|
|
11.60 |
% |
Ultimate healthcare trend rate
|
|
|
* |
|
|
|
* |
|
|
|
5.00 |
% |
|
|
5.10 |
% |
Year ultimate rate attained
|
|
|
* |
|
|
|
* |
|
|
|
2011 |
|
|
|
2014 |
|
Certain actuarial assumptions, such as the assumed discount
rate, the long-term rate of return and the assumed healthcare
cost trend rates, can have a significant effect on the amounts
reported for the periodic cost of pension benefits and
postretirement benefits, as well as the respective benefit
obligation amounts.
The assumed discount rate represents the market rate available
for investments in high-quality fixed income instruments based
on the expected benefit payments for the pension and
postretirement benefit plans. For 2004 pension benefit
obligations, the discount rate was reduced to 6.25% and for
postretirement benefit obligations the discount rate was reduced
to 6.00% to reflect market interest rate conditions.
The long-term rate of return for plan assets is based on current
and expected asset allocations, as well as historical and
expected returns on various categories of plan assets. Best
estimate assumptions are developed for each asset class by
reviewing return forecasts of external investment management
firms as well as historical returns for each asset class,
including incremental returns achieved through active management
and expected management fees and plan expenses. These
assumptions are applied to the expected asset mix to determine
the long-term rate of return assumption. The Company assumed an
expected return on plan assets of 8.75% for 2004 benefit
obligations, consistent with 2003.
The Company reviews external data and its own historical trends
for healthcare costs to determine the healthcare cost trend
rates for the postretirement benefit plans. For 2004
postretirement benefit obligations, the Company assumed a 10%
annual rate of increase in the per capita cost of covered
healthcare claims with the rate decreasing over 7 years
until reaching 5%. A one percentage point increase in the
assumed trend rate for healthcare costs would have increased the
postretirement accumulated benefit obligation for continuing and
discontinuing operations by $3 million recorded as of
November 30, 2004 and the effect on the service and
interest cost components of expense for 2004 would not have been
significant. A one percentage point decrease in the assumed
trend rate for healthcare costs would have decreased the
postretirement accumulated benefit obligation for continuing and
discontinued operations by $2 million recorded as of
November 30, 2004 and the effect on the service and
interest cost components of expense for fiscal 2004 would not
have been significant.
81
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Companys pension plans weighted average asset
allocation and the investment policy ranges at August 31,
2004 and 2003 (the Plans measurement dates), by asset category
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Target | |
|
|
2004 | |
|
2003 | |
|
Allocation(1) | |
|
|
| |
|
| |
|
| |
Domestic equity securities
|
|
|
42 |
% |
|
|
46% |
|
|
|
43 |
% |
International equity securities
|
|
|
15 |
|
|
|
16 |
|
|
|
15 |
|
Bonds
|
|
|
42 |
|
|
|
37 |
|
|
|
41 |
|
Real estate
|
|
|
1 |
|
|
|
1 |
|
|
|
1 |
|
|
|
(1) |
Target range is plus or minus 2%. |
The Companys investment strategy consists of a long-term,
risk-controlled approach using diversified investment options
with a minimal exposure to volatile investment options such as
derivatives and includes the use of a diversified allocation of
equity, bonds, and real estate exposures that are customized to
each plans projected cash flow requirements.
The Company expects to contribute $2 million to funded
pension plans in fiscal 2005, which is recoverable under
government contracts, and expects to pay $3 million in
benefits to participants for unfunded pension plans. The Company
expects to pay $15 million in other postretirement benefits
in fiscal 2005, of which $3 million is recoverable under
government contracts.
The following presents estimated future benefit payments,
including expected future service, as appropriate:
|
|
|
|
|
|
|
|
|
|
|
|
|
Other | |
|
|
Defined Benefit | |
|
Postretirement | |
|
|
Pension Plans | |
|
Benefit Plans | |
|
|
| |
|
| |
|
|
(In millions) | |
2005
|
|
$ |
131 |
|
|
$ |
15 |
|
2006
|
|
|
130 |
|
|
|
15 |
|
2007
|
|
|
128 |
|
|
|
14 |
|
2008
|
|
|
126 |
|
|
|
14 |
|
2009
|
|
|
125 |
|
|
|
13 |
|
Years 2010 2014
|
|
|
598 |
|
|
|
57 |
|
82
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of the net periodic expense for pension benefits
and other postretirement benefits for continuing operations are
detailed below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defined Benefit | |
|
|
|
Other Postretirement | |
|
|
Pension Plans | |
|
|
|
Benefit Plans | |
|
|
| |
|
|
|
| |
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
|
(In millions) | |
Service cost
|
|
$ |
12 |
|
|
$ |
10 |
|
|
$ |
7 |
|
|
$ |
|
|
|
$ |
1 |
|
|
$ |
1 |
|
Interest cost on benefit obligation
|
|
|
113 |
|
|
|
106 |
|
|
|
113 |
|
|
|
10 |
|
|
|
12 |
|
|
|
13 |
|
Assumed return on plan assets(1)
|
|
|
(135 |
) |
|
|
(139 |
) |
|
|
(155 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of transition obligation
|
|
|
(2 |
) |
|
|
(2 |
) |
|
|
(2 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Amortization of prior service costs
|
|
|
2 |
|
|
|
2 |
|
|
|
2 |
|
|
|
(4 |
) |
|
|
(4 |
) |
|
|
(5 |
) |
Amortization of net (gains) losses
|
|
|
48 |
|
|
|
13 |
|
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit (income) expense
|
|
$ |
38 |
|
|
$ |
(10 |
) |
|
$ |
(47 |
) |
|
$ |
6 |
|
|
$ |
9 |
|
|
$ |
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Actual returns on for continuing and discontinued operations
plan assets were $191 million in fiscal 2004,
$159 million in fiscal 2003 and a loss of $98 million
in fiscal 2002. |
The pension and postretirement benefit (income) expense for
discontinued operations is detailed below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended | |
|
|
November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Pension and postretirement benefit (income) expense
|
|
$ |
9 |
|
|
$ |
(5 |
) |
|
$ |
(3 |
) |
Settlement/curtailment(1)
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net periodic benefit (income) expense
|
|
$ |
19 |
|
|
$ |
(5 |
) |
|
$ |
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Related to the sale of the GDX business. |
The market-related value of plan assets is smoothed over a
three-year period to determine the expected return-on-assets
component of annual net pension costs. This methodology results
in a calculated market-related value of plan assets that is
close to current value, while still mitigating the effects of
short-term market fluctuations. Unrecognized gains and losses
are primarily a result of the disparity between actual and
expected investment returns on pension plan assets and changes
in the discount rate used to calculate the discounted cash flows
for both pension and postretirement benefit costs. These
unrecognized gains and losses are amortized over a five year
period.
In August 2004, the FASB issued Staff Position No. 106-2
(FSP 106-2), Accounting and Disclosure Requirements Related
to the Medicare Prescription Drug, Improvement and Modernization
Act of 2003 (the Act). The Act introduces a prescription
drug benefit under Medicare (Medicare Part D) as well as a
federal subsidy to sponsors of post-retirement health care
benefit plans that provide a benefit that is at least
actuarially equivalent to Medicare Part D. FSP 106-2
provides authoritative guidance on the accounting for the
federal subsidy and specifies the disclosure requirements for
employers who have adopted FSP 106-2, including those who are
unable to determine whether benefits provided under its plan are
actuarially equivalent to Medicare Part D. FSP 106-2 was
effective for the Company in the fourth quarter of fiscal 2004.
The Company reduced its accumulated plan benefit obligation by
$3 million related to the Act. The Company also expects to
receive an annual federal subsidy of less than $0.5 million
per year beginning in fiscal 2006 through fiscal 2014.
83
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
b. Defined Contribution Pension Plans |
The Company sponsors defined contribution pension plans and
participation in these plans is available to substantially all
domestic employees. Company contributions to these plans
generally are based on a percentage of employee contributions.
The cost of these plans for both continuing and discontinued
operations was $9 million in fiscal 2004, $7 million
in fiscal 2003 and $7 million in fiscal 2002. The
Companys contribution to the plans is invested entirely in
the GenCorp Stock Fund, and may be funded with cash or shares of
GenCorp common stock. Effective fiscal 2004, most participants
are allowed to diversify their investments in GenCorp stock to
other investment alternatives offered in the Plans.
|
|
|
c. Postemployment Benefits |
The Company provides postemployment benefits to its employees.
Such benefits include disability-related, workers
compensation benefits and severance payments for certain
employees. The Company accrues for the cost of such benefits
once an appropriate triggering event has occurred.
|
|
13. |
Commitments and Contingencies |
The Company and its subsidiaries lease certain facilities,
machinery and equipment and office buildings under long-term,
non-cancelable operating leases. The leases generally provide
for renewal options ranging from one to forty-five years and
require the Company to pay for utilities, insurance, taxes and
maintenance. Rent expense was $7 million in fiscal 2004,
$3 million in fiscal 2003 and $3 million in fiscal
2002. The Company also leases certain surplus facilities to
third parties. The Company recorded lease revenue of
$6 million in fiscal 2004, fiscal 2003 and fiscal 2002
related to these arrangements which have been included in net
sales. The future minimum rental commitments under all
non-cancelable operating leases and lease revenue in effect as
of November 30, 2004 were as follows:
|
|
|
|
|
|
|
|
|
|
|
Future Minimum | |
|
Lease | |
|
|
Rental Commitments | |
|
Revenue | |
|
|
| |
|
| |
|
|
(In millions) | |
2005
|
|
$ |
6 |
|
|
$ |
6 |
|
2006
|
|
|
4 |
|
|
|
6 |
|
2007
|
|
|
3 |
|
|
|
6 |
|
2008
|
|
|
|
|
|
|
5 |
|
2009
|
|
|
|
|
|
|
3 |
|
Thereafter
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ |
13 |
|
|
$ |
26 |
|
|
|
|
|
|
|
|
From time to time, GenCorp and its subsidiaries are subject to
legal proceedings, including litigation in federal and state
courts, which arise out of, and are incidental to, the ordinary
course of business. The Company is also subject to governmental
investigations by state and federal agencies. The Company cannot
predict the outcome of such proceedings with any degree of
certainty, and therefore as of November 30, 2004, an
estimate of probable loss or range of loss cannot be made. The
potential liabilities that may result could have a material
adverse effect on the Companys financial position or the
results of operations.
84
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Along with other industrial Potentially Responsible Parties
(PRPs) and area water purveyors, Aerojet was sued in three cases
by approximately 500 individual plaintiffs residing in the
vicinity of Aerojets facilities near Sacramento,
California (the Sacramento cases). One of the cases has
subsequently been dismissed by the plaintiff in that action. The
trial court determined that the Public Utility Commission
regulated water purveyor defendants did not serve water in
violation of state and federal standards. Accordingly, such
regulated water entities were dismissed from the litigation. The
Sacramento Superior Court through the initial pleading stage had
reduced the number of plaintiffs in the Sacramento cases to
approximately 300. On or about May 28, 2004 and
July 23, 2004, the Sacramento Superior Court dismissed,
without leave to amend, nearly 250 plaintiffs, leaving the
number of plaintiffs at 53. Subsequent dismissals have reduced
the number of plaintiffs to 27. The remaining individual
plaintiffs in the Sacramento cases generally seek damages for
illness (in some cases death) and economic injury allegedly
caused by their ingestion of groundwater contaminated or served
by defendants, without specifying actual damages. Discovery in
the Sacramento cases is ongoing and the first phase of the trial
has been set for August 2005. Aerojet has retained outside
counsel and is vigorously defending these actions.
Aerojet was also sued in 14 cases by approximately 1,100
individual plaintiffs residing in the vicinity of Aerojets
former facility in Azusa, California (the San Gabriel
Valley cases). In the San Gabriel Valley cases, the number
of plaintiffs has been reduced to approximately 500. The
San Gabriel Valley cases, coordinated for trial in Los
Angeles, California, are proceeding under two master complaints
and pretrial discovery is in process. The remaining individual
plaintiffs in the San Gabriel Valley cases generally seek
damages for illness (in some cases death) and economic injury
allegedly caused by their ingestion of groundwater contaminated
or served by defendants, without specifying actual damages.
Aerojet and other industrial defendants involved in the cases
are required to carry on certain investigations by order of the
U.S. Environmental Protection Agency (EPA) under the
Comprehensive Environmental Response, Compensation and Liability
Act (CERCLA).
The trial court in the San Gabriel Valley cases has ruled that
regulated water entity defendants will only be held accountable
based on quantitative or numerical standards such as
maximum contaminant levels (MCL) or
action levels. The trial court also ruled that a
single exceedance of a numerical standard does not constitute a
violation. Rather, a violation requires a failure to
comply with the regulatory scheme, and not merely by exceedances
of the MCL. Thus, an exceedance of an action level, by
itself, does not give rise to a cause of action. Plaintiffs have
sought to overturn these rulings, but a final determination has
not yet been made. The court also determined that the Public
Utility Commission regulated water entity defendants did not
serve water in violation of state and federal standards.
Accordingly, such regulated water entities were dismissed from
the litigation. Numerous defendants have settled with the
plaintiffs. Currently, 162 of the remaining approximately 500
San Gabriel Valley plaintiffs are subject to early
trial most likely in 2005. Aerojet has notified its
insurers, retained outside counsel and is vigorously defending
these actions.
Aerojet and other defendants were sued by the Orange County
Water District, a public entity with jurisdiction over
groundwater resources and water supplies in Orange County.
Orange County Water District v. Northrop Corporation, et al.,
Case No. O4CC00715, Orange County (CA) Superior
Court, served December 29, 2004. The plaintiff alleges that
groundwater in Orange County, California is contaminated with
chlorinated solvents that were allegedly released to the
environment by Aerojet and other industrial defendants causing
it to incur unspecified response costs and other damages. The
plaintiff seeks declaratory relief and recovery of past costs in
connection with investigation and remediation of groundwater
resources. Aerojet has filed its answer and discovery has
commenced.
85
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Air Pollution Cases
Aerojet and several other defendants have been sued by private
residents living in the vicinity of Chino and Chino Hills,
California. The cases have been consolidated and are pending in
the U.S. District Court for the Central District of California.
Baier, et al. v. Aerojet-General Corporation, et al.,
Case No. EDCV 00 618VAP (RNBx) CA; Kerr, et al. v.
Aerojet-General Corporation, Case No. EDCV 01-19VAP
(SGLx); and Taylor, et al. v. Aerojet-General Corporation, et
al., Case No. EDCV 01-106 VAP (RNBx). An additional
case involving similar allegations was filed in 2004. Yeh, et
al. v. Aerojet-General Corporation, Case No. RCV 083065
San Bernardino County Superior Court (transferred to U.S.
District Court, Central District, CA, renumbered Case
No. EDCV 04-1354-VAP(SHx). This case has been coordinated
with the Baier, Kerr and Taylor cases.
Plaintiffs generally allege that defendants released hazardous
chemicals into the air at their manufacturing facilities, which
allegedly caused illness, death, and economic injury. Various
motions have reduced the number of plaintiffs from 80 to 48.
Discovery is proceeding in the cases. Trial is likely to be
scheduled for 2006. Aerojet has notified its insurers and is
vigorously defending the actions.
Water Entity Cases
In October 2002, Aerojet, along with approximately 65 other
individual and corporate defendants, was served with four civil
suits filed in the U.S. District Court for the Central District
of California that seek recovery of costs allegedly incurred in
response to the contamination present at the South El Monte
Operable Unit (SEMOU) of the San Gabriel Valley Superfund
site. The cases are denominated as follows: The City of
Monterey Park v. Aerojet-General Corporation, et al.,
(CV-02-5909 ABC (RCx)); San Gabriel Basin Water Quality
Authority v. Aerojet-General Corporation, et al.,
(CV-02-4565 ABC (RCx)); San Gabriel Valley Water Company v.
Aerojet-General Corporation, et al., (CV-02-6346 ABC (RCx))
and Southern California Water Company v. Aerojet-General
Corporation, et al., (CV-02-6340 ABC (RCx)). The cases have
been coordinated for ease of administration by the court. The
plaintiffs claims are based upon allegations of discharges
from a former site in the El Monte area, as more fully discussed
below under the headings San Gabriel Valley Basin,
California South El Monte Operable Unit. The
total cost estimates to implement projects under the UAO
prepared by EPA and the water entities is approximately $90
million. Aerojet is vigorously defending the actions as its
investigations do not identify a credible connection between the
contaminants identified by the water entities in the SEMOU and
those detected at Aerojets former facility located in El
Monte, California, near the SEMOU (East Flair Drive site).
Aerojet has filed third-party complaints against several water
entities on the basis that they introduced
perchlorate-containing Colorado River water to the basin. Those
water entities have filed motions to dismiss Aerojets
complaints. The motions as well as discovery have been stayed
pending efforts to resolve the litigation through mediation.
Aerojet has notified its insurers of these claims.
Wotus, et al. v. GenCorp Inc.
and OMNOVA Solutions Inc.
In October 2000, a group of hourly retirees filed a federal
lawsuit against GenCorp Inc. (GenCorp) and OMNOVA Solutions Inc.
(OMNOVA) disputing certain retiree medical benefits.
Wotus, et al. v. GenCorp Inc., et al., U.S.D.C., N.D. OH
(Cleveland, OH), Case No. 5:00-CV-2604. The retirees seek
rescission of the then current Hourly Retiree Medical Plan
established in the spring of 1994, and the reinstatement of the
prior plan terms. The crux of the dispute relates to union and
GenCorp negotiated modifications to retiree benefits that, in
exchange for other consideration, now require retirees to make
benefit contributions as a result of caps on company-paid
retiree medical costs implemented in late 1993. A retirees
failure to pay contributions results in a termination of
benefits. The Company prevailed in similar litigation filed in
1995 involving salaried employees arising at the Companys
Wabash, Indiana location. Divine, et al. v. GenCorp Inc.,
U.S.D.C., N.D. IN (South Bend, IN), Case No. 96-CV-0394-AS.
86
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The initial plaintiffs consisted of four hourly retirees from
the Jeannette, Pennsylvania facility of OMNOVA, the company
spun-off from GenCorp on October 1, 1999, two hourly
retirees from OMNOVAs former Newcomerstown, Ohio facility,
and three hourly retirees from the Companys former tire
plants in Akron, Ohio; Mayfield, Kentucky; and Waco, Texas. The
plaintiffs sought class certification seeking to represent all
eligible hourly retirees formerly represented by the unions URW
or USWA. The unions are not party to the suit and have agreed
not to support such litigation pursuant to an agreement
negotiated with us. In December 2003, the trial court denied
plaintiffs motion for class action certification. The
plaintiffs filed a motion seeking reconsideration, and that
motion was denied. Plaintiffs petitioned the Sixth Circuit Court
of Appeals (Court of Appeals) for the right to seek an
interlocutory appeal of the trial courts denial of class
certification. The Court of Appeals denied that petition in
August 2004.
Following the Court of Appeals ruling on the interlocutory
appeal, the trial court lifted the stay on the Wotus case and
denied a pending motion filed on behalf of 241 individuals who
sought to intervene in the Wotus case. The result of these
rulings is that that the Wotus case will move forward with the
nine remaining individual plaintiffs or their estates. Extensive
discovery has already occurred in this case. The Company has
given notice to its insurance carriers and is receiving
reimbursement for portions of its defense fees and costs. The
Company is vigorously defending these claims. A trial in the
Ohio federal court is not expected until sometime after the
summer of 2005.
OMNOVA had requested defense and indemnification from the
Company regarding this matter. The Company denied this request
and the party-defendants engaged in arbitration as required
pursuant to the 1999 GenCorp-OMNOVA spin-off agreements. On
May 26, 2004, the arbitrator issued his decision holding
that the Company is required to defend and indemnify OMNOVA in
the Wotus matter. Because the Company believes that the
arbitrators ruling was overbroad and exceeded the scope of
the arbitration, the Company has sought clarification, and
possible modification, of the ruling in Ohio state court.
Baumgardner et al. v. GenCorp
Inc. and OMNOVA Solutions Inc.
On or about July 8, 2004, the 241 individuals who sought to
intervene in the Wotus matter filed a separate lawsuit against
GenCorp and OMNOVA, also in the U.S. District Court for the
Northern District of Ohio, seeking the same claims and relief
(other than class certification) as in the Wotus matter.
Baumgardner, et al. v. GenCorp Inc. et al., U.S.D.C.,
N.D. OH (Cleveland, OH), Case No. 1:04 CV 1278. The number
of plaintiffs in the Baumgardner case was subsequently increased
to 294. After the Sixth Circuit Court of Appeals denied the
Wotus plaintiffs petition for an interlocutory appeal, and
denied the Baumgardner plaintiffs motion to intervene in
the Wotus case, the trial court ruled that the joinder of the
294 individuals in the Baumgardner case was improper. As a
result of that decision, the trial court dismissed the
Baumgardner case, tolling the statute of limitations for such
individuals until October 31, 2004. The trial court
extended the tolling of the statute of limitations for the
former Baumgardner plaintiffs through February 28, 2005. On
February 4, 2005, the former Baumgardner plaintiffs filed
individual complaints against the Company and Omnova with the
same allegations that were made in the Baumgardner case.
GenCorp Inc. v. Olin
Corporation
In August 1991, Olin Corporation (Olin) advised the Company that
under a 1962 manufacturing agreement with Olin (the 1962
Agreement), it believed GenCorp to be jointly and severally
liable for certain Superfund remediation costs, estimated by
Olin to be $70 million. The costs are associated with a
former Olin manufacturing facility and its waste disposal sites
in Ashtabula County, Ohio. In 1993, the Company sought a
declaratory judgment in federal court (the Ohio Court) that it
was not responsible for such environmental remediation costs.
GenCorp Inc. v. Olin Corporation, Case
No. 5:93CV2269, U.S. District Court, N.D. Ohio. Olin
counterclaimed seeking a judgment that the Company was liable
for a share of remediation costs. The Company argued that it was
not derivatively or directly liable as an arranger for disposal
of waste at the Big D
87
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Campground landfill (Big D site), both as a matter of fact
and law. As a defense to Olins counterclaim, the Company
asserted that under the terms of the 1962 Agreement, Olin had a
contractual obligation to insure against environmental and other
risks and that its failure to protect such insurance payments
under these policies precluded Olin from recovery against the
Company for these remediation costs. Further, the Company claims
that any failure on Olins part to comply with the terms of
such insurance policies would result in the Company being
entitled to breach of contract remedies resulting in a reduction
in any CERCLA liability amounts determined to be owed to Olin
that would have otherwise been recovered from Olins
insurance carriers (the Reduction Claims).
In 1999, the Ohio Court rendered an interim decision on CERCLA
liability. The Ohio Court found GenCorp 30% liable and Olin 70%
liable for remediation costs at the Big D site. The Ohio Court
also found GenCorp 40% liable and Olin 60% liable for
remediation costs, including costs for off-site disposal (other
than the Big D site) and costs attributable to contamination at
the Olin TDI facility, a plant built and operated by Olin on
GenCorp property near the Big D site. However, the trial court
did not rule on the Companys Reduction Claims and
determined it would hold these claims in abeyance.
In a related case, on August 27, 2002, the U.S. District
Court for the Southern District of New York (the NY Court) ruled
that Olin failed to protect its right to payments under its
insurance policies for the Big D site. The NY Court based its
ruling on the fact that Olin had failed to timely notify its
insurance carriers of its claims. Given Olins contractual
obligations and the NY Courts finding that Olin failed to
give proper notice of a claim under these insurance policies,
management could not then, or at this time, estimate the
possible amount of liability arising from this case, if any.
Olin appealed the NY Courts ruling to the Second Circuit
Court of Appeals. In November 2003, the Second Circuit Court of
Appeals vacated the NY Courts decision with respect to
Olins excess insurance carriers. While the Second Circuit
Court of Appeals upheld the dismissal as to the primary
carriers, it held that the trial court failed to make a record
sufficient to dismiss the excess carriers. Thus, the case was
remanded to the NY Court for further proceedings. On further
review, the NY Court may still decide that Olins notice to
the excess insurance carriers remains untimely or could decide
it was timely. If the NY Court decides Olins notice was
untimely, the Ohio Court could rule in GenCorp Inc. v. Olin
Corporation that Olins late notice constituted a
breach of Olins obligation under the 1962 Agreement to
protect the insurance; or it could conclude that Olins
conduct does not support the Companys Reduction Claims and
thus does not reduce the Companys liability. If the Ohio
Court rules that Olins late notice is a breach of the 1962
Agreement, then it must determine the damages suffered by the
Company as a result of the breach. The Company has argued that
the proper measure of damages is the coverage limits of the
policies that Olin forfeited an amount in this case
that is more than sufficient to cover the Companys entire
liability.
On November 21, 2002, the Ohio Court issued a memorandum
opinion and judgment entering final judgment in
favor of Olin in the amount of approximately $19 million
plus prejudgment interest in the amount of approximately
$10 million. At that time, the Ohio Court did not decide
the Companys Reduction Claims against Olin. The Ohio Court
held that the Companys Reduction Claims are held in
abeyance pending the resolution of [Olins] appeal in the
New York insurance litigation.
On January 22, 2003, the Ohio Court issued a judgment order
stating the case was terminated on the Ohio
Courts docket. However, in its memorandum opinion and
order of the same date, the Ohio Court stated [w]hether
there was an insurable event upon which Olin would have been
entitled to recovery had it provided its insurers with timely
notice... and... whether GenCorp is entitled to credit based
upon Olins omission which foreclosed insurance recovery
for Big D, remain unresolved. Management believes that a
recovery on the Companys Reduction Claims could range from
a nominal amount to an amount sufficient to reduce the judgment
against the Company in its entirety.
88
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The Company appealed the CERCLA contribution liability to the
Sixth Circuit Court of Appeals (the Court of Appeals).
GenCorp Inc. v. Olin Corporation, Docket Nos. 03-3019;
03-3211, United States Court of Appeals for the Sixth Circuit.
In the appeal, the Company argued that it was not directly or
indirectly liable as an arranger for Olins waste disposal
at the Big D site and that it did not either actively control
Olins waste disposal choices or operate the plant on a
day-to-day basis. The Court of Appeals heard oral arguments on
June 11, 2004. On November 22, 2004, the Court of
Appeals issued its opinion ruling against the Company with
respect to all of its major claims. Subsequently, the Company
filed a petition for a rehearing en banc. The Company is
awaiting a decision on such petition.
The Reduction Claims portion of the case is on hold pending
final resolution of the NY Courts determination as to
whether Olins notice to its insurance carriers was or was
not timely. Irrespective of the outcome of its appeal, the
Company believes it has contractual protection against
Olins claims by virtue of Olins obligations to
procure and protect insurance. The Ohio Court had previously
stated that pursuant to the terms of the 1962 Agreement, it was
Olins contractual obligation to obtain insurance coverage
and the evidence adduced during the litigation showed that Olin
had in place insurance coverage during the period in question in
the amount of $40 million to $50 million.
In summary, while the Ohio Courts order finding the
Company liable to Olin for a CERCLA contribution payment was
upheld by the Sixth Circuit Court of Appeals, pending any
decision on the Companys petition for rehearing, the
Company has concluded it is not appropriate to accrue any
additional amount related to that finding because: (a) the
Company previously accrued the entire amount of its estimated
potential liability for contamination at the Olin TDI facility
and related offsite contamination, except for disposal at the
Big D site; (b) the Company believes it will prevail on
appeal on the basis that it is not derivatively or directly
liable as an arranger for disposal at the Big D site, both as a
matter of fact and law; and (c) irrespective of whether,
upon exhausting all avenues of appeal, there is a finding of
CERCLA liability, the Company believes that: (i) if Olin
prevails in the NY Court action against its excess insurance
carriers , the Company will ultimately benefit from available
insurance proceeds and may make no payment to Olin; or
(ii) if Olin fails in its appeal, that Olins breach
of its contractual obligations to provide insurance will result
in a reduction in, or elimination of, some or all of such
liability. In any event, the possible amount of additional
liability arising from this case or any reduction in the
Companys liability, if any, cannot be established at this
time.
Tolwin et al. v. GenCorp Inc.
et al.
In November 2004, an alleged shareholder of the Company filed a
lawsuit in Superior Court of the State of California, Sacramento
County, against the Company, its directors and one executive
officer. Tolwin et al. v. GenCorp Inc. et al. Plaintiff
alleges that the defendants breached their fiduciary duties by
failing to give adequate consideration to reasonable acquisition
offers. Plaintiff seeks class action status and on behalf of
herself and other similarly situated individuals, plaintiff
seeks damages and injunctive relief. The defendants have filed
an answer to the complaint. The Company has notified its
insurers and intend to vigorously defend this action.
Vinyl Chloride Cases
Between the early 1950s and 1985, the Company produced polyvinyl
chloride (PVC) resin at its former Ashtabula, Ohio
facility. PVC is one of the most common forms of plastic
currently on the market. A building block compound of PVC is
vinyl chloride (VC), now listed as a known carcinogen by several
governmental agencies. The Occupational Safety and Health
Administration (OSHA) has strictly regulated workplace
exposure to VC since 1974.
Since the mid-1990s, the Company has been named in 46 cases
involving alleged exposure to VC. With the exception of two
cases brought by families of former Ashtabula employees, the
Company is alleged to be a
89
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
supplier/manufacturer of PVC and/or a civil
co-conspirator with other VC and PVC manufacturers. Plaintiffs
generally allege that the Company suppressed information about
the carcinogenic risk of VC to industry workers, and placed VC
or PVC into commerce without sufficient warnings. A few of these
cases allege VC exposure through various aerosol consumer
products, in that VC had been used as an aerosol propellant
during the 1960s. Defendants in these aerosol cases
include numerous consumer product manufacturers, as well as the
more than 30 chemical manufacturers. The Company used VC
internally, but never supplied VC for aerosol or any other use.
Of the total 46 cases, 22 have been settled or dismissed on
terms favorable to the Company, including the cases where the
Company was the employer. The remaining 24 pending cases involve
employees at VC or PVC facilities owned or operated by others,
or allege aerosol exposure. One of the pending cases is a class
action seeking a medical monitoring program for former employees
at a PVC facility in New Jersey. The complaints in each of these
cases assert that the Companys involvement in the alleged
conspiracy stems from the Companys membership in trade
associations.
Given the lack of any significant consistency to claims (i.e.,
as to product, operational site, or other relevant assertions)
filed against the Company, the Company is unable to make a
reasonable estimate of the future costs of pending claims or
unasserted claims. Accordingly, no estimate of future liability
has been accrued for such contingencies. The Company is
vigorously defending against all claims in these cases.
Asbestos Litigation
Over the years, the Company has from time to time been named as
defendants in lawsuits alleging personal injury or death due to
exposure to asbestos in building materials or in manufacturing
operations. The majority have been filed in Madison County,
Illinois and San Francisco, California. Since 1998, more than
100 of these asbestos lawsuits have been resolved, with the
majority being dismissed and many being settled for less than
$0.1 million each. As of November 30, 2004, there were
70 pending asbestos cases.
In July 2004, PCC Flow Technologies, Inc. (PCC), a subsidiary of
Precision Castparts Corp., sent a demand letter to Aerojet
seeking indemnification for approximately fifty seven pending
asbestos cases, and forty two settled or closed asbestos cases.
PCC claims that it is the successor to the business of Johnston
Pump Company, a business operated by a subsidiary of Aerojet. In
1984, Johnston Pump Company sold certain assets relating to the
Johnston Pump and valve business. PCC contends that the purchase
agreement provided that the seller would retain liability for
product liability claims arising out of products manufactured
prior to the closing date in 1984 and would indemnify and defend
the buyer from such claims. PCC also contends that Aerojet
guaranteed the sellers alleged indemnity obligations
contained in the purchase agreement. PCC has filed a lawsuit
against two of the Companys subsidiaries seeking recovery
for past costs associated with defending these cases. The
Company has agreed in principle with PCC to settle this dispute
and as part of that settlement, the Company will be defending
PCC and its affiliates in approximately 48 additional pending
asbestos cases after the final settlement agreement is
negotiated and executed.
Given the lack of any significant consistency to claims (i.e.,
as to product, operational site, or other relevant assertions)
filed against the Company, the Company is unable to make a
reasonable estimate of the future costs of pending claims or
unasserted claims. Accordingly, no estimate of future liability
has been accrued for such contingencies.
Other Legal Matters
The Company is subject to other legal actions, governmental
investigations and proceedings relating to a wide range of
matters in addition to those discussed above. While there can be
no certainty regarding the outcome of any litigation,
investigation or proceeding, in the opinion of the
Companys management, after reviewing the information that
is currently available with respect to such matters, any
liability that may
90
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
ultimately be incurred with respect to these matters is not
expected to materially affect the Companys consolidated
financial condition. The effect of the resolution of these
matters on the Companys financial condition and results of
operations, the Companys liquidity and available financial
resources cannot be predicted because any such effect depends on
future results of operations, liquidity position and available
financial resources, and the amount and timing of the resolution
of such matters. In addition, it is possible that amounts could
be significant in any particular reporting period.
c. Environmental
Matters
Sacramento, California
In 1989, a federal district court in California approved a
Partial Consent Decree (Decree) requiring Aerojet to conduct a
Remedial Investigation/ Feasibility Study (RI/ FS) of a portion
of Aerojets Sacramento site. The Decree required Aerojet
to prepare a RI/ FS report on specific environmental conditions
present at the site and alternatives available to remediate such
conditions. Aerojet also is required to pay for certain
governmental oversight costs associated with Decree compliance.
Beginning in the mid-1990s, the State of California expanded its
surveillance of perchlorate and nitrosodimethylamine (NDMA).
Under the RI/ FS, traces of these chemicals were detected using
new testing protocols in public water supply wells near
Aerojets Sacramento site.
Aerojet completed the initial phase of a site-wide remedial
investigation in 1993. In addition, Aerojet has installed six
groundwater extraction and treatment facilities as interim
measures to control groundwater contamination at the Sacramento
site. Aerojet is also investigating groundwater contamination
both on and off its facilities through the development of
operable unit feasibility studies. On August 19, 2002, the
EPA issued an administrative order requiring Aerojet to
implement the EPA approved remedial action for the Western
Groundwater Operable Unit. A nearly identical order was issued
by the California Regional Water Quality Control Board, Central
Valley (Central Valley RWQCB). In fiscal 2003, Aerojet
discovered previously unidentified NDMA-contaminated groundwater
located to the north and west of the Western Groundwater
Operable Unit boundaries. Following such discovery, Aerojet
undertook investigation to characterize the extent of the
contamination. This investigation has been substantially
completed. This contaminated groundwater zone has been
incorporated into the Western Groundwater Operable Unit
remediation plan. Based on sampling, Aerojet believes that no
municipal drinking water wells are threatened by this finding.
Aerojet will continue to conduct feasibility studies to refine
technical approaches and costs to remediate the site. The
remediation costs are principally for design, construction,
enhancement and operation of groundwater and soil treatment
facilities, ongoing project management and regulatory oversight.
A discussion of Aerojets efforts to estimate these costs
is contained below under the heading Environmental
Reserves and Estimated Recoveries.
On April 15, 2002, the United States District Court
approved and entered a Stipulation and Order Modifying the
Partial Consent Decree (Stipulation and Order). Among other
things, the Stipulation and Order removed approximately 2,600
acres of Aerojets property from the requirements of the
Decree and from the Superfund site designation, enabling Aerojet
to put the 2,600 acres to more productive use. The Stipulation
and Order (i) requires the Company to provide a guarantee
of up to $75 million (in addition to a prior
$20 million guarantee) to assure that remediation
activities at the Sacramento site are fully funded;
(ii) requires Aerojet to provide a short-term and long-term
plan to replace lost water supplies; and (iii) divides the
Superfund site into Operable Units to allow Aerojet
and the regulatory agencies to more efficiently address and
restore priority areas. For the first three years of the
Stipulation and Order, the new guarantee is partially offset by
financial assurances provided in conjunction with the Baldwin
Park Operable Unit (BPOU) agreement (discussed below).
Obligations under the $75 million aggregate guarantee are
limited to $10 million in any year. Both the
$75 million aggregate guarantee and the $10 million annual
limitation are subject to adjustment annually for inflation.
91
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Aerojet leased the southern portion of the Sacramento site to
Douglas Aircraft for rocket assembly and testing from 1957 to
1961 and sold approximately 3,800 acres, including the formerly
leased portion, to Douglas Aircraft in 1961. Aerojet reacquired
such property known as IRCTS from MDC, the successor to Douglas
Aircraft and now an operating unit of The Boeing Company, in
1984. Both MDC and Aerojet were ordered to investigate and
remediate environmental contamination by certain orders issued
in 1991 and 1994 by the California Department of Toxic
Substances Control (DTSC) and a similar 1997 order of the
Central Valley RWQCB. In 1997, approximately 1,100 acres of the
property were released from the DTSC orders, and in 2001,
Aerojet sold such 1,100 acre property.
In March 2004, the California Office of Environmental Health
Hazard Assessment (OEHHA) established a perchlorate Public
Health Goal at 6 parts per billion (ppb). The California
Department of Health Services immediately established an Action
Level for perchlorate at 6 ppb. The previous Action Level was 4
ppb. The National Academy of Sciences (NAS) recently issued
its report on the health effects of perchlorate, which report
was designed to help policymakers set both federal and state
standards for perchlorate in drinking water. The NAS report
suggested a reference dose that translates into approximately 25
ppb. At this time it is unclear what actions, if any, the
federal and state regulatory agencies will take following the
NAS report.
San Gabriel Valley Basin,
California
Baldwin
Park Operable Unit
Aerojet, through its former Azusa, California operations, was
previously named by the U.S. Environmental Protection Agency as
a Potentially Responsible Party (PRP) for contamination in
the portion of the San Gabriel Valley Superfund Site known as
the Baldwin Park Operable Unit (BPOU).
From January 1995 January 1997 EPA issued Special
Notice Letters to Aerojet and eighteen other companies
requesting they implement a groundwater remedy. Subsequently,
perchlorate, NDMA, and 1,4-dioxane were identified as
contaminants in the BPOU and on June 30, 2000 the EPA
issued a Unilateral Administrative Order (UAO) ordering the
PRPs to implement a remedy consistent with the ROD, but
encouraging the PRPs to attempt to negotiate an agreement with
the local purveyors. Aerojet, along with seven other PRPs (the
Cooperating Respondents) signed a Project Agreement in late
March 2002 with the Water Quality Authority, Watermaster, Valley
County Water District, La Puente Valley Water District, San
Gabriel Valley Water Company, Suburban Water Systems and
California Domestic Water Company (the Water Entities). The
Project Agreement became effective on May 9, 2002. The
basic structure of the Project Agreement is for the Cooperating
Respondents to fund the capital, operation and maintenance
costs, and administrative costs through an escrow account for a
term of 15 years and settle the past environmental claims
of the Water Entities. There are also provisions for maintaining
financial assurance (in the form of cash or letters of credit).
When fully constructed, six treatment facilities will be
treating in excess of 25,000 gallons per minute for the purposes
of ROD implementation and providing a potable water supply.
Aerojet and the other Cooperating Respondents have entered into
an interim allocation agreement that establishes the interim
payment obligations of Aerojet and the remaining Cooperating
Respondents for the costs of the Project Agreement. Under the
interim allocation, Aerojet is responsible for approximately
two-thirds of all project costs, pending completion of any
allocation proceeding. All project costs are subject to
reallocation among the Cooperating Respondents. Aerojet intends
to continue to defend itself vigorously to assure that it is
appropriately treated with other PRPs and that costs of any
remediation are properly allocated among all PRPs. Aerojet has
notified its insurers and is pursuing claims under its insurance
policies.
A significant amount of public funding is available to offset
project costs. To date, Congress has appropriated approximately
$56 million (so called Title 16 or Dreier funds), which is
potentially available for payment of project costs. All such
funding will require Water Quality Authority (WQA) action to
allocate
92
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
funds to the project, which the WQA is currently considering.
Approximately $34 million of the funding has been allocated
to the project and additional funds may follow in later years.
As part of Aerojets sale of its Electronics and
Information Systems (EIS) business to Northrop Grumman
Corporation (Northrop) in October 2001, the EPA approved a
Prospective Purchaser Agreement with Northrop to absolve it of
pre-closing liability for contamination caused by the Azusa
facility, which liability will remain with Aerojet. As part of
that agreement, GenCorp agreed to provide a $25 million
guarantee of Aerojets obligations under the Project
Agreement. During the first three years of the Project
Agreement, the GenCorp guarantee is partially offset by other
financial assurances provided in conjunction with the Project
Agreement. Also as part of the EIS sale to Northrop, Aerojet
paid the EPA $9 million which was an amount to be offset
against Aerojets share of the EPAs total claimed
past costs (the EPA now claims total past costs attributable to
various parties are approximately $28 million). Aerojet and
the EPA have agreed to a final settlement for Aerojets
portion of such past costs and are negotiating a consent decree.
Unresolved at this time is the issue of Californias past
costs which were last estimated at approximately $4 million.
In addition to the EPAs UAO and the Project Agreement
executed with the Water Entities, the California Regional Water
Quality Control Board, Los Angeles Region (Los Angeles RWQCB)
issued orders to Aerojet and other PRPs to conduct groundwater
investigations on their respective sites (former Azusa,
California site). As a result, the Los Angeles RWQCB ordered
Aerojet to conduct limited soil vapor extraction, which Aerojet
completed in 2003 and is awaiting Los Angeles RWQCB approval for
closure. Los Angeles RWQCB also directed Aerojet to characterize
perchlorate contamination in soils. Aerojet submitted a Remedial
Action Plan (RAP) to the Los Angeles RWQCB and has begun
implementing the activities recommended in the RAP, and on
January 11, 2005 submitted a work plan to the Los Angeles
RWQCB for additional soil characterization.
South
El Monte Operable Unit (SEMOU)
On December 21, 2000, Aerojet received an order from the
Los Angeles Regional Water Quarter Control Board
(RWQCB) requiring a work plan for investigation of
Aerojets former El Monte facility. On January 22,
2001, Aerojet filed an appeal of the order with the Los Angeles
RWQCB asserting selective enforcement. The appeal had been held
in abeyance pending negotiations with the Los Angeles RWQCB, but
due to a two-year limitation on the abeyance period, the appeal
was dismissed without prejudice. In September 2001, Aerojet
submitted a limited work plan to the Los Angeles RWQCB. On
February 21, 2001, Aerojet received a General Notice Letter
from the EPA Region IX naming Aerojet as a PRP to the SEMOU of
the San Gabriel Valley Superfund site.
Aerojet continues to negotiate with the Los Angeles RWQCB
regarding an investigation of this former facility and has
recently agreed to a scope of work for additional field
activities and is currently implementing the field work. In the
event the RWQCB demands further site investigation, Aerojet may
re-file its appeal.
On April 1, 2002, Aerojet received a special notice letter
from the EPA (dated March 28, 2002) that requested Aerojet
to enter into negotiations with the EPA regarding the
performance of a remedial design and remedial action for the
SEMOU. In light of this letter, Aerojet performed a limited site
investigation of the East Flair Drive Site. The data collected
and summarized in the Field Investigation Report showed that
chemicals including TCE and PCE were present in the soil and
groundwater at and near the East Flair Drive Site. The Field
Investigation Report also showed that the hydraulic gradient at
the East Flair Drive Site is oriented toward the northeast. This
finding indicates that the site is not a likely source of
contamination at the SEMOU, as the groundwater flow at the site
is away from the SEMOU and not toward it. Given the data
indicating that the East Flair Drive Site is not a source of the
contamination at the SEMOU, Aerojet requested that the EPA
reconsider its issuance of the SEMOU special notice letter.
93
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
On August 29, 2003, the EPA issued a Unilateral
Administrative Order (UAO) against Aerojet and approximately 40
other parties requiring them to conduct the remedial design and
remedial action in the SEMOU. The impact of the UAO on the
recipients is not clear as much of the remedy is already being
implemented by the water entities. The cost estimate to
implement projects under the UAO prepared by the EPA and the
water entities is approximately $90 million.
The UAO requires the implementation of the Interim Record of
Decision (IROD). The EPA extended the deadline for compliance
with the UAO to allow the PRPs to resolve their liabilities with
respect to SEMOU. In return, the EPA required the submission of
a Good Faith Offer to implement the IROD. The Company has been
working closely with the other PRPs to resolve this matter and
submitted a Good Faith Offer to the EPA that was rejected on
May 20, 2004. The EPA alleges that the Company, along with
the other UAO recipients, has failed to transmit a Good Faith
Offer in compliance with its obligations under the UAO. The
Company is working diligently with the EPA and the other PRPs to
resolve this matter and insure compliance with the UAO.
Aerojet has been served with civil suits filed in the U.S.
District Court for the Central District of California by four
public and private water companies. The suits seek recovery of
costs allegedly incurred in response to the contamination
present in the SEMOU. Plaintiffs allege that groundwater in the
SEMOU is contaminated with chlorinated solvents and ammonium
perchlorate that were released into the environment by Aerojet
and other parties causing plaintiffs to incur unspecified
response costs and other damages. Aerojets investigations
to date have not identified a credible connection between the
contaminants identified by the water entities in the SEMOU and
those detected at Aerojets former facility located at 9100
and 9200 East Flair Drive, El Monte, California, which lies in
or near the SEMOU.
Aerojet was successful in its efforts to eliminate several of
the claims initially raised by the water entities. However,
other claims remain. Aerojet has filed third-party complaints
against several water entities on the basis that they introduced
perchlorate-containing Colorado River water to the basin. The
water entities have filed motions to dismiss Aerojets
complaints. Discovery and the motions have been stayed pending
efforts to resolve the litigation through mediation.
The Company has studied remediation alternatives for its closed
Lawrence, Massachusetts facility, which was primarily
contaminated with polychlorinated biphenyls, and has begun site
remediation and off-site disposal of debris. As part of these
remediation efforts, the Company is working with local, state
and federal officials and regulatory agencies to return the
property to a beneficial use. The time frame for the remediation
and redevelopment project is currently estimated to range from
two to three years.
The Company is also currently involved in approximately 32 other
remediation actions. In many of these matters, the Company is
involved with other PRPs. In many instances, the Companys
liability and proportionate share of costs have not been
determined largely due to uncertainties as to the nature and
extent of site conditions and the Companys involvement.
While government agencies frequently claim PRPs are jointly and
severally liable at such sites, in the Companys
experience, interim and final allocations of liability costs are
generally made based on relative contributions of waste. In the
Companys previous experience, the Company allocated share
has frequently been minimal, and in many instances, has been
less than one percent. Also, the Company is seeking recovery of
its costs from its insurers.
|
|
|
d. Environmental Reserves and Estimated
Recoveries |
The Company continually reviews estimated future remediation
costs that could be incurred by the Company which take into
consideration the investigative work and analysis of the
Companys engineers, and
94
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
the advice of its legal staff regarding the status and
anticipated results of various administrative and legal
proceedings. In most cases only a range of reasonably possible
costs can be estimated. In establishing the Companys
reserves, the most probable estimated amount is used when
determinable and the minimum is used when no single amount is
more probable. The timing of payment for estimated future
environmental costs is subject to variability and depends on the
timing of regulatory approvals for planned remedies and the
construction and completion of the remedies.
Annually, the Company completes a review of estimated future
environmental costs which incorporates, but is not limited to
the following: (i) status of work completed since the last
estimate; (ii) expected cost savings related to the
substitution of new remediation technology and to information
not available previously; (iii) obligations for
reimbursement of regulatory agency service costs;
(iv) updated BPOU cost estimates; (v) costs of
complying with the Western Groundwater Administrative Order,
including replacement water and remediation upgrades at
Aerojets Sacramento site; (vi) estimated costs
related to IRCTS and Aerojets Sacramento site;
(vii) new information related to the extent and location of
previously unidentified contamination; and
(viii) additional construction costs. The Companys
review of estimated future remediation costs resulted in a net
increase in the Companys environmental reserves of
$25 million in fiscal 2004, $12 million in fiscal
2003, and $107 million in fiscal 2002.
The effect of the final resolution of environmental matters and
the Companys obligations for environmental remediation and
compliance cannot be accurately predicted due to the uncertainty
concerning both the amount and timing of future expenditures and
due to regulatory or technological changes. The Company
believes, on the basis of presently available information, that
the resolution of environmental matters and the Companys
obligations for environmental remediation and compliance will
not have a material adverse effect on the Companys results
of operations, liquidity or financial condition. The Company
will continue its efforts to mitigate past and future costs
through pursuit of claims for recoveries from insurance coverage
and other PRPs and continued investigation of new and more cost
effective remediation alternatives and associated technologies.
A summary of the Companys environmental reserve activity
is shown below:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
November 30, | |
|
2002 | |
|
2002 | |
|
November 30, | |
|
2003 | |
|
2003 | |
|
November 30, | |
|
2004 | |
|
2004 | |
|
November 30, | |
|
|
2001 | |
|
Additions | |
|
Expenditures | |
|
2002 | |
|
Additions | |
|
Expenditures | |
|
2003 | |
|
Additions | |
|
Expenditures | |
|
2004 | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Aerojet
|
|
$ |
252 |
|
|
$ |
107 |
|
|
$ |
(41 |
) |
|
$ |
318 |
|
|
$ |
12 |
|
|
$ |
(32 |
) |
|
$ |
298 |
|
|
$ |
23 |
|
|
$ |
(34 |
) |
|
$ |
287 |
|
Other Sites
|
|
|
27 |
|
|
|
|
|
|
|
(5 |
) |
|
|
22 |
|
|
|
|
|
|
|
(5 |
) |
|
|
17 |
|
|
|
2 |
|
|
|
(2 |
) |
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Environmental Reserve
|
|
$ |
279 |
|
|
$ |
107 |
|
|
$ |
(46 |
) |
|
$ |
340 |
|
|
$ |
12 |
|
|
$ |
(37 |
) |
|
$ |
315 |
|
|
$ |
25 |
|
|
$ |
(36 |
) |
|
$ |
304 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, 2004, the Aerojet reserves include
$170 million for the Sacramento site, $99 million for
BPOU, and $18 million for other Aerojet sites. The reserves
for Other Sites include $7 million for the Lawrence,
Massachusetts site.
On January 12, 1999, Aerojet and the U.S. government
implemented the October 1997 Agreement in Principle (Global
Settlement) resolving certain prior environmental and facility
disagreements, with retroactive effect to December 1,
1998. The Global Settlement covered all environmental
contamination at the Sacramento and Azusa sites. Under the
Global Settlement, Aerojet and the U.S. government resolved
disagreements about an appropriate cost-sharing ratio. The
Global Settlement provides that the cost-sharing ratio will
continue for a number of years.
Pursuant to the Global Settlement covering environmental costs
associated with Aerojets Sacramento site and its former
Azusa site, the Company can recover up to 88% of its
environmental remediation costs for
95
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
these sites through the establishment of prices for
Aerojets products and services sold to the
U.S. government. Allowable environmental costs are charged
to these contracts as the costs are incurred. Aerojets mix
of contracts can affect the actual reimbursement made by the
U.S. government. Because these costs are recovered through
forward-pricing arrangements, the ability of Aerojet to continue
recovering these costs from the U.S. government depends on
Aerojets sustained business volume under
U.S. government contracts and programs and the relative
size of Aerojets commercial business.
In conjunction with the sale of EIS, Aerojet entered into an
agreement with Northrop whereby Aerojet will be reimbursed by
Northrop for a portion of environmental expenditures eligible
for recovery under the Global Settlement. Amounts reimbursed are
subject to annual limitations, with excess amounts carrying over
to subsequent periods, the total of which will not exceed
$190 million over the term of the agreement, which ends in
2028. As of November 30, 2004, $158 million in
potential future reimbursements was available over the remaining
life of the agreement.
As part of the acquisition of the ARC propulsion business,
Aerojet entered into an agreement with ARC pursuant to which
Aerojet is responsible for up to $20 million of costs
(Pre-Close Environmental Costs) associated with environmental
issues that arose prior to Aerojets acquisition of the ARC
propulsion business. Pursuant to a separate agreement with the
U.S. government which was entered into prior to closing of
the ARC acquisition, these Pre-Close Environmental Costs will be
treated as allowable overhead costs combined with Aerojets
environmental costs under the Global Settlement, and will be
recovered through the establishment of prices for Aerojets
products and services sold to the U.S. government. These
costs will be allocated to all Aerojet operations (including the
previously excluded Redmond, Washington operations) beginning in
2005.
As a result of the ARC acquisition, Aerojet has signed a
Memorandum of Understanding with the U.S. government
agreeing to key assumptions and conditions that will preserve
the original methodology to be used in recalculating the
percentage split between Aerojet and Northrop. Aerojet presented
a proposal to the U.S. government based on the Memorandum
of Understanding and expects to complete an agreement in the
near term.
In conjunction with the review of its environmental reserves
discussed above, the Company revised its estimate of costs that
will be recovered under the Global Settlement based on business
expected to be conducted under contracts with the
U.S. government and its agencies in the future. The
adjustments to the environmental remediation reserves and
estimated future cost recoveries did not affect operating
results in fiscal 2002 as the impact of increases to the
reserves of $107 million was offset by increased estimated
future recoveries. In fiscal 2003, due to the Global Settlement
and Memorandum of Understanding with the government, both
discussed above, which allow for costs to be allocated to all
Aerojet operations beginning in 2005 and for a decrease of the
costs allocated to Northrop annually, Aerojet increased its
environmental reserves by $12 million and estimated
recoveries by $13 million, which resulted in other income
of $1 million in the Companys statement of
operations. The recovery of costs under the Global Settlement is
based, in part on the relative size of Aerojets commercial
business base, which has historically included the Fine
Chemicals operating segment because it was previously a
division of Aerojet. As a result of our plan to sell Fine
Chemicals, Aerojet revised its estimated recovery of costs under
the Global Settlement during fiscal 2004. As a result, Aerojet
increased its estimated recoveries by $38 million and
recorded $16 million of other income (expense), net in
fiscal 2004.
96
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
e. |
Arrangements with Off-Balance Sheet Risk |
As of November 30, 2004, obligations required to be
disclosed in accordance with FASB Interpretation No. 45
(FIN 45), Guarantors Accounting and Disclosure
Requirements for Guarantees, Including Indirect Guarantees of
the Indebtedness of Others consisted of (see Note 10):
|
|
|
$58 million in outstanding commercial letters
of credit expiring in 2005 and securing obligations for
environmental remediation, insurance coverage and litigation. |
|
|
Up to $120 million aggregate in guarantees by
GenCorp of Aerojets obligations to government agencies for
environmental remediation activities, subject to partial offsets
for other financial assurances provided in conjunction with
these obligations. |
|
|
Guarantees, jointly and severally, by its material
domestic subsidiaries, including certain subsidiaries classified
as discontinued operations, of GenCorps obligations under
its bank credit agreement and its $150 million Senior
Subordinated Notes due August 2013. |
|
|
|
f. Concentration of Credit Risk |
The Company invests available cash in money market securities of
various banks, commercial paper and asset-backed securities of
various financial institutions, other companies with high credit
ratings and securities backed by the U.S. government.
At November 30, 2004, Lockheed Martin and Raytheon
accounted for 41% and 16%, respectively, of accounts receivable.
At November 30, 2003, Lockheed Martin accounted for 31% of
accounts receivable. Assets of discontinued operations include
receivables of $92 million as of November 30, 2003. Of
this total, $87 million as of November 30, 2003, were
due from General Motors Corporation, the Ford Motor Company and
Volkswagen AG. The Companys accounts receivables are
generally unsecured and are not backed by collateral from its
customers.
As of November 30, 2004 and 2003, receivables include
unbilled amounts of $38 million and $39 million,
respectively, relating to long-term contracts. The unbilled
receivable amounts as of November 30, 2004 and 2003
expected to be collected after one year were $6 million and
$28 million, respectively. Such amounts are billed either
upon delivery of completed units or settlements of contracts.
|
|
g. |
Dependence on Single Source and Other Third Party
Suppliers |
The Company depends on a single or limited number of outside
suppliers for raw materials. The Company closely monitors
sources of supply to assure that adequate raw materials needed
in the Companys manufacturing processes are available. As
a U.S. government contractor, the Company is frequently
limited to procuring materials and components from sources of
supply that can meet rigorous customer and/ or government
specifications. In addition, as business conditions, the DoD
budget, and Congressional allocations change, suppliers of
specialty chemicals and materials sometimes consider dropping
low volume items from their product lines, which may require, as
it has in the past, qualification of new suppliers for raw
materials on key programs. The supply of ammonium perchlorate, a
principal raw material used in the Companys operations, is
limited to a single source that supplies the entire domestic
solid propellant industry. This single source, however,
maintains two separate manufacturing lines a reasonable distance
apart, which mitigates the likelihood of a fire, explosion, or
other problem impacting all production. The Company also
presently relies on one primary supplier for graphite fiber,
which is used in the production of composite materials. This
supplier has multiple manufacturing lines for graphite fiber.
Although other sources of graphite fiber exist, the addition of
a new supplier would require the Company to qualify the new
source for use.
Current suppliers of some insulation materials used in rocket
motors have announced plans to close manufacturing plants and
discontinue product lines. These materials include polymers used
in ethylene
97
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
propylene diene monomer rubber insulation and aerospace-grade
rayon used in nozzles. The Company is in the process of
qualifying new replacement materials for some programs. For
other programs, the Company produced sufficient inventory to
cover current program requirements and is in the process of
qualifying new replacement materials to be qualified in time to
meet future production needs.
Prolonged disruptions in the supply of any of key raw materials,
difficulty completing qualification of new sources of supply, or
implementing use of replacement materials or new sources of
supply could have a material adverse effect on the
Companys operating results and financial condition.
|
|
a. |
Preference Stock and Preferred Share Purchase
Rights |
In January 1997, the Board of Directors extended for ten
additional years GenCorps Shareholder Rights Plan (Plan),
as amended. When the Plan was originally adopted in 1987, the
Directors declared a dividend of one Preferred Share Purchase
Right (Right) on each outstanding share of common stock, payable
to shareholders of record on February 27, 1987. Rights
outstanding as of November 30, 2004 and 2003 totaled
54.4 million and 44.1 million, respectively. The Plan
provides that under certain circumstances each Right will
entitle shareholders to buy one one-hundredth of a share of a
new Series A Cumulative Preference Stock at an exercise
price of $100. The Rights are exercisable only if a person or
group acquires 20% or more of GenCorps common stock or
announces a tender or exchange offer that will result in such
person or group acquiring 30% or more of the common stock.
GenCorp is entitled to redeem the Rights at two cents per Right
at any time until ten days after a 20% position has been
acquired (unless the Board elects to extend such time period,
which in no event may exceed 30 days). If the Company is
involved in certain transactions after the Rights become
exercisable, a holder of Rights (other than Rights beneficially
owned by a shareholder who has acquired 20% or more of
GenCorps common stock, which Rights become void) is
entitled to buy a number of the acquiring companys common
shares, or GenCorps common stock, as the case may be,
having a market value of twice the exercise price of each Right.
A potential dilutive effect may exist upon the exercise of the
Rights. The Rights under the extended Plan expire on
February 18, 2007. Until a Right is exercised, the holder
has no rights as a stockholder of the Company including, without
limitation, the right to vote as a stockholder or to receive
dividends.
As of November 30, 2004, 1.5 million shares of
$1.00 par value Series A Cumulative Preference Stock
were reserved for issuance upon exercise of Preferred Share
Purchase Rights.
As of November 30, 2004, the Company had 150.0 million
authorized shares of common stock, par value $0.10 per
share (Common Stock), of which 54.6 million shares were
issued, 54.0 million shares were outstanding and
23.2 million shares were reserved for future issuance for
discretionary payments of the Companys portion of
retirement savings plan contributions, exercise of stock
options, payment of awards under stock-based compensation plans
and conversion of the Companys Notes (see Note 10).
During each quarter of fiscal 2002 and fiscal 2003 and during
the first two quarters of fiscal 2004, the Company paid a
quarterly cash dividend on its common stock of $0.03 per
share. The Companys Board of Directors eliminated the
payment of quarterly dividends for future periods, beginning
with the third quarter of fiscal 2004.
On November 23, 2004, the Company closed a public offering
of 8,625,000 shares of its common stock at $16.00 per
share. The Company received net proceeds from the offering of
approximately $131 million.
98
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
c. |
Stock-based Compensation |
The Company accounts for stock-based compensation under
APB 25 and related interpretations. Under APB 25,
stock options granted to employees by the Company generate no
expense when the exercise price of the stock options at the date
of grant equals the market value of the underlying common stock.
The 1999 Equity and Performance Incentive Plan (1999 Plan),
provides for grants of stock options and stock appreciation
rights (SARS) to key employees and directors. Stock options
and SARS issued under the 1999 Plan are, in general, exercisable
in one-third increments at one year, two years, and three years
from the date of grant.
The 1999 Plan also provides for grants of restricted stock.
Grants to certain key employees of the Company were made under
the plan with vesting either based upon the attainment of
specified performance targets or time-frame up to three years.
Key employees of the Company were granted 68,400, 239,000 and
130,000 restricted shares in fiscal 2004, fiscal 2003 and fiscal
2002, respectively. Restricted shares granted in fiscal 2002
vest based on stock performance or three years from date of
grant. Restricted shares granted in fiscal 2003 generally vest
annually over a three year period if the Company meets EPS
targets set by the Organization & Compensation
Committee of the Board. Unvested restricted shares are canceled
upon the employees termination of employment or if
earnings or stock performance targets are not achieved.
Restricted shares granted in fiscal 2004 primarily vest
twenty-five months from date of grant. During fiscal 2004,
fiscal 2003 and fiscal 2002, 43,000, 33,500 and
139,950 shares, respectively were canceled due to
terminations. In fiscal 2004, fiscal 2003 and fiscal 2002,
26,600, 17,900, and 66,550 shares, respectively were
canceled because earnings targets were not achieved. The
Organization & Compensation Committee of the Board has
discretion over increasing or decreasing the actual number of
shares to vest in any period.
The Companys 1997 Stock Option Plan and 1993 Stock Option
Plan each provide for an aggregate of 2.5 million shares of
the Companys Common Stock to be purchased pursuant to
stock options or to be subject to stock appreciation rights
which may be granted to selected officers and key employees at
prices equal to the fair market value of a share of common stock
on the date of grant. Stock options issued under the 1997 and
1993 Stock Option Plans are, in general, exercisable in 25%
increments at six months, one year, two years and three years
from the date of grant. No stock appreciation rights have been
granted.
A summary of the Companys stock option activity, and
related information for the fiscal years ended November 30
is as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
|
|
Weighted | |
|
|
|
Weighted | |
|
|
|
Weighted | |
|
|
Stock | |
|
Average | |
|
Stock | |
|
Average | |
|
Stock | |
|
Average | |
|
|
Options | |
|
Exercise | |
|
Options | |
|
Exercise | |
|
Options | |
|
Exercise | |
|
|
(000s) | |
|
Price | |
|
(000s) | |
|
Price | |
|
(000s) | |
|
Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
Outstanding at beginning of year
|
|
|
3,511 |
|
|
$ |
10.41 |
|
|
|
3,307 |
|
|
$ |
10.72 |
|
|
|
3,512 |
|
|
$ |
10.38 |
|
Granted
|
|
|
36 |
|
|
$ |
10.92 |
|
|
|
477 |
|
|
$ |
8.10 |
|
|
|
426 |
|
|
$ |
12.06 |
|
Exercised
|
|
|
(1,001 |
) |
|
$ |
8.83 |
|
|
|
(48 |
) |
|
$ |
8.71 |
|
|
|
(226 |
) |
|
$ |
8.36 |
|
Forfeited/canceled
|
|
|
(157 |
) |
|
$ |
10.06 |
|
|
|
(225 |
) |
|
$ |
10.46 |
|
|
|
(405 |
) |
|
$ |
10.56 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding at end of year
|
|
|
2,389 |
|
|
$ |
11.10 |
|
|
|
3,511 |
|
|
$ |
10.41 |
|
|
|
3,307 |
|
|
$ |
10.72 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Exercisable at end of year
|
|
|
2,062 |
|
|
$ |
11.35 |
|
|
|
2,765 |
|
|
$ |
10.56 |
|
|
|
2,451 |
|
|
$ |
10.49 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The weighted average grant-date fair value of stock options
granted in fiscal 2004 was $4.45, $3.37 for stock options
granted in fiscal 2003, and $4.91 for stock options granted in
fiscal 2002.
99
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The following table summarizes the range of exercise prices and
weighted-average exercise prices for options outstanding and
exercisable as of November 30, 2004 under the
Companys stock option plans:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Outstanding | |
|
|
|
|
|
|
| |
|
Exercisable | |
Year in |
|
|
|
|
|
Weighted | |
|
| |
Which Stock |
|
|
|
Stock | |
|
Weighted | |
|
Average | |
|
Stock | |
|
Weighted | |
Options |
|
|
|
Options | |
|
Average | |
|
Remaining | |
|
Options | |
|
Average | |
Were |
|
Range of Exercise | |
|
Outstanding | |
|
Exercise | |
|
Contractual | |
|
Exercisable | |
|
Exercise | |
Issued |
|
Prices | |
|
(000s) | |
|
Price | |
|
Life (years) | |
|
(000s) | |
|
Price | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
|
| |
1995
|
|
|
$ 5.94 |
|
|
|
62 |
|
|
$ |
5.94 |
|
|
|
0.8 |
|
|
|
62 |
|
|
$ |
5.94 |
|
1996
|
|
|
$ 6.93 |
|
|
|
3 |
|
|
$ |
6.93 |
|
|
|
1.4 |
|
|
|
3 |
|
|
$ |
6.93 |
|
1997
|
|
$ |
10.03 $15.64 |
|
|
|
258 |
|
|
$ |
12.03 |
|
|
|
2.5 |
|
|
|
258 |
|
|
$ |
12.03 |
|
1998
|
|
$ |
12.67 $16.06 |
|
|
|
334 |
|
|
$ |
15.93 |
|
|
|
3.3 |
|
|
|
334 |
|
|
$ |
15.93 |
|
1999
|
|
$ |
9.40 $13.59 |
|
|
|
290 |
|
|
$ |
10.21 |
|
|
|
4.3 |
|
|
|
290 |
|
|
$ |
10.21 |
|
2000
|
|
$ |
8.19 $10.13 |
|
|
|
311 |
|
|
$ |
9.53 |
|
|
|
5.2 |
|
|
|
311 |
|
|
$ |
9.53 |
|
2001
|
|
$ |
10.44 $13.05 |
|
|
|
424 |
|
|
$ |
11.03 |
|
|
|
6.3 |
|
|
|
424 |
|
|
$ |
11.03 |
|
2002
|
|
$ |
9.77 $15.43 |
|
|
|
287 |
|
|
$ |
12.61 |
|
|
|
7.5 |
|
|
|
202 |
|
|
$ |
12.52 |
|
2003
|
|
$ |
6.53 $ 9.29 |
|
|
|
385 |
|
|
$ |
8.03 |
|
|
|
8.3 |
|
|
|
161 |
|
|
$ |
7.96 |
|
2004
|
|
|
$10.92 |
|
|
|
35 |
|
|
$ |
10.92 |
|
|
|
9.2 |
|
|
|
17 |
|
|
$ |
10.92 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2,389 |
|
|
|
|
|
|
|
|
|
|
|
2,062 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
d. |
Other Comprehensive Income (Loss), Net of Income
Taxes |
The Companys other comprehensive income (loss) consists of
the accumulated effects of foreign currency translation
adjustments, changes in the fair value of certain derivative
financial instruments and changes in the minimum funding
liability for pension obligations. At November 30, 2004,
the Company had a balance of $2 million of foreign currency
translation losses. At November 30, 2003, the Company had a
balance of $35 million of foreign currency translation
gains. At November 30, 2004 and 2003, the Company had
$1 million and $2 million, respectively, of minimum
funding liabilities for pension obligations. Additionally, at
November 30, 2004 and 2003, the Company had a balance of
less than $1 million and $1 million, respectively, of
losses on derivative financial instruments.
Prior to the sale of substantially all of the GDX business, the
Company had an accumulated foreign currency translation gain of
$35 million that was reflected as a net increase of
consolidated shareholders equity and related solely to the
GDX business. In accordance with Statement of Financial
Accounting Standards No. 52, Foreign Currency
Translation, this amount has been included in the
determination of the loss on sale of GDX and in accordance with
Statement of Financial Accounting Standards No. 130,
Reporting Comprehensive Income, an equal amount is
reported as a reclassification adjustment.
100
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
The components of other comprehensive income (loss) and the
related income tax effects are presented in the following table:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net income (loss)
|
|
$ |
(398 |
) |
|
$ |
22 |
|
|
$ |
30 |
|
|
Other comprehensive income (loss), net of income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Effects of foreign currency translation adjustments
|
|
|
(2 |
) |
|
|
46 |
|
|
|
22 |
|
|
|
Change in minimum pension liability
|
|
|
1 |
|
|
|
|
|
|
|
(1 |
) |
|
|
Change in fair value of interest rate swap
|
|
|
1 |
|
|
|
(1 |
) |
|
|
|
|
|
|
Reclassification adjustment
|
|
|
(35 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total comprehensive income (loss)
|
|
$ |
(433 |
) |
|
$ |
67 |
|
|
$ |
51 |
|
|
|
|
|
|
|
|
|
|
|
|
|
15. |
Operating Segments and Related Disclosures |
As discussed in Note 17, the Companys management
decided to divest the GDX Automotive and Aerojet Fine Chemical
business units during fiscal 2004. These businesses, which were
previously considered separate operating segments, have been
classified as discontinued operations. As a result, the
Companys continuing operations are now organized into two
operating segments based on different products and customer
bases: Aerospace and Defense and Real Estate. The accounting
policies of the operating segments are the same as those
described in the summary of significant accounting policies (see
Note 1).
The Company evaluates its operating segments based on several
factors, of which the primary financial measure is segment
performance. Segment performance represents net sales from
continuing operations less applicable costs, expenses and
provisions for unusual items relating to operations. Segment
performance excludes corporate income and expenses, provisions
for unusual items not related to the operations, interest
expense and income taxes (see Note 18 for a discussion on
unusual items).
During fiscal 2004, Lockheed Martin and Raytheon accounted for
32% and 15%, respectively, of net sales. During fiscal 2003,
Lockheed Martin, Boeing, and Raytheon accounted for 28%, 15%,
and 10%, respectively, of net sales. During fiscal 2002,
Lockheed Martin, Boeing, Raytheon, and NASA accounted for 21%,
18%, 13%, and 13%, respectively, of net sales. Sales in fiscal
2004, fiscal 2003 and fiscal 2002 directly and indirectly to the
U.S. government and its agencies, including sales to the
Companys significant customers discussed above, totaled
$420 million, $263 million and $243 million,
respectively.
101
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Selected financial information for each reportable segment is as
follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net Sales:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
492 |
|
|
$ |
321 |
|
|
$ |
271 |
|
|
Real Estate
|
|
|
15 |
|
|
|
32 |
|
|
|
6 |
|
|
Intersegment sales elimination
|
|
|
(8 |
) |
|
|
(5 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
499 |
|
|
$ |
348 |
|
|
$ |
277 |
|
|
|
|
|
|
|
|
|
|
|
Segment Performance:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
57 |
|
|
$ |
45 |
|
|
$ |
32 |
|
|
Retirement benefit plan income (expense)
|
|
|
(27 |
) |
|
|
3 |
|
|
|
24 |
|
|
Unusual items, net
|
|
|
|
|
|
|
(5 |
) |
|
|
(12 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense Total
|
|
|
30 |
|
|
|
43 |
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Real Estate
|
|
|
12 |
|
|
|
23 |
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
$ |
42 |
|
|
$ |
66 |
|
|
$ |
47 |
|
|
|
|
|
|
|
|
|
|
|
Reconciliation of segment performance to income (loss) from
continuing operations before income taxes:
|
|
|
|
|
|
|
|
|
|
|
|
|
Segment Performance
|
|
$ |
42 |
|
|
$ |
66 |
|
|
$ |
47 |
|
|
Interest expense
|
|
|
(35 |
) |
|
|
(22 |
) |
|
|
(9 |
) |
|
Corporate retirement benefit plan income (expense)
|
|
|
(17 |
) |
|
|
(2 |
) |
|
|
14 |
|
|
Corporate and other expenses
|
|
|
(38 |
) |
|
|
(31 |
) |
|
|
(30 |
) |
|
Corporate unusual items, net
|
|
|
(9 |
) |
|
|
|
|
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income
taxes
|
|
$ |
(57 |
) |
|
$ |
11 |
|
|
$ |
19 |
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
21 |
|
|
$ |
11 |
|
|
$ |
14 |
|
|
Real Estate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Corporate
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital Expenditures
|
|
$ |
21 |
|
|
$ |
11 |
|
|
$ |
14 |
|
|
|
|
|
|
|
|
|
|
|
|
Aerospace and Defense
|
|
$ |
25 |
|
|
$ |
22 |
|
|
$ |
17 |
|
|
Real Estate
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
Corporate
|
|
|
6 |
|
|
|
5 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Depreciation and Amortization
|
|
$ |
31 |
|
|
$ |
28 |
|
|
$ |
21 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
As of November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Aerospace and Defense
|
|
$ |
943 |
|
|
$ |
940 |
|
Real Estate
|
|
|
37 |
|
|
|
49 |
|
|
|
|
|
|
|
|
Identifiable assets
|
|
|
980 |
|
|
|
989 |
|
Corporate
|
|
|
421 |
|
|
|
248 |
|
Discontinued operations
|
|
|
94 |
|
|
|
692 |
|
|
|
|
|
|
|
|
|
Assets
|
|
$ |
1,495 |
|
|
$ |
1,929 |
|
|
|
|
|
|
|
|
The Companys continuing operations are located primarily
in the United States. Inter-area sales are not significant to
the total sales of any geographic area. Unusual items included
in segment performance pertained only to the United States.
102
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
16. Quarterly Financial Data
(Unaudited)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended | |
|
|
| |
|
|
February 28 | |
|
May 31 | |
|
August 31 | |
|
November 30 | |
|
|
| |
|
| |
|
| |
|
| |
|
|
(In millions, except per share amounts) | |
2004
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ |
110 |
|
|
$ |
124 |
|
|
$ |
116 |
|
|
$ |
149 |
|
Cost of products sold
|
|
|
98 |
|
|
|
107 |
|
|
|
114 |
|
|
|
128 |
|
Unusual items
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Loss from continuing operations before income taxes
|
|
|
(15 |
) |
|
|
(12 |
) |
|
|
(12 |
) |
|
|
(18 |
) |
Loss from continuing operations
|
|
|
(9 |
) |
|
|
(48 |
) |
|
|
(15 |
) |
|
|
(14 |
) |
Loss from discontinued operations
|
|
|
(10 |
) |
|
|
(264 |
) |
|
|
(32 |
) |
|
|
(6 |
) |
Net loss
|
|
|
(19 |
) |
|
|
(312 |
) |
|
|
(47 |
) |
|
|
(20 |
) |
Basic and diluted loss per share from continuing operations
|
|
|
(0.22 |
) |
|
|
(1.08 |
) |
|
|
(0.33 |
) |
|
|
(0.30 |
) |
Basic and diluted loss per share from discontinued operations
|
|
|
(0.22 |
) |
|
|
(5.98 |
) |
|
|
(0.72 |
) |
|
|
(0.12 |
) |
Basic and diluted loss per share
|
|
$ |
(0.44 |
) |
|
$ |
(7.06 |
) |
|
$ |
(1.05 |
) |
|
$ |
(0.42 |
) |
2003
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net sales
|
|
$ |
63 |
|
|
$ |
84 |
|
|
$ |
98 |
|
|
$ |
103 |
|
Cost of products sold
|
|
|
49 |
|
|
|
68 |
|
|
|
71 |
|
|
|
72 |
|
Unusual items
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
2 |
|
Income (loss) from continuing operations before income taxes
|
|
|
|
|
|
|
(3 |
) |
|
|
7 |
|
|
|
7 |
|
Income (loss) from continuing operations
|
|
|
|
|
|
|
(1 |
) |
|
|
5 |
|
|
|
8 |
|
Income (loss) from discontinued operations
|
|
|
3 |
|
|
|
11 |
|
|
|
(8 |
) |
|
|
4 |
|
Net income (loss)
|
|
|
3 |
|
|
|
10 |
|
|
|
(3 |
) |
|
|
12 |
|
Basic and diluted income (loss) per share from continuing
operations
|
|
|
0.00 |
|
|
|
(0.02 |
) |
|
|
0.11 |
|
|
|
0.18 |
|
Basic and diluted income (loss) per share from discontinued
operations
|
|
|
0.07 |
|
|
|
0.25 |
|
|
|
(0.18 |
) |
|
|
0.09 |
|
Basic and diluted income (loss) per share
|
|
$ |
0.07 |
|
|
$ |
0.23 |
|
|
$ |
(0.07 |
) |
|
$ |
0.27 |
|
17. Discontinued Operations
During the second quarter of fiscal 2004, the Company announced
plans to sell the GDX business. This decision was a result of
declining volumes and continued challenges in this market
environment including increased material costs, high development
and start-up costs, anticipated working capital requirements as
well as adverse customer pricing pressures. In accordance with
the Companys plan to sell the GDX business, the GDX
operating segment was classified as a discontinued operation
during the second quarter of fiscal 2004. During the third
quarter of fiscal 2004, the Company signed a definitive
agreement to sell GDX, including substantially all of the assets
of GenCorp Inc. that were used in the GDX business and
substantially all of GenCorp Inc.s worldwide subsidiaries
that were engaged in the GDX business, to Cerberus for
$147 million, subject to adjustment, of which
$140 million has been received as of November 30,
2004. The Company closed the transaction on August 31,
2004. For operating segment reporting, GDX was reported as a
separate operating segment.
103
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
During the second quarter of fiscal 2004, the GDX operating
segment net assets were adjusted to managements estimate
of proceeds to be received on disposition less costs to sell
that resulted in a $261 million loss being recorded. An
additional loss of $18 million was recorded in the third
quarter of fiscal 2004 to reflect the net assets of the GDX
business and managements estimate of the proceeds from the
sale of the GDX business to Cerberus.
In accordance with EITF 87-24, Allocation of Interest to
Discontinued Operations, the Company allocated interest to
discontinued operations based on interest on debt that would be
required to be repaid using estimated proceeds to be received
from the anticipated sale of the GDX Automotive and Fine
Chemicals businesses. This allocation resulted in interest of
approximately $4 million, $4 million, and
$6 million for fiscal 2004, fiscal 2003 and fiscal 2002,
respectively.
In fiscal 2002, the Company announced a restructuring in the GDX
Automotive business. The plan resulted in the closure of a plant
in Germany in early 2003 and reduced staffing levels at the
Farmington Hills, Michigan headquarters resulting in a
$2 million charge. The charge is included as a component of
discontinued operations.
In November 2003, the Company announced it was closing a GDX
manufacturing facility in Chartres, France. The decision
resulted primarily from declining sales volumes with French
automobile manufacturers. In June 2004, the Company completed
the legal process for closing the facility and establishing a
social plan. As a result, the Company recorded pre-tax expense
of approximately $14 million during fiscal 2004 primarily
related to employee social costs in accordance with
SFAS No. 146, Accounting for Costs Associated with
Exit or Disposal Activities. The charge is included as a
component of discontinued operations. The Company has not yet
recorded expenses associated with certain social benefits due to
the uncertainty of the benefit amount. These additional social
costs are expected to result in additional pre-tax expense of
$1 million to $3 million and are anticipated to be
incurred over the next two years. The Company will recognize the
related costs once they are certain.
During the third quarter of fiscal 2004, the Company classified
the Fine Chemicals segment as a discontinued operation as a
result of its plans to sell the business. This plan was a result
of managements decision to focus its capital and resources
on its Aerospace and Defense and Real Estate operating segments.
The Company anticipates that the sale of Fine Chemicals will be
announced in fiscal 2005. For operating segment reporting, Fine
Chemicals business was previously reported as a separate
operating segment.
Summarized financial information for the GDX and Fine Chemicals
operations (discontinued operations) is set forth below:
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, |
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Net sales
|
|
$ |
629 |
|
|
$ |
844 |
|
|
$ |
858 |
|
Income (loss) before income taxes
|
|
|
(308 |
) |
|
|
6 |
|
|
|
23 |
|
Income tax benefit (provision)
|
|
|
(4 |
) |
|
|
4 |
|
|
|
(8 |
) |
Net income (loss) from discontinued operations
|
|
|
(312 |
) |
|
|
10 |
|
|
|
15 |
|
104
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
As of November 30, 2004 and 2003, the components of assets
and liabilities of discontinued operations in the consolidated
balance sheets are as follows:
|
|
|
|
|
|
|
|
|
As of November 30, |
|
2004 | |
|
2003 | |
|
|
| |
|
| |
|
|
(In millions) | |
Accounts receivable, net
|
|
$ |
8 |
|
|
$ |
92 |
|
Inventories, net
|
|
|
10 |
|
|
|
61 |
|
Other assets
|
|
|
3 |
|
|
|
170 |
|
Property, plant and equipment, net
|
|
|
73 |
|
|
|
369 |
|
|
|
|
|
|
|
|
Assets of discontinued operations
|
|
$ |
94 |
|
|
$ |
692 |
|
|
|
|
|
|
|
|
Accounts payable
|
|
$ |
8 |
|
|
$ |
77 |
|
Other liabilities
|
|
|
10 |
|
|
|
112 |
|
|
|
|
|
|
|
|
Liabilities of discontinued operations
|
|
$ |
18 |
|
|
$ |
189 |
|
|
|
|
|
|
|
|
18. Unusual Items
Charges associated with unusual items are summarized as follows:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Year Ended November 30, | |
|
|
| |
|
|
2004 | |
|
2003 | |
|
2002 | |
|
|
| |
|
| |
|
| |
|
|
(In millions) | |
Aerospace and Defense:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Unrecoverable portion of legal settlement with local water
company
|
|
$ |
|
|
|
$ |
5 |
|
|
$ |
|
|
|
Write-off of the Redmond, Washington operations in-process
research and development
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
Final settlement on Aerojet sale of EIS business
|
|
|
|
|
|
|
|
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
5 |
|
|
|
12 |
|
Corporate Headquarters:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Reacquisition of Fine Chemicals minority interest
|
|
|
|
|
|
|
|
|
|
|
2 |
|
|
Loss on repayment of convertible subordinated notes
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
Write-off of bank fees for term loan repayment
|
|
|
|
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Unusual expense
|
|
$ |
9 |
|
|
$ |
5 |
|
|
$ |
15 |
|
|
|
|
|
|
|
|
|
|
|
In fiscal 2004, the Company incurred a $9 million charge as
a result of the repayment of $70 million of principal of
the
53/4%
Notes.
In fiscal 2003, Aerojet recorded an unusual charge of
$5 million representing the unrecoverable portion of an
estimated legal settlement with a local water company related to
contaminated wells.
In fiscal 2002, Aerojet charged $6 million to expense for
acquired in-process research and development in conjunction with
the acquisition of the Redmond, Washington operations. In fiscal
2002, Aerojet reached an agreement with Northrop on purchase
price adjustments related to the sale of its EIS business
whereby Aerojet reduced the purchase price by $6 million.
Also in fiscal 2002, the Company reacquired the minority
ownership interest in its AFC subsidiary and certain agreements
between AFC and NextPharma were terminated, resulting in an
expense of $2 million.
105
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
19. Condensed Consolidating
Financial Information
The Company is providing condensed consolidating financial
information for its material domestic subsidiaries that have
guaranteed the Senior Subordinated Notes and for those
subsidiaries that have not guaranteed the Senior Subordinated
Notes. These 100% owned subsidiary guarantors have, jointly and
severally, fully and unconditionally guarantee the Senior
Subordinated Notes. The subsidiary guarantees are senior
subordinated obligations of each subsidiary guarantor and rank
(i) prior in right of payment with all senior indebtedness,
(ii) equal in right of payment with all senior subordinated
indebtedness and (iii) senior in right of payment to all
subordinated indebtedness, in each case, of that subsidiary
guarantor. The subsidiary guarantees will also be effectively
subordinated to any secured indebtedness of the subsidiary
guarantor with respect to the assets securing that indebtedness.
Absent both default and notice as specified in the
Companys Credit Facility and agreements governing the
Companys outstanding convertible notes and the Senior
Subordinated Notes, there are no restrictions on the
Companys ability to obtain funds from its subsidiary
guarantors by dividend or loan. Two subsidiary guarantors were
released in accordance with the indenture upon completion of the
sale of the GDX business on August 31, 2004 (see
Note 17).
The Company has not presented separate financial and narrative
information for each of the subsidiary guarantors, because it
believes that such financial and narrative information would not
provide investors with any additional information that would be
material in evaluating the sufficiency of the guarantees.
Therefore, the following condensed consolidating financial
information summarizes the financial position, and results of
operations and cash flows for the Companys guarantor and
non-guarantor subsidiaries.
Condensed Consolidating Statements of Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2004 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Net sales
|
|
$ |
|
|
|
$ |
499 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
499 |
|
Cost of products sold
|
|
|
|
|
|
|
447 |
|
|
|
|
|
|
|
|
|
|
|
447 |
|
Selling, general and administrative
|
|
|
36 |
|
|
|
13 |
|
|
|
|
|
|
|
|
|
|
|
49 |
|
Depreciation and amortization
|
|
|
6 |
|
|
|
25 |
|
|
|
|
|
|
|
|
|
|
|
31 |
|
Interest expense
|
|
|
34 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
Other, (income) expense, net
|
|
|
9 |
|
|
|
(15 |
) |
|
|
|
|
|
|
|
|
|
|
(6 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
|
|
(85 |
) |
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
(57 |
) |
Income tax (benefit) provision
|
|
|
(2 |
) |
|
|
31 |
|
|
|
|
|
|
|
|
|
|
|
29 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(83 |
) |
|
|
(3 |
) |
|
|
|
|
|
|
|
|
|
|
(86 |
) |
Income (loss) from discontinued operations
|
|
|
(73 |
) |
|
|
15 |
|
|
|
(254 |
) |
|
|
|
|
|
|
(312 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before equity earnings
|
|
|
(156 |
) |
|
|
12 |
|
|
|
(254 |
) |
|
|
|
|
|
|
(398 |
) |
Equity (losses) earnings of subsidiaries
|
|
|
(242 |
) |
|
|
|
|
|
|
|
|
|
|
242 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
(398 |
) |
|
$ |
12 |
|
|
$ |
(254 |
) |
|
$ |
242 |
|
|
$ |
(398 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
106
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2003 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Net sales
|
|
$ |
|
|
|
$ |
348 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
348 |
|
Cost of products sold
|
|
|
|
|
|
|
260 |
|
|
|
|
|
|
|
|
|
|
|
260 |
|
Selling, general and administrative
|
|
|
24 |
|
|
|
7 |
|
|
|
|
|
|
|
|
|
|
|
31 |
|
Depreciation and amortization
|
|
|
5 |
|
|
|
23 |
|
|
|
|
|
|
|
|
|
|
|
28 |
|
Interest expense
|
|
|
21 |
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
22 |
|
Other, (income) expense, net
|
|
|
(3 |
) |
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
|
|
(47 |
) |
|
|
58 |
|
|
|
|
|
|
|
|
|
|
|
11 |
|
Income tax (benefit) provision
|
|
|
(21 |
) |
|
|
20 |
|
|
|
|
|
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(26 |
) |
|
|
38 |
|
|
|
|
|
|
|
|
|
|
|
12 |
|
Income (loss) from discontinued operations
|
|
|
2 |
|
|
|
5 |
|
|
|
3 |
|
|
|
|
|
|
|
10 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before equity earnings
|
|
|
(24 |
) |
|
|
43 |
|
|
|
3 |
|
|
|
|
|
|
|
22 |
|
Equity (losses) earnings of subsidiaries
|
|
|
46 |
|
|
|
|
|
|
|
|
|
|
|
(46 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
22 |
|
|
$ |
43 |
|
|
$ |
3 |
|
|
$ |
(46 |
) |
|
$ |
22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2002 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Net sales
|
|
$ |
|
|
|
$ |
277 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
277 |
|
Cost of products sold
|
|
|
|
|
|
|
200 |
|
|
|
|
|
|
|
|
|
|
|
200 |
|
Selling, general and administrative
|
|
|
(3 |
) |
|
|
11 |
|
|
|
|
|
|
|
|
|
|
|
8 |
|
Depreciation and amortization
|
|
|
4 |
|
|
|
17 |
|
|
|
|
|
|
|
|
|
|
|
21 |
|
Interest expense
|
|
|
9 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
9 |
|
Other, net
|
|
|
14 |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
|
|
20 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations before income taxes
|
|
|
(24 |
) |
|
|
43 |
|
|
|
|
|
|
|
|
|
|
|
19 |
|
Income tax (benefit) provision
|
|
|
(11 |
) |
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) from continuing operations
|
|
|
(13 |
) |
|
|
28 |
|
|
|
|
|
|
|
|
|
|
|
15 |
|
Income (loss) from discontinued operations
|
|
|
(17 |
) |
|
|
3 |
|
|
|
29 |
|
|
|
|
|
|
|
15 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Income (loss) before equity earnings
|
|
|
(30 |
) |
|
|
31 |
|
|
|
29 |
|
|
|
|
|
|
|
30 |
|
Equity earnings of subsidiaries
|
|
|
60 |
|
|
|
|
|
|
|
|
|
|
|
(60 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net income (loss)
|
|
$ |
30 |
|
|
$ |
31 |
|
|
$ |
29 |
|
|
$ |
(60 |
) |
|
$ |
30 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
107
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed Consolidating Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2004 (In Millions) |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Cash and cash equivalents
|
|
$ |
67 |
|
|
$ |
1 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
68 |
|
Restricted cash
|
|
|
23 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
23 |
|
Accounts receivable, net
|
|
|
4 |
|
|
|
84 |
|
|
|
|
|
|
|
|
|
|
|
88 |
|
Inventories, net
|
|
|
|
|
|
|
159 |
|
|
|
|
|
|
|
|
|
|
|
159 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
|
|
|
|
36 |
|
|
|
|
|
|
|
|
|
|
|
36 |
|
Prepaid expenses and other
|
|
|
1 |
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
6 |
|
Assets of discontinued operations
|
|
|
|
|
|
|
93 |
|
|
|
1 |
|
|
|
|
|
|
|
94 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
95 |
|
|
|
378 |
|
|
|
1 |
|
|
|
|
|
|
|
474 |
|
Restricted cash
|
|
|
178 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
178 |
|
Property, plant and equipment, net
|
|
|
1 |
|
|
|
144 |
|
|
|
|
|
|
|
|
|
|
|
145 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
|
|
|
|
197 |
|
|
|
|
|
|
|
|
|
|
|
197 |
|
Prepaid pension asset
|
|
|
122 |
|
|
|
156 |
|
|
|
|
|
|
|
|
|
|
|
278 |
|
Goodwill
|
|
|
|
|
|
|
103 |
|
|
|
|
|
|
|
|
|
|
|
103 |
|
Intercompany, net
|
|
|
(429 |
) |
|
|
444 |
|
|
|
(15 |
) |
|
|
|
|
|
|
|
|
Other noncurrent assets and intangibles, net
|
|
|
937 |
|
|
|
97 |
|
|
|
10 |
|
|
|
(924 |
) |
|
|
120 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
904 |
|
|
$ |
1,519 |
|
|
$ |
(4 |
) |
|
$ |
(924 |
) |
|
$ |
1,495 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings and current portion of long-term debt
|
|
$ |
23 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
|
|
|
$ |
23 |
|
Accounts payable
|
|
|
6 |
|
|
|
49 |
|
|
|
|
|
|
|
|
|
|
|
55 |
|
Reserves for environmental remediation
|
|
|
7 |
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
51 |
|
Income taxes payable
|
|
|
23 |
|
|
|
12 |
|
|
|
|
|
|
|
|
|
|
|
35 |
|
Other current liabilities and other postretirement benefits
other than pensions
|
|
|
35 |
|
|
|
121 |
|
|
|
|
|
|
|
|
|
|
|
156 |
|
Liabilities of discontinued operations
|
|
|
|
|
|
|
11 |
|
|
|
7 |
|
|
|
|
|
|
|
18 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
94 |
|
|
|
237 |
|
|
|
7 |
|
|
|
|
|
|
|
338 |
|
Long-term debt, net of current portion
|
|
|
554 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
554 |
|
Reserves for environmental remediation
|
|
|
9 |
|
|
|
244 |
|
|
|
|
|
|
|
|
|
|
|
253 |
|
Other noncurrent liabilities
|
|
|
106 |
|
|
|
103 |
|
|
|
|
|
|
|
|
|
|
|
209 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
763 |
|
|
|
584 |
|
|
|
7 |
|
|
|
|
|
|
|
1,354 |
|
|
Total shareholders equity
|
|
|
141 |
|
|
|
935 |
|
|
|
(11 |
) |
|
|
(924 |
) |
|
|
141 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$ |
904 |
|
|
$ |
1,519 |
|
|
$ |
(4 |
) |
|
$ |
(924 |
) |
|
$ |
1,495 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
108
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed Consolidating Balance Sheets
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2003 (In Millions) |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations | |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
| |
|
| |
Cash
|
|
$ |
9 |
|
|
$ |
3 |
|
|
$ |
52 |
|
|
$ |
|
|
|
$ |
64 |
|
Accounts receivable
|
|
|
3 |
|
|
|
85 |
|
|
|
|
|
|
|
|
|
|
|
88 |
|
Inventories, net
|
|
|
|
|
|
|
142 |
|
|
|
|
|
|
|
|
|
|
|
142 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
|
|
|
|
37 |
|
|
|
|
|
|
|
|
|
|
|
37 |
|
Prepaid expenses and other
|
|
|
11 |
|
|
|
2 |
|
|
|
|
|
|
|
|
|
|
|
13 |
|
Assets of discontinued operations
|
|
|
108 |
|
|
|
94 |
|
|
|
490 |
|
|
|
|
|
|
|
692 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current assets
|
|
|
131 |
|
|
|
363 |
|
|
|
542 |
|
|
|
|
|
|
|
1,036 |
|
Property, plant and equipment, net
|
|
|
|
|
|
|
148 |
|
|
|
|
|
|
|
|
|
|
|
148 |
|
Recoverable from the U.S. government and other third parties for
environmental remediation costs
|
|
|
|
|
|
|
183 |
|
|
|
|
|
|
|
|
|
|
|
183 |
|
Prepaid pension asset
|
|
|
131 |
|
|
|
183 |
|
|
|
|
|
|
|
|
|
|
|
314 |
|
Goodwill
|
|
|
1 |
|
|
|
99 |
|
|
|
|
|
|
|
|
|
|
|
100 |
|
Intercompany, net
|
|
|
(278 |
) |
|
|
415 |
|
|
|
(137 |
) |
|
|
|
|
|
|
|
|
Other noncurrent assets, net
|
|
|
1,171 |
|
|
|
142 |
|
|
|
10 |
|
|
|
(1,175 |
) |
|
|
148 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total assets
|
|
$ |
1,156 |
|
|
$ |
1,533 |
|
|
$ |
415 |
|
|
$ |
(1,175 |
) |
|
$ |
1,929 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Short-term borrowings and current portion of long-term debt
|
|
$ |
22 |
|
|
$ |
|
|
|
$ |
30 |
|
|
$ |
|
|
|
$ |
52 |
|
Accounts payable
|
|
|
5 |
|
|
|
32 |
|
|
|
|
|
|
|
|
|
|
|
37 |
|
Reserves for environmental remediation
|
|
|
6 |
|
|
|
47 |
|
|
|
|
|
|
|
|
|
|
|
53 |
|
Income taxes payable
|
|
|
(10 |
) |
|
|
36 |
|
|
|
10 |
|
|
|
|
|
|
|
36 |
|
Other current liabilities
|
|
|
43 |
|
|
|
122 |
|
|
|
|
|
|
|
|
|
|
|
165 |
|
Liabilities of discontinued operations
|
|
|
64 |
|
|
|
9 |
|
|
|
116 |
|
|
|
|
|
|
|
189 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total current liabilities
|
|
|
130 |
|
|
|
246 |
|
|
|
156 |
|
|
|
|
|
|
|
532 |
|
Long-term debt, net of current portion
|
|
|
479 |
|
|
|
|
|
|
|
7 |
|
|
|
|
|
|
|
486 |
|
Reserves for environmental remediation
|
|
|
11 |
|
|
|
251 |
|
|
|
|
|
|
|
|
|
|
|
262 |
|
Postretirement benefits other than pensions
|
|
|
94 |
|
|
|
54 |
|
|
|
|
|
|
|
|
|
|
|
148 |
|
Other noncurrent liabilities
|
|
|
14 |
|
|
|
59 |
|
|
|
|
|
|
|
|
|
|
|
73 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities
|
|
|
728 |
|
|
|
610 |
|
|
|
163 |
|
|
|
|
|
|
|
1,501 |
|
|
Total shareholders equity
|
|
|
428 |
|
|
|
923 |
|
|
|
252 |
|
|
|
(1,175 |
) |
|
|
428 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total liabilities and shareholders equity
|
|
$ |
1,156 |
|
|
$ |
1,533 |
|
|
$ |
415 |
|
|
$ |
(1,175 |
) |
|
$ |
1,929 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
109
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed Consolidating Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2004 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
|
|
| |
Net cash provided by (used in) operating activities
|
|
$ |
(89 |
) |
|
$ |
73 |
|
|
$ |
(14 |
) |
|
$ |
|
|
|
$ |
(30 |
) |
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(21 |
) |
|
|
|
|
|
|
|
|
|
|
(21 |
) |
Proceeds from business disposition
|
|
|
140 |
|
|
|
4 |
|
|
|
|
|
|
|
|
|
|
|
144 |
|
Other investing activities
|
|
|
(209 |
) |
|
|
(9 |
) |
|
|
(24 |
) |
|
|
|
|
|
|
(242 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash used in investing activities
|
|
|
(69 |
) |
|
|
(26 |
) |
|
|
(24 |
) |
|
|
|
|
|
|
(119 |
) |
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net transfers (to) from parent
|
|
|
9 |
|
|
|
(42 |
) |
|
|
33 |
|
|
|
|
|
|
|
|
|
Borrowings (repayments) on notes payable and long-term
debt, net
|
|
|
57 |
|
|
|
|
|
|
|
(36 |
) |
|
|
|
|
|
|
21 |
|
Net proceeds from common stock issuance
|
|
|
131 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
131 |
|
Other financing activities
|
|
|
19 |
|
|
|
(7 |
) |
|
|
(7 |
) |
|
|
|
|
|
|
5 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
216 |
|
|
|
(49 |
) |
|
|
(10 |
) |
|
|
|
|
|
|
157 |
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
(4 |
) |
|
|
|
|
|
|
(4 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
58 |
|
|
|
(2 |
) |
|
|
(52 |
) |
|
|
|
|
|
|
4 |
|
Cash and cash equivalents at beginning of year
|
|
|
9 |
|
|
|
3 |
|
|
|
52 |
|
|
|
|
|
|
|
64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$ |
67 |
|
|
$ |
1 |
|
|
$ |
|
|
|
$ |
|
|
|
$ |
68 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Condensed Consolidating Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2003 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
|
|
| |
Net cash provided by (used in) operating activities
|
|
$ |
(1 |
) |
|
$ |
32 |
|
|
$ |
13 |
|
|
$ |
|
|
|
$ |
44 |
|
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(11 |
) |
|
|
|
|
|
|
|
|
|
|
(11 |
) |
Acquisitions of businesses, net of cash acquired
|
|
|
|
|
|
|
(138 |
) |
|
|
|
|
|
|
|
|
|
|
(138 |
) |
Other investing activities
|
|
|
(10 |
) |
|
|
(2 |
) |
|
|
(19 |
) |
|
|
|
|
|
|
(31 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing activities
|
|
|
(10 |
) |
|
|
(151 |
) |
|
|
(19 |
) |
|
|
|
|
|
|
(180 |
) |
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net transfers (to) from parent
|
|
|
(86 |
) |
|
|
109 |
|
|
|
(23 |
) |
|
|
|
|
|
|
|
|
Borrowings (repayments) on notes payable and long-term
debt, net
|
|
|
117 |
|
|
|
|
|
|
|
26 |
|
|
|
|
|
|
|
143 |
|
Other financing activities
|
|
|
(11 |
) |
|
|
|
|
|
|
12 |
|
|
|
|
|
|
|
1 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by financing activities
|
|
|
20 |
|
|
|
109 |
|
|
|
15 |
|
|
|
|
|
|
|
144 |
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
8 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
9 |
|
|
|
(10 |
) |
|
|
17 |
|
|
|
|
|
|
|
16 |
|
Cash and cash equivalents at beginning of year
|
|
|
|
|
|
|
13 |
|
|
|
35 |
|
|
|
|
|
|
|
48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$ |
9 |
|
|
$ |
3 |
|
|
$ |
52 |
|
|
$ |
|
|
|
$ |
64 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
110
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
Condensed Consolidating Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Guarantor | |
|
Non-guarantor | |
|
|
|
|
November 30, 2002 |
|
Parent | |
|
Subsidiaries | |
|
Subsidiaries | |
|
Eliminations |
|
Consolidated | |
|
|
| |
|
| |
|
| |
|
|
|
| |
Net cash provided by (used in) operating activities
|
|
$ |
7 |
|
|
$ |
(55 |
) |
|
$ |
31 |
|
|
$ |
|
|
|
$ |
(17 |
) |
Cash flows from investing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Capital expenditures
|
|
|
|
|
|
|
(14 |
) |
|
|
|
|
|
|
|
|
|
|
(14 |
) |
Acquisitions of businesses, net of cash acquired
|
|
|
(8 |
) |
|
|
(93 |
) |
|
|
|
|
|
|
|
|
|
|
(101 |
) |
Other investing activities
|
|
|
(4 |
) |
|
|
(8 |
) |
|
|
(14 |
) |
|
|
|
|
|
|
(26 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash (used in) investing activities
|
|
|
(12 |
) |
|
|
(115 |
) |
|
|
(14 |
) |
|
|
|
|
|
|
(141 |
) |
Cash flows from financing activities:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net transfers (to) from parent
|
|
|
(175 |
) |
|
|
180 |
|
|
|
(5 |
) |
|
|
|
|
|
|
|
|
Borrowings (repayments) on notes payable and long-term
debt, net
|
|
|
161 |
|
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
160 |
|
Other financing activities
|
|
|
18 |
|
|
|
|
|
|
|
(19 |
) |
|
|
|
|
|
|
(1 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net cash provided by (used in) financing activities
|
|
|
4 |
|
|
|
180 |
|
|
|
(25 |
) |
|
|
|
|
|
|
159 |
|
Effect of exchange rate fluctuations on cash and cash equivalents
|
|
|
|
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
3 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Net increase (decrease) in cash and cash equivalents
|
|
|
(1 |
) |
|
|
10 |
|
|
|
(5 |
) |
|
|
|
|
|
|
4 |
|
Cash and cash equivalents at beginning of year
|
|
|
1 |
|
|
|
3 |
|
|
|
40 |
|
|
|
|
|
|
|
44 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Cash and cash equivalents at end of year
|
|
$ |
|
|
|
$ |
13 |
|
|
$ |
35 |
|
|
$ |
|
|
|
$ |
48 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
20. |
New Accounting Pronouncements |
In August 2004, the FASB issued Staff Position No. 106-2
(FSP 106-2), Accounting and Disclosure Requirements
Related to the Medicare Prescription Drug, Improvement and
Modernization Act of 2003 (the Act). The Act introduces a
prescription drug benefit under Medicare (Medicare Part D)
as well as a federal subsidy to sponsors of post-retirement
health care benefit plans that provide a benefit that is at
least actuarially equivalent to Medicare Part D.
FSP 106-2 provides authoritative guidance on the accounting
for the federal subsidy and specifies the disclosure
requirements for employers who have adopted FSP 106-2,
including those who are unable to determine whether benefits
provided under its plan are actuarially equivalent to Medicare
Part D. FSP 106-2 was effective for the Company in the
fourth quarter of fiscal 2004. The Company reduced its
accumulated plan benefit obligation by $3 million related
to the Act.
In September 2004, Emerging Issues Task Force reached a
consensus on EITF 04-08. Under current interpretations of
FASB No. 128, Earnings per Share, issuers of
contingently convertible debt instruments (Co-Cos) generally
exclude the potential common shares underlying the Co-Cos from
the calculation of diluted earnings per share until the
underlying common stock achieves a specified price target, or
other contingency is met. EITF 04-08 requires that Co-Cos
should be included in diluted earnings per share computations,
if dilutive, regardless of whether the market price trigger has
been met. The Company will adopt the requirements of
EITF 04-08 beginning with the quarter ending
February 28, 2005. The application of EITF 04-08 will
require the Company to include the Companys 4% Notes
which were issued in January 2004 in its calculation of diluted
earnings per share, if dilutive.
In October 2004, the FASB concluded that Statement 123R,
Share-Based Payment, which would require all companies to
measure compensation cost for all share-based payments
(including employee stock options) at fair value, would be
effective for public companies for interim or annual periods
beginning after June 15, 2005. The Company could adopt the
new standard in one of two ways the modified
prospective transition method or the modified retrospective
transition method. The Company will adopt Statement 123R in
the
111
GENCORP INC.
NOTES TO CONSOLIDATED FINANCIAL
STATEMENTS (Continued)
fourth quarter of fiscal 2005, and it is currently evaluating
the effect that the adoption of Statement 123R will have on
its financial position and results of operations.
In November 2004, the FASB issued Statement 151,
Inventory Costs, an amendment of ARB No. 43,
Chapter 4, which would be effective for inventory costs
incurred during fiscal years beginning after June 15, 2005.
The amendments made by Statement 151 will improve financial
reporting by clarifying those abnormal amounts of idle facility
expense, freight, handling costs, and wasted materials
(spoilage) should be recognized as current-period charges and by
requiring the allocation of fixed production overheads to
inventory based on the normal capacity of the production
facilities. The Company does not anticipate that the adoption of
the Statement 151 will have a significant effect on
earnings or the financial position of the Company.
In December 2004, the Company closed a new $180 million
credit facility (New Credit Facility) with a syndicate of
lenders. The New Credit Facility provides for an
$80 million revolving credit facility maturing in December
2009, and a $100 million credit-linked facility maturing in
December 2010. The credit-linked facility consists of a
$25 million term loan subfacility and a $75 million
letter of credit subfacility. The interest rate on the revolving
credit facility is LIBOR plus 275 basis points, subject to
adjustment based on the Companys leverage ratio, and the
interest rate on the term loan is LIBOR plus 300 basis
points.
The New Credit Facility is secured by substantially all of the
Companys assets, including the stock and assets of its
material domestic subsidiaries who are guarantors of the
facility. The Company is subject to certain limitations
including the ability to: incur additional debt or sell assets,
with restrictions on the use of proceeds; make certain
investments and acquisitions; grant liens; and make restricted
payments. The Company is also subject to financial covenants
effective for the period ending February 28, 2005, which
include an interest coverage ratio, a leverage ratio, a senior
leverage ratio, and a fixed charge coverage ratio. For fiscal
year 2005 the financial covenants are: a minimum interest
coverage ratio of 2.00 to 1.00, a maximum leverage ratio of 8.25
to 1.0 through May 31, 2005 and reducing to 7.50 to 1.0, a
maximum senior leverage ratio of 3.0 to 1.0 through May 31,
2005 and reducing to 2.5 to 1.0, and a maximum fixed charge
coverage ratio of 1.05 to 1.0 through May 31, 2005 and
reducing to 1.10 to 1.0. As of November 30, 2004, the
Company meets the financial covenants effective
February 28, 2005.
The New Credit Facility replaces the previous credit facility
(Restated Credit Facility) which was terminated by the Company
in December 2004. The outstanding term loans totaling
$141 million plus accrued interest under the Restated
Credit Facility were repaid in full using restricted cash from
the proceeds of the GDX Automotive sale completed in August 2004
and the equity offering completed in November 2004. Cash
proceeds from the $25 million term loan, net of
underwriting fees and expenses associated with the New Credit
Facility were $21 million and will be used for general
corporate purposes.
In December 2004, an initial purchaser exercised its option to
purchase additional
21/4% Debentures
totaling approximately $66 million aggregate principal
amount. Cash proceeds, net of underwriting discounts and
transaction costs, were approximately $64 million and were
used to repurchase approximately $60 million of the
53/4% Notes,
plus premium, accrued interest, and transaction costs (see
Note 10).
In February 2005, the Company redeemed $53 million
principal amount of its
91/2% Notes,
representing 35% of the $150 million aggregate principal
outstanding (see Note 10). In accordance with the indenture
governing the notes, the redemption price was 109.5% of the
principal amount of the notes redeemed, plus accrued and unpaid
interest. The Company paid the redemption price using a portion
of the proceeds from the equity offering completed in November
2004 (see Note 14).
In the first quarter of fiscal 2005, the Company will record a
charge of approximately $19 million as a result of the
termination of the Restated Credit Facility, the redemption of
$53 million of principal of the
91/2% Notes,
and the repayment of $66 million of principal of the
53/4% Notes.
112
|
|
Item 9. |
Changes in and Disagreements with Accountants on
Accounting and Financial Disclosure |
None.
|
|
Item 9A. |
Controls and Procedures |
Under the supervision and with the participation of our
management, including the principal executive officer and
principal financial officer, we conducted an evaluation of the
effectiveness of the design and operation of its disclosure
controls and procedures, as defined in Rules 13a-15(e) and
15d-15(e) under the Securities Exchange Act of 1934, as amended,
as of November 30, 2004, the end of the period covered by
this report. Based on this evaluation, our principal executive
officer and principal financial officer concluded as of the
November 30, 2004 that our disclosure controls and
procedures were effective at the reasonable assurance level such
that the information relating to us and our consolidated
subsidiaries, required to be disclosed in our Securities and
Exchange Commission (SEC) reports (i) is recorded,
processed, summarized and reported within the time periods
specified in SEC rules and forms, and (ii) is accumulated
and communicated to our management, including our principal
executive officer and principal financial officer, as
appropriate to allow timely decisions regarding required
disclosure.
There have not been any changes in our internal control over
financial reporting that occurred during the fiscal quarter
ended November 30, 2004, that have materially affected, or
are reasonably likely to materially affect, our internal control
over financial reporting.
Managements Report on Internal Control over Financial
Reporting
Our management is also responsible for establishing and
maintaining adequate internal control over financial reporting,
as defined in Rules 13a-15(f) and 15d-15(f) under the
Securities Exchange Act of 1934. Our management, including our
principal executive officer and principal financial officer,
conducted an assessment of the effectiveness of our internal
control over financial reporting as of November 30, 2004.
In conducting its assessment, our management used the criteria
issued by the Committee of Sponsoring Organizations of the
Treadway Commission in Internal Control Integrated
Framework. Based on this assessment, our management concluded
that the Companys internal control over financial
reporting was effective at the reasonable assurance level as of
November 30, 2004. Reasonable assurance includes the
understanding that there is a remote likelihood that material
misstatements will not be prevented or detected on a timely
basis.
Our independent registered public accounting firm has issued an
attestation report on managements assessment of our
internal control over financial reporting, which appears on the
following page of this Annual Report on Form 10-K.
113
REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Shareholders of GenCorp Inc.
We have audited managements assessment, included in the
accompanying Managements Report on Internal Controls over
Financial Reporting, that GenCorp Inc. maintained effective
internal control over financial reporting as of
November 30, 2004, based on criteria established in
Internal Control Integrated Framework issued by the
Committee of Sponsoring Organizations of the Treadway Commission
(the COSO criteria). GenCorps management is responsible
for maintaining effective internal control over financial
reporting and for its assessment of the effectiveness of
internal control over financial reporting. Our responsibility is
to express an opinion on managements assessment and an
opinion on the effectiveness of the companys internal
control over financial reporting based on our audit.
We conducted our audit in accordance with the standards of the
Public Company Accounting Oversight Board (United States). Those
standards require that we plan and perform the audit to obtain
reasonable assurance about whether effective internal control
over financial reporting was maintained in all material
respects. Our audit included obtaining an understanding of
internal control over financial reporting, evaluating
managements assessment, testing and evaluating the design
and operating effectiveness of internal control, and performing
such other procedures as we considered necessary in the
circumstances. We believe that our audit provides a reasonable
basis for our opinion.
A companys internal control over financial reporting is a
process designed to provide reasonable assurance regarding the
reliability of financial reporting and the preparation of
financial statements for external purposes in accordance with
generally accepted accounting principles. A companys
internal control over financial reporting includes those
policies and procedures that (1) pertain to the maintenance
of records that, in reasonable detail, accurately and fairly
reflect the transactions and dispositions of the assets of the
company; (2) provide reasonable assurance that transactions
are recorded as necessary to permit preparation of financial
statements in accordance with generally accepted accounting
principles, and that receipts and expenditures of the company
are being made only in accordance with authorizations of
management and directors of the company; and (3) provide
reasonable assurance regarding prevention or timely detection of
unauthorized acquisition, use, or disposition of the
companys assets that could have a material effect on the
financial statements.
Because of its inherent limitations, internal control over
financial reporting may not prevent or detect misstatements.
Also, projections of any evaluation of effectiveness to future
periods are subject to the risk that controls may become
inadequate because of changes in conditions, or that the degree
of compliance with the policies or procedures may deteriorate.
In our opinion, managements assessment that GenCorp Inc.
maintained effective internal control over financial reporting
as of November 30, 2004, is fairly stated, in all material
respects, based on the COSO criteria. Also, in our opinion,
GenCorp Inc. maintained, in all material respects, effective
internal control over financial reporting as of
November 30, 2004, based on the COSO criteria.
We also have audited, in accordance with the standards of the
Public Company Accounting Oversight Board (United States), the
consolidated balance sheets of GenCorp Inc. as of
November 30, 2004 and 2003, and the related consolidated
statements of income, shareholders equity, and cash flows
for each of the three years in the period ended
November 30, 2004 of GenCorp Inc. and our report dated
February 9, 2005 expressed an unqualified opinion thereon.
Sacramento, California
February 9, 2005
114
Item 9B. Other
Information
None.
PART III
Item 10. Directors and
Executive Officers of the Registrant
Directors of the Registrant
Information with respect to nominees who will stand for election
as a director of the Company at the March 30, 2005 Annual
Meeting of Shareholders is set forth under the heading
NOMINEES FOR ELECTION AT THIS MEETING TO TERM EXPIRING IN
MARCH 2008 in our 2005 Proxy Statement and is incorporated
herein by reference. Information with respect to directors of
the Company whose terms extend beyond the March 30, 2005
Annual Meeting of Shareholders is set forth under the headings
DIRECTORS WHOSE TERMS CONTINUE UNTIL MARCH 2006 and
DIRECTORS WHOSE TERMS CONTINUE UNTIL MARCH 2007 in
our 2005 Proxy Statement and is incorporated herein by reference.
Executive Officers of the Registrant
The following information is given as of December 31, 2004,
and except as otherwise indicated, each individual has held the
same office during the preceding five-year period.
|
|
|
|
|
|
|
|
|
Name |
|
Title |
|
Other Business Experience Since 12/1/99 |
|
Age | |
|
|
|
|
|
|
| |
Terry L. Hall
|
|
Chairman of the Board (since December 2003), President and Chief
Executive Officer (since July 2002) |
|
Senior Vice President and Chief Operating Officer, November
2001 July 2002; Senior Vice President and Chief
Financial Officer of the Company, July 2001 November
2001; Senior Vice President and Chief Financial Officer;
Treasurer of the Company, October 1999 July 2001; on
special assignment as Chief Financial Officer of Aerojet, May
1999 October 1999, Senior Vice President and Chief
Financial Officer of US Airways Group, Inc., 1998, Chief
Financial Officer of Apogee Enterprise Inc., 1995
1997 |
|
|
50 |
|
Yasmin R. Seyal
|
|
Senior Vice President and Chief Financial Officer (since May
2002) |
|
Acting Chief Financial Officer and Senior Vice President,
Finance, November 2001 May 2002; Treasurer of the
Company, July 2000 September 2002; Assistant
Treasurer and Director of Taxes of the Company, March
2000 July 2000; Director of Treasury and Taxes of
the Company, October 1999 April 2000; Director of
Taxes as well as other management positions within Aerojet,
1989 April 1999 |
|
|
47 |
|
Michael F. Martin
|
|
Vice President of the Company and President of Aerojet (since
November 2001) |
|
Acting President of Aerojet, April 2001 October
2001; Vice President and Controller of the Company, October
1999 November 2001; Vice President and Controller of
Aerojet, September 1993 October 1999 |
|
|
58 |
|
115
|
|
|
|
|
|
|
|
|
Name |
|
Title |
|
Other Business Experience Since 12/1/99 |
|
Age | |
|
|
|
|
|
|
| |
Dr. Joseph Carleone
|
|
Vice President of the Company and President of Aerojet Fine
Chemicals LLC (since September 2000) |
|
Vice President and General Manager, Remote Sensing Systems and
Vice President, Operations at Aerojet, 1999 2000;
Vice President, Operations, 1997 2000; Vice
President, Tactical Product Sector, 1994 1997 |
|
|
58 |
|
William A. Purdy Jr.
|
|
Vice President of the Company and President, Real Estate (since
March 2002) |
|
Managing Director, Development, Transwestern Investment Company
LLC, January 1997 March 2002; Chief Financial
Officer of American Health Care Providers Inc., April
1996 January 1997 |
|
|
60 |
|
Chris W. Conley
|
|
Vice President, Environmental, Health & Safety (since
October 1999) |
|
Director Environmental, Health & Safety, March
1996 October 1999; Environmental Consultant,
1994 1996. |
|
|
46 |
|
Linda B. Cutler
|
|
Vice President, Corporate Communications (since May 2002) |
|
Vice President, Communications of the Company, March
2002 May 2002; Strategic Market Manager,
Telecommunications and Video Services of Output Technology
Solutions, September 2000 March 2002; Vice
President, Marketing and Corporate Communications of Output
Technology Solutions, January 2000 September 2000;
Vice President, Investor Relations and Corporate Communications
of USCS International, April 1996 December 1999. |
|
|
51 |
|
Kari Van Gundy
|
|
Vice President, Treasurer (since October 2002) |
|
Senior Vice President, eCommerce, Zenith Insurance Company, June
2000 September 2002; Senior Vice President, Finance
& Treasurer, CalFarm Insurance Company, May 1997
September 1999 |
|
|
47 |
|
Mark A. Whitney
|
|
Vice President, Law; Deputy General Counsel and Assistant
Secretary (since April 2003) |
|
Senior Corporate Counsel, Tyco International (US) Inc.,
June 1999 March 2003; Associate Corporate Counsel,
Tyco International (US) Inc., November 1996
June 1999 |
|
|
41 |
|
The Companys executive officers generally hold terms of
office of one year and/or until their successors are elected.
Code of Ethics and Corporate Governance Guidelines
The Company has adopted a code of ethics known as the Code
of Business Conduct that applies to the Companys
employees including the principal executive officer, principal
financial officer, principal accounting officer and controller.
The Company makes available on its website at www.GenCorp.com
(and in print to any shareholder who requests them) the
Companys current Code of Business Conduct and the
Companys corporate governance guidelines.
116
Section 16(a) Beneficial Ownership Reporting
Compliance
Information regarding compliance with Section 16(a) of the
Exchange Act is set forth under the heading
Section 16(a) Beneficial Ownership Reporting
Compliance in our 2005 Proxy Statement and is incorporated
herein by reference.
Material Changes for Director Nominee Procedures
Since the date of our 2004 Proxy Statement, our Board of
Directors has not made any material changes to the procedures by
which shareholders of the Company may recommend nominees to our
Board of Directors
Audit Committee and Audit Committee Financial Expert
Information regarding the Audit Committee and the Audit
Committees Financial Expert is set forth under the heading
Board Committees in our 2005 Proxy Statement and is
incorporated herein by reference.
Item 11. Executive
Compensation
Information regarding executive compensation is set forth under
the heading Executive Compensation in our 2005 Proxy
Statement and is incorporated herein by reference. Information
regarding director compensation is set forth under the heading
Director Compensation in our 2005 Proxy Statement
and is incorporated herein by reference. Information regarding
employment contracts, termination of employment and change in
control agreements is set forth under the heading
Employment Contracts and Termination of Employment and
Change in Control Arrangements in our 2005 Proxy Statement
and is incorporated herein by reference. Information regarding
compensation committee interlocks is set forth under the heading
Compensation Committee Interlocks and Insider
Participation in our 2005 Proxy Statement and is
incorporated herein by reference. The Companys Board
Compensation Committee Report on Executive Compensation is set
forth under the heading Report of the Organization &
Compensation Committee of the Board of Directors on Executive
Compensation in our 2005 Proxy Statement and is
incorporated herein by reference. The performance graph required
by this Item is set forth under the heading Performance
Graph in our 2005 Proxy Statement and is incorporated
herein by reference.
|
|
Item 12. |
Security Ownership of Certain Beneficial Owners and
Management and Related Stockholder Matters |
Information regarding the security ownership of certain
beneficial owners and management is set forth under the heading
Security Ownership of Officers and Directors in our
2005 Proxy Statement and is incorporated herein by reference.
117
Equity Compensation Plan Information
The table below sets forth certain information regarding the
following equity compensation plans of the Company, pursuant to
which we have made equity compensation available to eligible
persons, as of November 30, 2004: (i) GenCorp Inc. 1993
Stock Option Plan; (ii) GenCorp Inc. 1997 Stock Option
Plan; and (iii) GenCorp Inc. 1999 Equity and Performance
Incentive Plan. All three plans have been approved by
shareholders.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Number of Securities | |
|
|
|
|
|
|
Remaining Available for | |
|
|
|
|
|
|
Future Issuance Under | |
|
|
Number of Securities to be | |
|
Weighted-Average | |
|
Equity Compensation | |
|
|
Issued Upon Exercise of | |
|
Exercise Price of | |
|
Plans (Excluding | |
|
|
Outstanding Options, | |
|
Outstanding Options, | |
|
Securities Reflected in | |
Plan Category |
|
Warrants and Rights | |
|
Warrants and Rights | |
|
Column (a)) | |
|
|
| |
|
| |
|
| |
|
|
(a) | |
|
(b) | |
|
(c) | |
Equity compensation plans approved by shareholders
|
|
|
2,388,785 |
|
|
$ |
11.10 |
|
|
|
298,660 |
(1) |
Equity compensation plans not approved by shareholders(2)
|
|
|
|
|
|
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total
|
|
|
2,388,785 |
|
|
$ |
11.10 |
|
|
|
298,660 |
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
The number of shares issued as restricted shares, deferred
shares or performance shares is limited under the GenCorp Inc.
1999 Equity and Performance Incentive Plan to 900,000 common
shares and, during any period of three consecutive fiscal years,
the maximum number of common shares covered by awards of
restricted shares, deferred shares or performance shares granted
to any one participant is limited to 900,000 common shares. The
GenCorp Inc. 1999 Equity and Performance Incentive Plan further
provides that no participant may receive an award in any one
calendar year of performance shares or performance units having
an aggregate maximum value as of the date of grant in excess of
$2,000,000. |
|
(2) |
The Company also maintains the GenCorp Inc. and Participating
Subsidiaries Deferred Bonus Plan. This plan allows participating
employees to defer a portion of their compensation for future
distribution. All or a portion of such deferrals may be
allocated to an account based on the Companys common stock
and does permit limited distributions in the form of Company
common shares. However, distributions in the form of common
shares are permitted only at the election of the Organization
& Compensation Committee of the Board of Directors and,
according to the terms of the plan, individuals serving as
officers or directors of the Company are not permitted to
receive distributions in the form of Company common shares until
at least 6 months after such individual ceases to be an
officer or director of the Company. The table does not include
information about this plan because no options, warrants or
rights are available under this plan and no specific number of
shares is set aside under this plan as available for future
issuance. Based upon the price of Company common shares on
November 30, 2004, the maximum number of shares that could
be distributed to employees not subject to the restrictions on
officers and directors(if permitted by the Organization &
Compensation Committee) would be 23,080. |
Item 13. Certain
Relationships and Related Transactions
Information regarding certain transactions and employment
agreements with management is set under the heading
Employment Contracts and Termination of Employment and
Change of Control Arrangements in our 2005 Proxy Statement
and is incorporated herein by reference.
Item 14. Principal
Accountant Fees and Services
Information regarding fees for professional audit services
rendered by Ernst & Young (E&Y) for the audit of our
annual financial statements for the years ended
November 30, 2004 and November 30, 2003, and fees
billed for other services rendered by E&Y during those
periods as well as information regarding the Audit
Committees approval relating to such engagements is
disclosed under the heading Ratification of Independent
Registered Public Accounting Firm and Policy on
Audit Committee Pre-Approval of Audit and
118
Permissible Non-Audit Services of Independent Registered Public
Accounting Firm in our 2005 Proxy Statement and is
incorporated herein by reference.
PART IV
Item 15. Exhibits and
Financial Statement Schedules
The following documents are filed as part of this report:
(a)(1) and (2) FINANCIAL STATEMENTS AND FINANCIAL STATEMENT
SCHEDULES
A listing of financial statements and financial statement
schedules is set forth in a separate section of this report on
page 108 which is incorporated herein by reference.
(a)(3) EXHIBITS
An index of exhibits begins on page 111 of this report which is
incorporated herein by reference.
(b) EXHIBITS
The response to this portion of Item 15 is set forth in a
separate section of this report immediately following the
exhibit index.
(c) FINANCIAL STATEMENT SCHEDULES
All financial statement schedules have been omitted because they
are inapplicable, not required by the instructions or because
the required information is either incorporated herein by
reference or included in the financial statements or notes
thereto included in this report.
119
ANNUAL REPORT ON FORM 10-K
ITEM 15(a)(1)(2) and (3), (c) and (d)
LIST OF FINANCIAL STATEMENTS AND
FINANCIAL STATEMENT SCHEDULES
EXHIBIT INDEX
CERTAIN EXHIBITS
FISCAL YEAR ENDED NOVEMBER 30, 2003
GENCORP INC.
SACRAMENTO, CALIFORNIA 95853-7012
120
GENCORP INC.
Item 15(a)(1) and (2)
Index to Consolidated Financial Statements and Financial
Statement Schedules
|
|
|
|
|
|
|
|
Page | |
|
|
Number | |
|
|
| |
(1) Financial Statements
|
|
|
|
|
The following consolidated financial statements of GenCorp are
included in Part II, Item 8 of this report:
|
|
|
|
|
|
Report of Independent Registered Public Accounting Firm
|
|
|
53 |
|
|
Consolidated Statements of Income for each of the three years in
the period ended November 30, 2004
|
|
|
54 |
|
|
Consolidated Balance Sheets as of November 30, 2004 and 2003
|
|
|
55 |
|
|
Consolidated Statements of Shareholders Equity for each of
the three years in the period ended November 30, 2004
|
|
|
56 |
|
|
Consolidated Statements of Cash Flows for each of the three
years in the period ended November 30, 2004
|
|
|
57 |
|
|
Notes to Consolidated Financial Statements
|
|
|
58 |
|
Consolidated Financial Statement Schedules
All financial statement schedules have been omitted because they
are inapplicable, not required by the instructions or because
the required information is either incorporated herein by
reference or included in the financial statements or notes
thereto included in this report.
121
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the
Securities Exchange Act of 1934, the registrant has duly caused
this report to be signed on its behalf by the undersigned,
thereunto duly authorized.
February 14, 2005
|
|
|
|
|
Terry L. Hall |
|
Chairman of the Board, President and |
|
Chief Executive Officer |
Pursuant to the requirements of the Securities Exchange Act of
1934, this report has been signed below by the following persons
on behalf of the registrant and in the capacities and on the
dates indicated.
|
|
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date | |
|
|
|
|
| |
|
By: |
|
/s/ TERRY L. HALL
Terry
L. Hall |
|
Chairman of the Board, President and Chief Executive
Officer/Director (Principal Executive Officer) |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ YASMIN R. SEYAL
Yasmin
R. Seyal |
|
Senior Vice President, Chief Financial Officer (Principal
Financial Officer and Principal Accounting Officer) |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
J.
Robert Anderson |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
C.
F. Bolden Jr. |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
J.
Gary Cooper |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
James
J. Didion |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
William
K. Hall |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
James
M. Osterhoff |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ *
Steven
G. Rothmeier |
|
Director |
|
|
February 14, 2005 |
|
122
|
|
|
|
|
|
|
|
|
Signature |
|
Title |
|
Date | |
|
|
|
|
| |
|
By: |
|
/s/ *
Sheila
E. Widnall |
|
Director |
|
|
February 14, 2005 |
|
|
By: |
|
/s/ YASMIN R. SEYAL
Yasmin
R. Seyal |
|
Attorney-in-Fact pursuant to Powers of Attorney filed herewith |
|
|
February 14, 2005 |
|
123
EXHIBIT INDEX
|
|
|
|
|
Table | |
|
|
Item No. | |
|
Exhibit Description |
| |
|
|
|
2 |
.1 |
|
Asset Purchase Agreement by and between Aerojet-General
Corporation and Northrop Grumman Systems, dated April 19,
2001 was filed as Exhibit 2.1 to the Companys Current
Report on Form 8-K dated November 5, 2001 (File
No. 1-1520), and is incorporated herein by reference.** |
|
2 |
.2 |
|
Amendment No. 1 to Asset Purchase Agreement by and between
Aerojet and Northrop Grumman, dated September 19, 2001 was
filed as Exhibit 2.2 to the Companys Current Report
on Form 8-K, dated November 5, 2001 (File
No. 1-1520), and is incorporated herein by reference.** |
|
2 |
.3 |
|
Amendment No. 2 to Asset Purchase Agreement by and between
Aerojet and Northrop Grumman, dated October 19, 2001 was
filed as Exhibit 2.3 to the Companys Current Report
on Form 8-K dated November 5, 2001 (File
No. 1-1520), and is incorporated herein by reference.** |
|
2 |
.4 |
|
Amended and Restated Environmental Agreement by and between
Aerojet and Northrop Grumman, dated October 19, 2001 was
filed as Exhibit 2.4 to the Companys Current Report
on Form 8-K dated November 5, 2001 (File
No. 1-1520), and is incorporated herein by reference. |
|
2 |
.5 |
|
Guaranty Agreement by GenCorp Inc. for the Benefit of Northrop
Grumman was filed as Exhibit 2.5 to the Companys
Current Report on Form 8-K dated November 5, 2001
(File No. 1-1520), and is incorporated herein by reference. |
|
2 |
.6 |
|
Purchase Agreement, dated May 2, 2003, between Atlantic
Research Corporation and Aerojet-General Corporation was filed
as Exhibit 10.1 to GenCorp Inc.s Quarterly Report on
Form 10-Q for the fiscal quarter ended May 31, 2003
(File No. 1-1520) and is incorporated herein by reference.** |
|
2 |
.7 |
|
First Amendment to Purchase Agreement, dated August 29,
2003, between Aerojet-General Corporation and Atlantic Research
Corporation was filed as Exhibit 2.2 to GenCorps
Form S-4 Registration Statement dated October 6, 2003
(File No. 333-109518) and is incorporated herein by
reference.** |
|
2 |
.8 |
|
Second Amendment to Purchase Agreement, dated September 30,
2003, between Aerojet-General Corporation and Atlantic Research
Corporation was filed as Exhibit 2.2 to GenCorp Inc.s
Quarterly Report on Form 10-Q for the fiscal quarter ended
August 31, 2003 (File No. 1-1520) and is incorporated
herein by reference.** |
|
2 |
.9 |
|
Third Amendment to Purchase Agreement, dated October 16,
2003, between Aerojet-General Corporation and Atlantic Research
Corporation was filed as Exhibit 2.4 to GenCorps
Amendment No. 1 to Form S-4 Registration Statement
dated December 15, 2003 (file no. 333-109518) and is
incorporated herein by reference.** |
|
2 |
.10 |
|
Stock and Asset Purchase Agreement by and between GDX Holdings
LLC and GenCorp Inc. dated July 16, 2004 (filed as
Exhibit 2.1 to GenCorp Inc.s Current Report on
Form 8-K dated September 7, 2004 (File
No. 1-1520) and incorporated herein by reference).** |
|
2 |
.11 |
|
First Amendment to Stock and Asset Purchase Agreement by and
between GenCorp Inc. and GDX Holdings LLC dated as of
August 31, 2004 (filed as Exhibit 2.2 to GenCorp
Inc.s Current Report on Form 8-K dated
September 7, 2004 (File No. 1-1520) and incorporated
herein by reference).** |
|
2 |
.12 |
|
Second Amendment to Stock and Asset Purchase Agreement by and
between GenCorp Inc. and GDX Holdings LLC dated as of
October 14, 2004 (filed as Exhibit 2.3 to GenCorp
Inc.s Quarterly Report on Form 10-Q for the fiscal
quarter ended August 31, 2004 (File No. 1-1520), as
amended, and incorporated herein by reference).** |
|
3 |
.1 |
|
Amended Articles of Incorporation of GenCorp filed with the
Secretary of State of Ohio on August 7, 2003 was filed as
Exhibit 3.1 to GenCorps Form S-4 Registration
Statement dated October 6, 2003 (File No. 333-109518)
and is incorporated herein by reference. |
|
3 |
.2 |
|
The Amended Code of Regulations of GenCorp, as amended on
March 29, 2000, was filed as Exhibit 3.2 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended August 31, 2000 (File No. 1-1520), and
is incorporated herein by reference. |
|
4 |
.1 |
|
Amended and Restated Rights Agreement (with exhibits) dated as
of December 7, 1987 between GenCorp and Morgan Shareholder
Services Trust Company as Rights Agent was filed as
Exhibit D to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1987
(File No. 1-1520), and is incorporated herein by reference. |
124
|
|
|
|
|
Table | |
|
|
Item No. | |
|
Exhibit Description |
| |
|
|
|
4 |
.2 |
|
Amendment to Rights Agreement among GenCorp, The First Chicago
Trust Company of New York, as resigning Rights Agent and The
Bank of New York, as successor Rights Agent, dated
August 21, 1995, was filed as Exhibit A to the
Companys Annual Report on Form 10-K for the fiscal
year ended November 30, 1995 (File No. 1-1520), and is
incorporated herein by reference. |
|
4 |
.3 |
|
Amendment to Rights Agreement between GenCorp and The Bank of
New York as successor Rights Agent, dated January 20, 1997,
was filed as Exhibit 4.1 to the Companys Current
Report on Form 8-K dated January 20, 1997 (File
No. 1-1520), and is incorporated herein by reference. |
|
4 |
.4 |
|
Indenture dated April 5, 2002 between GenCorp and The Bank
of New York, as trustee, relating to GenCorps
53/4% Convertible
Subordinated Notes due 2007 was filed as Exhibit 4.4 to
GenCorps Form S-3 Registration Statement
No. 333-89796 dated June 4, 2002 and is incorporated
herein by reference. |
|
4 |
.5 |
|
Form of
53/4% Convertible
Subordinated Notes (included in Exhibit 4.4) was filed as
Exhibit 4.6 to GenCorps Form S-3 Registration
Statement No. 333-89796 dated June 4, 2002 and is
incorporated herein by reference. |
|
4 |
.6 |
|
Indenture, dated as of August 11, 2003, between GenCorp
Inc., the Guarantors named therein and The Bank of New York as
trustee was filed as Exhibit 4.1 to GenCorps
Form S-4 Registration Statement dated October 6, 2003
(File No. 333-109518) and is incorporated herein by
reference. |
|
4 |
.7 |
|
Registration Rights Agreement, dated as of August 11, 2003,
among GenCorp, the Guarantors named therein and the Initial
Purchasers named therein was filed as Exhibit 4.2 to
GenCorps Form S-4 Registration Statement dated
October 6, 2003 (File No. 333-109518) and is
incorporated herein by reference. |
|
4 |
.8 |
|
Form of Initial
91/2% Senior
Subordinated Notes (included in Exhibit 4.7) was filed as
Exhibit 4.3 to GenCorps Form S-4 Registration
Statement dated October 6, 2003 (File No. 333-109518)
and is incorporated herein by reference. |
|
4 |
.9 |
|
Form of
91/2% Senior
Subordinated Notes (included in Exhibit 4.7) was filed as
Exhibit 4.4 to GenCorps Form S-4 Registration
Statement dated October 6, 2003 (File No. 333-109518)
and is incorporated herein by reference. |
|
4 |
.10 |
|
First Supplemental Indenture dated as of October 29, 2004
to the Indenture between GenCorp Inc. and The Bank of New York,
as trustee relating to GenCorps
91/2% Senior
Subordinated Notes due 2013 (filed as Exhibit 10.1 to
GenCorp Inc.s Current Report on Form 8-K dated
November 1, 2004 (File No. 1-1520) and incorporated
herein by reference). |
|
4 |
.11 |
|
Indenture dated January 16, 2004 between GenCorp and The
Bank of New York, as trustee, relating to GenCorps 4%
Contingent Convertible Subordinated Notes due 2024 was filed as
Exhibit 4.11 to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 2003
(File No. 1-1520) and is incorporated herein by reference. |
|
4 |
.12 |
|
Registration Rights Agreement dated January 16, 2004 by and
among GenCorp, Deutsche Bank Securities Inc., Wachovia Capital
Markets, LLC, Scotia Capital (USA) Inc., BNY Capital Markets,
Inc., NatCity Investments, Inc. and Wells Fargo Securities, LLC
was filed as Exhibit 4.12 to the Companys Annual
Report on Form 10-K for the fiscal year ended
November 30, 2003 (File No. 1-1520) and is
incorporated herein by reference. |
|
4 |
.13 |
|
Form of 4% Contingent Convertible Subordinated Notes was filed
as Exhibit 4.13 (and included in Exhibit 4.11) to the
Companys Annual Report on Form 10-K for the fiscal
year ended November 30, 2003 (File No. 1-1520) and is
incorporated herein by reference. |
|
4 |
.14 |
|
Indenture, dated as of November 23, 2004, between GenCorp
Inc. and The Bank of New York Trust Company, N.A., as trustee
relating to GenCorp Inc.s
21/4% Convertible
Subordinated Debentures due 2024 (filed as Exhibit 4.01 to
GenCorp Inc.s Current Report on Form 8-K dated
November 23, 2004 (File No. 1-1520), as amended, and
incorporated herein by reference). |
|
4 |
.15 |
|
Registration Rights Agreement, dated as of November 23,
2004, by and between GenCorp Inc. and Wachovia Capital Markets,
LLC, as representative for the several initial purchasers of the
21/4% Convertible
Subordinated Debentures due 2024 (filed as Exhibit 4.14 to
GenCorp Inc.s Form S-3 Registration Statement dated
January 11, 2005 (File No. 333-121948) and
incorporated herein by reference). |
125
|
|
|
|
|
Table | |
|
|
Item No. | |
|
Exhibit Description |
| |
|
|
|
4 |
.16 |
|
Form of
21/4% Convertible
Subordinated Debenture (filed as Exhibit 4.02 to GenCorp
Inc.s Current Report on Form 8-K dated
November 23, 2004 (File No. 1-1520), as amended, and
incorporated herein by reference). |
|
10 |
.1 |
|
Distribution Agreement dated September 30, 1999 between
GenCorp Inc. and OMNOVA Solutions Inc. (OMNOVA) was filed as
Exhibit B to the Companys Annual Report on
Form 10-K for the fiscal year ended November 19, 1999
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.2 |
|
Tax Matters Agreement dated September 30, 1999 between
GenCorp and OMNOVA was filed as Exhibit C to the
Companys Annual Report on Form 10-K for the fiscal
year ended November 30, 1999 (File No 1-1520), and is
incorporated herein by reference. |
|
10 |
.3 |
|
Alternative Dispute Resolution Agreement dated
September 30, 1999 between GenCorp and OMNOVA was filed as
Exhibit D to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1999
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.4 |
|
Agreement to Amend and Restate dated as of October 2, 2002,
among GenCorp, The Bank of Nova Scotia as Documentation Agent,
ABN AMRO Ban, N.V., as Syndication Agent, and Deutsche Bank
Trust Company Americas (f/k/a Bankers Trust Company), as
Administrative Agent together with Annex I which is the
Amended and Restated Credit Agreement among GenCorp Inc., as the
Borrower, Deutsche Bank Trust Company Americas, as
Administrative Agent, ABM AMRO Bank, N.V., as Syndication Agent,
Deutsche Bank Securities Inc. and ABM AMRO Incorporated, as
Joint Lead Arrangers, The Bank of Nova Scotia, as Documentation
Agent and various lending institutions dated as of
December 28, 2002 and amended and restated as of
October 2, 2002 was filed as Exhibit 10.3 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended August 31, 2002 (File No. 1-1520) and is
incorporated herein by reference. |
|
10 |
.5 |
|
Amendment No. 1 to Amended and Restated Credit Agreement
and Limited Waiver and Consent, dated July 29, 2003, among
GenCorp, Deutsche Bank Trust Company Americas (f/k/a Bankers
Trust Company), for itself, as a Lender, and as Administrative
Agent for the Lenders, and the other Lenders signatory thereto
was filed as Exhibit 10.1 to GenCorps Form S-4
Registration Statement dated October 6, 2003 (File
No. 333-109518) and is incorporated herein by reference. |
|
10 |
.6 |
|
Amendment No. 2 to Amended and Restated Credit Agreement,
dated August 25, 2003, among GenCorp, Deutsche Bank Trust
Company Americas (f/k/a Bankers Trust Company), for itself, as a
Lender, and as Administrative Agent for the Lenders, and the
other Lenders signatory thereto was filed as Exhibit 10.2
to GenCorps Form S-4 Registration Statement dated
October 6, 2003 (File No. 333-109518) and is
incorporated herein by reference. |
|
10 |
.7 |
|
Amendment No. 3 to Amended and Restated Credit Agreement,
dated December 31, 2003, among GenCorp, Deutsche Bank Trust
Company Americas (f/k/a Bankers Trust Company), for itself, as a
Lender, and as Administrative Agent for the Lenders, and the
other Lenders signatory thereto, was filed as Exhibit 10.8
to the Companys Annual Report on Form 10-K for the
fiscal year ended November 30, 2003 (File No. 1-1520)
and is incorporated herein by reference. |
|
10 |
.8 |
|
Amendment No. 4 to Amended and Restated Credit Agreement,
Consent and Waiver dated as of August 30, 2004 by and among
GenCorp Inc., Deutsche Bank Trust Company Americas, for itself,
as a Lender, and as Administrative Agent for the Lenders, and
the other Lenders signatory thereto (filed as Exhibit 10.1
to GenCorp Inc.s Current Report on Form 8-K dated
August 31, 2004 (File No. 1-1520) and incorporated
herein by reference). |
|
10 |
.9 |
|
Amendment No. 5 to Amended and Restated Credit Agreement,
Consent and Waiver dated October 13, 2004 and effective as
of August 30, 2004 by and among GenCorp Inc., Deutsche Bank
Trust Company Americas, for itself, as a Lender, and as
Administrative Agent for the Lenders, and the other Lenders
signatory thereto, was filed as Exhibit 10.2 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended August 31, 2004 (File No. 1-1520) and is
incorporated herein by reference. |
|
10 |
.10 |
|
Amendment No. 6 to Amended and Restated Credit Agreement,
Consent and Waiver dated November 3, 2004 and effective as
of November 18, 2004 by and among GenCorp Inc., Deutsche
Bank Trust Company Americas, for itself, as a Lender, and as
Administrative Agent for the Lenders, and the other Lenders
signatory thereto, was filed as Exhibit 10.1 to GenCorp
Inc.s Current Report on Form 8-K dated
November 22, 2004 (File No. 1-1520) and is
incorporated herein by reference. |
126
|
|
|
|
|
Table | |
|
|
Item No. | |
|
Exhibit Description |
| |
|
|
|
10 |
.11 |
|
Amendment No. 7 to Amended and Restated Credit Agreement,
Consent and Waiver dated November 3, 2004 among GenCorp
Inc., Deutsche Bank Trust Company Americas, for itself, as a
Lender, and as Administrative Agent for the Lenders, and the
other Lenders signatory thereto, was filed as Exhibit 10.1
to GenCorp Inc.s Current Report on Form 8-K dated
November 8, 2004 (File No. 1-1520) and is incorporated
herein by reference. |
|
10 |
.12 |
|
Credit Agreement, dated as of December 6, 2004, among
GenCorp, as the Borrower, each of those Material Domestic
Subsidiaries of the Borrower identified as a
Guarantor on the signature pages thereto and such
other Material Domestic Subsidiaries of the Borrower as may from
time to time become a party thereto, the several banks and other
financial institutions from time to time parties to such Credit
Agreement, and Wachovia Bank, National Association, a national
banking association, as Administrative Agent, was filed as
Exhibit 10.1 to GenCorp Inc.s Current Report on
Form 8-K dated December 8, 2004 (File No. 1-1520)
and is incorporated herein by reference. |
|
10 |
.13 |
|
Modified Employment Retention Agreement dated July 26,
2002, between the Company and Robert A. Wolfe was filed as
Exhibit 10.39 to the Companys Annual Report on Form
10-K for the fiscal year ended November 30, 2002 (File
No. 1-1520), and is incorporated herein by reference. |
|
10 |
.14 |
|
GenCorp 1996 Supplemental Retirement Plan for Management
Employees effective March 1, 1996 was filed as
Exhibit B to the Companys Annual Report on Form 10-K
for the fiscal year ended November 30, 1996 (File
No. 1-1520), and is incorporated herein by reference. |
|
10 |
.15 |
|
Benefits Restoration Plan for Salaried Employees of GenCorp Inc.
and Certain Subsidiary Companies as amended and restated
effective December 1, 1986, was filed as Exhibit G to
the Companys Annual Report on Form 10-K for the fiscal
year ended November 30, 1987 (File No. 1-1520), and is
incorporated herein by reference. |
|
10 |
.16 |
|
Information relating to the Deferred Bonus Plan of GenCorp Inc.
is contained in Post-Effective Amendment No. 1 to
Form S-8 Registration Statement No. 2-83133 dated
April 18, 1986 and is incorporated herein by reference. |
|
10 |
.17 |
|
Amendment to the Deferred Bonus Plan of GenCorp Inc. effective
as of April 5, 1987, was filed as Exhibit I to the
Companys Annual Report on Form 10-K for the fiscal year
ended November 30, 1987 (File No. 1-1520), and is
incorporated herein by reference. |
|
10 |
.18 |
|
GenCorp Inc. Deferred Compensation Plan for Nonemployee
Directors effective January 1, 1992 was filed as
Exhibit A to the Companys Annual Report on Form 10-K
for the fiscal year ended November 30, 1991 (File
No. 1-1520), and is incorporated herein by reference. |
|
10 |
.19 |
|
GenCorp Inc. 1993 Stock Option Plan effective March 31,
1993 was filed as Exhibit 4.1 to Form S-8 Registration
Statement No. 33-61928 dated April 30, 1993 and is
incorporated herein by reference. |
|
10 |
.20 |
|
GenCorp Inc. 1997 Stock Option Plan effective March 26,
1997 was filed as Exhibit 4.1 to Form S-8 Registration
Statement No. 333-35621 dated September 15, 1997 and
is incorporated herein by reference. |
|
10 |
.21 |
|
GenCorp Inc. 1999 Equity and Performance Incentive Plan was
filed as Exhibit H to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1999 (File
No. 1-1520), and is incorporated herein by reference. |
|
10 |
.22 |
|
GenCorp Inc. Executive Incentive Compensation Program, amended
September 8, 1995 to be effective for the 1996 fiscal year
was filed as Exhibit E to the Companys Annual Report
on Form 10-K for the fiscal year ended November 30,
1997 (File No. 1-1520), and is incorporated herein by
reference. |
|
10 |
.23 |
|
2001 Supplemental Retirement Plan For GenCorp Executives
effective December 1, 2001, incorporating the
Companys Voluntary Enhanced Retirement Program was filed
as Exhibit 10.29 to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 2001 (File
No. 1-1520) and is incorporated herein by reference. |
|
10 |
.24 |
|
Form of Restricted Stock Agreement between the Company and
Nonemployee Directors providing for payment of part of
Directors compensation for service on the Board of
Directors in Company stock was filed as Exhibit 10.1 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended February 28, 1998 (File No. 1-1520), and
is incorporated herein by reference. |
127
|
|
|
|
|
Table | |
|
|
Item No. | |
|
Exhibit Description |
| |
|
|
|
10 |
.25 |
|
Form of Restricted Stock Agreement between the Company and
Nonemployee Directors providing for payment of part of
Directors compensation for service on the Board of
Directors in Company stock was filed as Exhibit 10.1 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended February 28, 1999 (File No. 1-1520), and
is incorporated herein by reference. |
|
10 |
.26* |
|
Form of Restricted Stock Agreement between the Company and
Directors or Employees for grants of time-based vesting of
restricted stock under the GenCorp Inc. 1999 Equity and
Performance Incentive Plan. |
|
10 |
.27* |
|
Form of Stock Appreciation Rights Agreement between the Company
and Employees for grants of stock appreciation rights under the
GenCorp Inc. 1999 Equity and Performance Incentive Plan. |
|
10 |
.28* |
|
Form of Stock Appreciation Rights Agreement between the Company
and Directors for grants of stock appreciation rights under the
GenCorp Inc. 1999 Equity and Performance Incentive Plan. |
|
10 |
.29* |
|
Form of Restricted Stock Agreement between the Company and
Employees for grants of performance-based vesting of restricted
stock under the GenCorp Inc. 1999 Equity and Performance
Incentive Plan. |
|
10 |
.30 |
|
Form of Director Nonqualified Stock Option Agreement between the
Company and Nonemployee Directors providing for annual grant of
nonqualified stock options prior to February 28, 2002,
valued at $30,000 was filed as Exhibit 10.1 to the
Companys Quarterly Report on Form 10-Q for the fiscal
quarter ended May 31, 2002 (File No. 1-1520), and is
incorporated herein by reference. |
|
10 |
.31 |
|
Form of Director Nonqualified Stock Option Agreement between the
Company and Nonemployee Directors providing for an annual grant
of nonqualified stock options on or after February 28,
2002, valued at $30,000 in lieu of further participation in
Retirement Plan for Nonemployee Directors was filed as
Exhibit 10.2 to the Companys Quarterly Report on
Form 10-Q for the fiscal quarter ended May 31, 2002
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.32 |
|
Form of Director and Officer Indemnification Agreement was filed
as Exhibit L to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1999
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.33 |
|
Form of Director Indemnification Agreement was filed as
Exhibit M to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1999
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.34 |
|
Form of Officer Indemnification Agreement was filed as
Exhibit N to the Companys Annual Report on
Form 10-K for the fiscal year ended November 30, 1999
(File No. 1-1520), and is incorporated herein by reference. |
|
10 |
.35 |
|
Form of Severance Agreement granted to certain executive
officers of the Company was filed as Exhibit D to the
Companys Annual Report on Form 10-K for the fiscal
year ended November 30, 1997 (File No. 1-1520), and is
incorporated herein by reference. |
|
21 |
.1* |
|
Subsidiaries of the Company. |
|
23 |
.1* |
|
Consent of Independent Registered Public Accounting Firm. |
|
24 |
.1* |
|
Powers of Attorney executed by J. R. Anderson, C. F.
Bolden Jr., J. G. Cooper, J. J. Didion, W. K.
Hall, J. M. Osterhoff, S. G. Rothmeier, and S. E.
Widnall, Directors of the Company. |
|
31 |
.1* |
|
Certification of Principal Executive Officer pursuant to
Rule 13a-14(a) of the Securities Exchange Act of 1934, as
amended. |
|
31 |
.2* |
|
Certification of Principal Financial Officer pursuant to
Rule 13a-14(a) of the Securities Exchange Act of 1934, as
amended. |
|
32 |
.1* |
|
Certification of Principal Executive Officer and Principal
Accounting Officer pursuant to Rule 13a-14(b) under the
Securities Exchange Act of 1934 as amended, and 18 U.S.C.
1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002. |
|
|
|
|
* |
Filed herewith. All other exhibits have been previously filed. |
|
|
** |
Schedules and Exhibits have been omitted, but will be furnished
to the SEC upon request. |
128